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The Rockefeller University 2021 
 
 Tissue stem cells (SCs) maintain, regenerate, and repair the body over the course of an 
organism’s lifetime. To preserve their long-term function, SCs must exert precise control over 
their cell state dynamics as they move from quiescence to activation and commit to full 
differentiation. My graduate research has been centered on investigating the molecular 
mechanisms that fuel these transitions in melanocyte stem cells (McSCs), a unique neural crest-
derived SC population located in the hair follicle (HF). Through periodic bouts synchronous with 
HF cycling, quiescent McSCs become activated to proliferate, giving rise to committed 
proliferative progeny (McCP) that differentiate into mature pigment-producing melanocytes. The 
signaling factors and gene expression programs that orchestrate these cellular changes are still 
incompletely understood. To elucidate new insights into this process, I developed fluorescence-
activated cell sorting strategies to isolate quiescent, activated, and differentiating McSC lineage 
cells from the mouse skin at discrete stages of the hair cycle. I then performed single cell RNA-
sequencing (scRNA-seq) to reveal the evolving transcriptional signatures of the lineage with high 
resolution. Comparative bioinformatic analyses suggested that BMP and WNT signaling increase 
concomitantly throughout differentiation. I then sought to understand the role of BMP signaling 
in McSC lineage progression and whether this pathway engages in crosstalk with WNT signaling. 
To do so, I performed conditional lineage-specific genetic ablation of Bmpr1a to extinguish BMP 
signaling, which resulted in gray hair. However, McSCs remained intact and functional in these 
mutant animals, indicating dysfunction in their differentiating progeny. ScRNA-seq and 
pseudotime analysis of Bmpr1a null cells indicated a block in the differentiation program just 
downstream of the early McCP stage, and I detected further signs of melanocyte immaturity using 
immunofluorescence and electron microscopy analyses. Seeking mechanistic understanding, I 
interrogated changes in transcription factor expression at this blockage point. I found reduced 
nuclear levels of the master regulator MITF and WNT mediator LEF1. Using WNT mutant mouse 
models, cell culture systems, and chromatin profiling, I provide evidence demonstrating 
cooperation of BMP and WNT signaling to trigger complete differentiation of McCP into 
melanocytes through MITF and LEF1 activity. Altogether, I have generated a thorough 
characterization of the transcriptional and chromatin landscape changes that temporally define 
McSC lineage commitment in vivo. My findings underscore a critical role for signaling through 
BMPR1a to achieve full melanocyte differentiation in the HF. These findings raise intriguing 
questions about the role of BMP in hair and coat color variation, age-related hair graying, and 
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1.1 Melanocytes and their embryonic origins 
 
 Looking across the animal kingdom, there is astonishing variety in hair, fur, skin, and 
feather pigmentation and patterning. These shades and their unique organization have myriad 
functions including protection from ultraviolet (UV) light, thermoregulation, camouflage, sexual 
selection, and communication (Caro and Mallarino, 2020). Underlying this phenotypic diversity 
are melanocytes, a specialized cell type found in vertebrates that synthesize and transfer black-
brown eumelanin and red-yellow pheomelanin pigment (Mort et al., 2015). Given the overt visible 
effects induced by changes in this lineage, melanocytes and their precursor cells have long been 
an attractive system for developmental and cell biologists and geneticists to harness. From the 
wide array of coat colors in “fancy mice” to animals recapitulating human cancer and disease, mice 
continue to be an excellent model organism in which to study this unique lineage.  
 The cells that terminally differentiate into melanocytes initially emerge during embryonic 
development from the trunk region of the neural crest. A small number of founder progenitor cells 
called melanoblasts are specified in a process governed chiefly by WNT signaling (Luciani et al., 
2011; Thomas and Erickson, 2008). WNT induces neural crest formation and also directs 
downstream specification of melanoblasts. WNT1 and WNT3a ligands are expressed in the dorsal 
neural tube, and double knockout (KO) mice show defects in melanocyte specification, along with 
other neural crest-derived lineages (Ikeya et al., 1997). Consistently, neural crest-specific KO of 
downstream WNT mediator β-catenin using Wnt1-Cre causes loss of melanocytes (Hari et al., 
2002; Hari et al., 2012). BMP signaling appears to act antagonistically, and BMP4 is 
downregulated in the neural tube at the time of melanoblast specification. Cultured neural crest 
cells treated with WNT3a adopt a melanocyte fate, while BMP4 drives cells instead towards a 




melanocyte and glial fated cells, while WNT/β-catenin activates the master regulator of the 
melanocyte lineage microphthalmia-associated transcription factor (MITF) (Dorsky et al., 2000; 
Takeda et al., 2000). Differentiation between these two lineages occurs via FOXD3, which 
represses MITF to favor neuron and glial cell fates (Thomas and Erickson, 2009). SOX10 and 
PAX3 then in turn regulate MITF (Potterf et al., 2000). 
 Around embryonic day (E) 9 in mice, melanoblasts begin to depart from the neural crest 
and embark on a spectacular migratory journey to colonize their destination niches throughout the 
body. They move along two major routes:  the dorsolateral and ventral pathways. In the more well-
characterized dorsolateral pathway, melanoblasts travel between the somites and ectoderm in what 
appears to be a first wave of migration (Erickson and Goins, 1995). It was later discovered that 
bipotent precursor cells with the capacity to differentiate into either melanoblasts or Schwann cells 
migrate along developing nerve sheaths in a second wave to populate the limbs with melanocytes 
(Adameyko et al., 2009). In cells migrating along the dorsolateral pathway, the expression of 
lineage-specific markers such as MITF and melanogenic enzyme dopachrome tautomerase (DCT) 
occurs around E10.5 (Larue et al., 2013; Mort et al., 2015).  
 By E11.5, melanoblasts begin to cross the basement membrane from the dermis to invade 
the epidermis. Their migration and invasion relies on several cytoskeletal organization factors such 
as RAC1 (Li et al., 2011; Mort et al., 2015). Outside of intrinsic migratory factors, melanoblasts 
presumably require external guidance cues to find the epidermis, although the identity and timing 
of such factors are largely unknown. However, evidence from 3-dimensional culture systems 
suggests that the membrane-bound form of stem cell factor (SCF, also known as kit ligand, KITL) 




juncture (Tabone-Eglinger et al., 2012). While many melanoblasts cross into and expand in the 
epidermis, a subset of cells persist in the dermis.  
 As melanoblasts migrate throughout the developing embryo, they undergo massive 
proliferation (Larue et al., 2013). Again, WNT/β-catenin signaling is critical here, driving 
proliferation in both the epidermal and dermal compartments (Luciani et al., 2011). Lineage-
specific ablation studies in vivo have revealed other key genes and pathways regulating 
melanoblast migration and proliferation, with mutant animals displaying loss of pigmentation and 
white spotting phenotypes. Endothelin 3 (EDN3) is expressed in mesenchymal cells and signals 
through endothelin receptor-B (EDNRB) on melanoblasts, driving their proliferation in the dermis 
as well as their migration (Larue et al., 2013; Lee et al., 2003; Shin et al., 1999). SCF/c-KIT 
signaling also plays an essential role in proliferation, as well as in cell survival and migration 
(Yoshida et al., 1996a, Yoshida et al., 1996b). This crucial ligand is expressed by the mesenchyme 
and epidermis during embryonic development, driving melanoblast expansion specifically once 
cells reach the epidermis. 
 By E15.5, melanoblasts cluster around developing hair follicles (HFs) and sweat glands 
through a process that is still poorly characterized. There is some evidence that the chemokine 
receptor CXCR4 expressed on melanoblasts plays a role in their positioning, as disruption of this 
receptor in vivo results in melanoblasts aggregating abnormally in the epidermis. In culture, the 
CXCR4 ligand SDF-1 functions as a chemoattractant (Belmadani et al., 2009). Experiments using 
Dct-LacZ embryonic skin explants and ligand-coated beads demonstrated that while SCF serves 
as a chemokinetic factor facilitating melanoblast migration, it does not act as an attractive force 




that a plethora of other factors in addition to SDF-1 and SCF instruct melanoblast localization to 
their target destinations. 
 Once at the HFs, these progenitors migrate towards the base of the down-growing hair bulb 
and continue to differentiate into pigment-producing melanocytes that supply melanin for the first 
round of hair growth. However, a fraction of the migrating melanoblasts associate with the mid-
portion of the HF in a specialized region known as the bulge where hair follicle stem cells (HFSCs) 
reside. Here, melanoblasts are maintained in an immature and quiescent state. It is still not 
understood how these colonizing melanoblasts initially become segregated into two compartments 
of bulge-associated immature and hair bulb matrix-associated differentiating cells.  
 The major localization of melanocytes is the skin, where they reside in both HFs and the 
basal layer of the epidermis. However, melanocytes are found in other organs, including the eye, 
inner ear, brain, and heart. While their primary purpose is to generate melanin pigment for UV 
protection, their unexpected locations in other sites throughout the body seem to suggest that 
melanocytes may have surprising auxiliary functions. While melanocytes in the kidney marrow of 
fish shield hematopoietic stem and progenitor cells from UV damage (Kapp et al., 2018), 
analogous to their role in the skin, conversely, melanocytes in the ear are actually critical for 
hearing and are thought to modulate the chemical composition of endolymph (Price and Fisher, 
2001). Future studies on these unconventional melanocyte-lineage populations may lend further 
insight into other potential roles these cells play in the skin.  
 
1.2 Tissue melanocyte stem cells (McSCs) and their progeny in the HF 
  
 Adult tissue-specific stem cells (SCs) are populations of long-lived cells that maintain and 




decades, researchers posited that a pool of SCs must exist in order to replenish the melanocytes of 
the HF, which are eliminated at the end of each hair cycle (Nishimura, 2011). Furthermore, so-
called “amelanotic melanocytes” were observed in the ORS of human HFs (Staricco, 1959). In 
2002, Nishimura et al. demonstrated that the melanoblasts that initially localize to the bulge region 
fulfill the criteria for tissue SCs. These Dct-LacZ+ cells remained immature and unpigmented 
through adulthood and were slow-cycling, as demonstrated by their ability to retain 
bromodeoxyuridine (BrdU) in pulse-chase experiments. After depletion of their differentiating 
progeny with KIT blocking antibody, these immature cells in the bulge survived and were able to 
both self-renew and repopulate the hair bulb compartment with differentiating melanocytes in the 
subsequent hair cycle. In hair reconstitution assays using whisker follicle fragments, only implants 
with the lower permanent portion of HFs (where these undifferentiated Dct-LacZ+ cells were 
localized) gave rise to pigmented hair in albino animals. This population of cells are hence referred 
to as melanocyte stem cells (McSCs) (Nishimura et al., 2002; Nishimura, 2011) 
 To achieve growth of pigmented hair, HFSCs, which fuel the growth and regeneration of 
the HF, and McSCs must coordinate their behavior. Hair growth occurs through stages of rest, 
active growth, and regression (Fig. 1.1) (Gonzales and Fuchs, 2017). In telogen, hair follicles are 
at rest, with both HFSCs and neighboring McSCs in quiescence. At the onset of anagen, or active 
hair growth, HFSCs at the base of the bulge and nearby McSCs become activated to proliferate. 
HFSCs of the hair germ (HG) give rise to short-lived proliferative progeny that envelope the 
mesenchymal dermal papilla (DP), forming a hair bulb of matrix cells. HFSCs in the bulge 
generate the downward growing outer root sheath (ORS), creating distance from the proliferating 
hair bulb and DP and restoring quiescence to the bulge and upper ORS compartments (Hsu et al., 




window of proliferation to give rise to committed, proliferative progeny (McCP). The McCP 
become spatially segregated from the SC compartment and associate with the DP and hair matrix. 
Here in the hair bulb, McCP continue to differentiate into melanocytes that produce and transfer 
pigment to neighboring hair cells, imparting color to the growing hair. Finally, in catagen, the 
destructive phase of the hair cycle, mature melanocytes undergo apoptosis alongside the lower two 
thirds of the follicle (Tobin et al., 1998).  
 
Figure 1.1 McSCs undergo periodic bouts of quiescence, activation, and differentiation 
throughout the hair cycle.  
 
 Hair cycling in mice is highly predictable and can be easily tracked and manipulated 
through method such as hair plucking, which induces anagen. Given that the tissue SC populations 
residing in the HF exhibit periodic bouts of activity in sync with cycling, the mouse skin is an 
excellent system with which to temporally investigate SC quiescence (reversible cell cycle exit), 
activation (proliferation), lineage commitment, and differentiation in vivo. While HFSCs have 









          













McSCs. Here, mouse models present an additional advantage, because unlike human skin, mouse 
back skin lacks epidermal melanocytes. Unlike the melanocyte progeny generated by McSCs in 
the HF, epidermal melanocytes divide infrequently and produce and transfer melanin depending 
on the skin’s UV exposure (Davis et al., 2019). Therefore, the mouse skin provides a simplified 
system in which to specifically probe McSCs and their lineage. A more complete understanding 
of melanocyte lineage progression under homeostatic conditions is a critical prerequisite to 
achieving greater insight into melanocyte-related pathologies like melanoma and eventually 
developing novel therapeutic approaches for such conditions. 
 
1.3 Key regulators of McSC quiescence, activation, and melanocyte differentiation  
 
 Tissue SCs protect their long term potential through precisely controlling their transitions 
between quiescence, activation, and differentiation. Like Muscle SCs, hematopoietic SCs, neural 
SCs, and HFSCs, McSCs exhibit periodic activity (van Velthoven and Rando, 2019). 
Dysregulation of the cellular states of SCs occurs during aging and can contribute to declining 
tissue repair and fitness, as well as in disease states characterized by excessive cell proliferation, 
such as cancer. Regulation of these states and the transitions between them occurs at both the cell 
intrinsic and extrinsic levels. 
 Lineage and cell state-specific TF expression is a defining feature of cell-intrinsic 
regulation. Master regulator MITF directs diverse cellular processes at all stages of development, 
including survival, proliferation, and melanocyte differentiation (Goding and Arnheiter, 2019). It 
coordinates these myriad functions by acting differently at low, medium, and high levels (Carreira 
et al., 2006), as well as by interacting with other TFs (Goding and Arnheiter, 2019). Its expression 




2000). In McSCs, PAX3 is thought to both restrict lineage potential and prevent differentiation 
(Lang et al., 2005). SOX10 is necessary for McSC maintenance, but if levels are too high, SCs 
prematurely differentiate and are lost  (Harris et al., 2013). In addition to these critical TFs, 
expression of the anti-apoptotic protein BCL2 is necessary for McSC maintenance and is 
especially critical as cells return to quiescence (Nishimura et al., 2005). During McSC activation, 
B-RAF and C-RAF kinases together are essential for cell cycle entry (Valluet et al., 2012). 
 Ultimately, the role of the niche and the extrinsic cues it provides are indispensable for the 
appropriate regulation of McSC activity, converging on these TFs to control cellular behavior. 
Functional studies in mice have demonstrated that neighboring HFSCs to which McSCs adhere 
are a crucial component of their specialized microenvironment. HFSCs express the 
hemidesmosomal transmembrane collagen, COL17A1, which is essential for their maintenance, 
quiescence, and expression of transforming growth factor beta (TGF-β) (Tanimura et al., 2011). 
While COL17A1 is essential for the structural integrity of the McSC niche, TGF-β from HFSCs 
promotes McSC quiescence (Nishimura et al., 2010; Tanimura et al., 2011). Cell-cell interactions 
are again important for Notch signaling, which is necessary for McSC maintenance (Moriyama et 
al., 2006; Schouwey et al., 2007). At the same time, Notch signaling through RBP-J in HFSCs 
regulates levels of retinoic acid, changes in which sensitize McSCs to differentiation (Lu et al., 
2020). 
 At the onset of anagen, WNT/β-catenin signaling activates both HFSCs and McSCs. 
Additional crosstalk occurs here, as activated HFSCs secrete EDN-1 which further induces McSC 
proliferation (Rabbani et al., 2011; Takeo et al., 2016). Loss of the TF NFIB in HFSCs leads to 
expression of EDN-2, causing expansion of McSCs and precocious differentiation (Chang et al., 




signaling continue to be essential, as mice lacking β-catenin in the melanocyte lineage show 
reduced proliferation of McSCs in the bulge as well as in their progeny in the hair bulb, which fail 
to fully differentiate (Rabbani et al., 2011). Proliferating and differentiating lineage cells (McCP) 
express c-KIT receptor, and overexpression of its ligand stem cell factor (SCF) increases the 
number of melanocytes in the hair bulb. Conversely, interrupting this signaling cascade with c-
KIT blocking antibody induces hair graying due to reduced melanocytes and impaired 
differentiation (Botchkareva et al., 2001). In their landmark study identifying McSCs, Nishimura 
et al. (2002) employed this blocking antibody to show that McSCs persist and replenish 
differentiating progeny in subsequent hair cycles. Later, Krox20-expressing hair shaft progenitors 
in the matrix were found to be a key source of essential SCF that fuels melanocyte differentiation 
(Liao et al., 2017). 
 However, HFSCs and their lineage are not the only niche cell types that influence McSC 
activity. Groundbreaking work by Zhang et al. (2020) investigating the link between stress and 
hair graying revealed the influence of sympathetic nerves on McSC activity. qMcSCs express 
ADRB2, which receive stress signals from nerves via the neurotransmitter norepinephrine, 
inducing proliferation, migration, and differentiation out of the bulge niche. The mesenchymal DP 
of the HF is also a key regulator and source of SCF (Yoshida et al., 1996). Wnt/β-catenin activity 
in the DP directs pigment-type production in melanocytes via agouti signaling protein (ASIP) or 
agouti-inhibitor corin expression. Melanocortin 1 receptor (MC1R) is expressed on melanocyte 
lineage cells and binds either alpha-melanocyte-stimulating hormone α-MSH or ASIP to induce 





 The melanocyte lineage can also be regulated on a systemic level. Hormones like 
proopiomelanocortin (POMC)-derived neuropeptides adrenocorticotropic hormone (ACTH) and 
several MSHs are produced in the pituitary gland and can induce pigment production in 
melanocytes of the skin (Ito et al., 2005; Suzuki et al., 1996). Interestingly, a form of epidermal 
hyperpigmentation known as melasma can be triggered by fluctuations in sex hormones from 
pregnancy or medication (Filoni et al., 2019). There is also evidence of an emerging role of McSC 
crosstalk with the innate immune system via MITF (Harris et al., 2018). 
 Throughout the animal kingdom, regulators of the McSC lineage are manipulated to 
achieve hair color variations and patterns with functions beyond UV protection, including 
camouflage, inter- and intra-species signaling, mating rituals, and thermoregulation. Different 
colors can be achieved through loss of key components of pigment production (i.e. mutation of 
Tyr in CD-1 mice, resulting in albinism), or through more global mechanisms impacting the McSC 
differentiation trajectory. For example, the back stripe pattern of the African mouse Rhabdomys 
pumilio is achieved through differential expression of the TF Alx3, which suppresses MITF-
induced differentiation to produce regions with lighter hair (Mallarino et al., 2016). Differential 
regulation and timing of SC activity and differentiation to achieve patterning has also been 
demonstrated in birds, where nonpigmented melanocyte progenitors in the lower bulge region of 
feather follicles periodically give rise to transit-amplifying progeny that differentiate as they move 
upward into the so-called barb region (Lin et al., 2013). 
 
1.4 Dysfunction in McSCs and their lineage in aging and disease 
 
 As is the case for other tissue SC types throughout the body, dysfunction in how and when 




correcting abnormalities in this lineage stem from cosmetic to life-saving motivations. Over the 
course of aging, humans exhibit hair graying and also areas of skin hyper- and hypopigmentation. 
This reduced pigmentation can compromise UV protection, contributing to increased damage and 
decline of the skin tissue overall. With advanced age, the prevalence of melanoma also increases. 
Melanoma is the deadliest form of skin cancer, with cutaneous cases accounting for 55,500 deaths 
per year, as of 2018 (Schadendorf et al., 2018). Therefore, understanding how McSCs and their 
melanocyte lineage can go awry in these contexts is important not only for SC biology, but also 
for combatting serious clinical issues. 
 
1.4.1 Natural mechanisms of McSC depletion  
  
 Dysfunction in the McSC lineage in the HF results in hair graying (also known as canities), 
one of the most ubiquitous and visible signs of aging (Nishimura, 2011). Gray or white hair 
phenotypes in mice can occur through two major routes:  1) dysfunction or loss of cells in the 
McSC compartment, or 2) in the differentiating progeny (Fig. 1.2 A-B). Some have posited that 
age-related hair graying is caused by oxidative stress in melanocytes of the hair bulb, where 
reactive byproducts of melanin biosynthesis damage cells over time and lead to their eventual loss 
(Wood et al., 2009). However, Nishimura et al. (2005) demonstrated that in both humans and mice, 
age-related hair graying can result from loss of McSCs. Without the bulge SC reservoir, during 
active hair growth, fewer or no pigment-producing progeny can be generated, leading to 





Figure 1.2 Loss of hair color can occur through defects in McSCs or their progeny. (A) Loss 
or dysfunction in McSCs results in the generation of fewer or no differentiating progeny to make 
pigment. (B) Alternatively, problems downstream in the differentiating progeny themselves can 
result in reduced pigment production and or transfer.   
 
 There are several causes and mechanisms through which McSCs can be depleted. The 
accumulation of genotoxic damage in qMcSCs can lead to ectopic differentiation in the bulge and 
compromised self-renewal, and mice lacking ataxia-telangiectasia mutated (ATM) kinase are 
sensitized to McSC differentiation upon ionizing radiation (Inomata et al., 2009; Ueno et al. 2014). 
Indeed, individuals with progeria syndromes have impaired DNA damage response mechanisms 
and often show premature hair graying (Nishimura, 2011). During acute stress, experiences of 
A
B
Loss of McSCs, leading to hair graying




which accumulate over an organism’s lifetime, norepinephrine is secreted by sympathetic nerves 
and induces McSC proliferation and migration to the epidermis, depleting the bulge population 
and resulting in gray hair (Zhang et al., 2020). At the same time, the aging HF niche and epidermis 
can compromise McSCs as well as differentiated melanocytes. In human and mouse skin, 
COL17A1 levels are reduced with age, leading to McSC differentiation in HFs and loss of 
epidermal melanocytes (Liu et al., 2019; Matsumura et al., 2016; Tanimura et al., 2011).  
 On a more local scale, McSCs can be affected by insults to the skin such as wounding, UV 
exposure, and inflammation. Dermatologists and patients have long noticed the presence of 
hyperpigmentation around wounded and scarred areas of the skin. While epidermal melanocytes 
are likely also affected here, Chou et al. (2013) demonstrated that after excisional wounding and 
UVB irradiation in mice, McSCs migrate out of the HF niche. They do so without self-renewing, 
moving upward into the epidermis where they differentiate into melanocytes and are thought to 
provide additional UV protection to vulnerable damaged cells during wound healing. This 
phenomenon results in white hairs in the wound area due to permanent McSC depletion from HFs. 
UVB-induced McSC migration is in fact the basis of a form of re-pigmentation phototherapy used 
to treat vitiligo, a skin condition characterized by depigmented patches of skin due to loss of 
epidermal melanocytes (Nishimura, 2011). Multiple causes of melanocyte destruction have been 
proposed, from cell detachment to oxidative stress, but the prevailing notion is that it occurs 
through autoimmune attack (Bergqvist and Ezzedine, 2020). Follicular McSCs appear to be spared 
from these assaults and can therefore be stimulated by UV light therapy to migrate to the epidermis 
and differentiate into melanocytes to replenish skin pigmentation. A recent study has provided new 
insights into how the melanocyte lineage normally defends itself against the immune system. 




relative to control. Curiously, when viral mimics were introduced into Sox10 overexpressing mice 
to raise an innate immune response, hair graying was induced through an unknown mechanism 
(Harris et al., 2018). These findings indicate that MITF plays a role in repressing interferon 
signature genes normally, and in certain circumstances, a heightened immune response can 
contribute to hair graying.  
 Finally, there is currently scant evidence for the how autophagy, a self-degradation process 
whereby cells clear damaged organelles or proteins, affects McSCs. However, given its role in 
protecting against oxidative stress, which is increased by melanin production, and protecting the 
integrity of other long-lived tissue and quiescent SCs (van Velthoven and Rando, 2019), disrupted 
autophagy is a plausible route through which McSCs might become compromised in aging. As the 
body’s first line of defense, the skin will encounter various challenges over the course of an 
organism’s lifetime. It is likely that many if not all of the mechanisms discussed culminate to 
contribute to the overall depletion of McSCs and dysfunction of their melanocyte progeny.  
 
1.4.2 Melanoma and its SC properties 
 
 On the other end of the spectrum is cancer, a pathologic shift towards overactivation and 
unrestrained proliferation. Melanoma is a highly aggressive form of skin cancer prone to metastatic 
spread. It can occur in cutaneous, acral (on the palms of hands, soles of feet, or nailbeds), mucosal, 
uveal, and conjugtival forms. Common oncogenic driver mutations include BRAFV600E, NRAS, 
NFI, and genes in cell cycle regulation, with loss-of-function mutations in tumor suppressors genes 
like P53 and PTEN (Schadendorf et al., 2018). Such mutations induce overactivation of several 
pathways like MAPK and PI3K signaling. Different melanomas exhibit distinct mutational 
signatures and molecular features (Trucco et al., 2019), depending on body location, disease stage 




immune system. For instance, UV-induced cutaneous melanomas exhibit a high mutational burden 
characterized by CàT and GàT mutations, while non-UV induced acral and mucosal melanomas 
often have fewer mutations but higher incidence of structural variants like copy number variation. 
(Alexandrov et al., 2013; Hayward et al., 2017; Schadendorf et al., 2018; Trucco et al., 2019). As 
primary lesions progress, they are prone to metastasize through the lymphatics (Ubellacker et al., 
2020) to the lymph nodes and then to the blood circulation to disseminate throughout the body. 
Once a patient has progressed to metastatic disease, prognosis and survival outcomes are 
significantly worse (Davis et al., 2019).      
 These cancer cells exhibit a high degree of plasticity and are able to undergo “phenotype 
switching” to oscillate between more or less proliferative and or differentiated states, which is 
often dictated by levels of MITF (Carreira et al., 2006; Cheli et al., 2011). This agility can be 
exploited to change behavior throughout melanoma progression (i.e. proliferative cancer cells in 
the tumor switching to a more stem-like state during invasion) and may in some cases confer drug 
resistance. For example, in response to inflammatory cytokines released by T cells, melanomas 
can dedifferentiate and downregulate their expression of melanocytic antigens in order to evade 
immunotherapy (Landsberg et al., 2012). Another aspect of this plasticity centers on heterogeneity 
within the tumor (Tirosh et al., 2016) and the concept of a subpopulation of “melanoma stem cells” 
endowed with unique properties that allow them to self-renew and both sustain and repopulate 
tumors (Schatton et al., 2008). These cells may be identified by expression of distinct markers, and 
although often slow-cycling, drive tumor growth through supplying proliferative progeny (Boiko 
et al., 2010; Fang et al., 2005; Roesch et al., 2010).  
 A popular hypothesis that has been proposed to explain the deadly propensities of 




crest and or SC programs. The capacities of melanoblasts for exponential proliferation and 
impressive migration and colonization during embryogenesis are tightly regulated, but if 
transformed cells could tap into these developmental mechanisms without proper restraints, the 
results would be disastrous. Gupta et al. (2005) demonstrated that when transformed with the same 
oncogenes, melanocytes give rise to melanomas that metastasize, but fibroblasts and mammary 
epithelial cells produce tumors that rarely lead to metastatic disease. These findings point to the 
importance of the melanocyte lineage cellular context in endowing these aggressive capabilities. 
Studies in zebrafish have been particularly illuminating here, highlighting the neural crest features 
that underlie melanoma initiation, invasion, and drug resistance (Fazio et al., 2021; Johansson et 
al., 2020; Kaufman et al., 2016; Santoriello et al., 2020). For example, a key study by Kaufman et 
al. (2016) employed a crestin-eGFP reporter to demonstrate that p53 and BRAF mutant cells 
induce a neural crest gene signature during melanoma initiation (Kaufman et al., 2016). Similarly, 
global embryonic melanoblast transcriptomic data has recently been mined to uncover novel 
regulators of melanoma metastasis (Marie et al., 2020).  
 Given the striking parallels between melanomas and their neural crest and melanoblast 
precursors, the field has debated whether adult McSCs in HFs and sweat glands can act as the 
melanoma cell-of-origin. Indeed, McSCs not only give rise to proliferative progeny but retain 
migratory capacity, abilities that in a malignant context are akin to fueling tumor expansion and 
metastasizing, respectively. McSC quiescence is also interesting here, as melanoma cells that have 
metastasized are able to exist in a state of dormancy for years in distal sites of the body before 
being reactivated to generate a metastatic tumor. Curiously, immunocompromised patients can 
develop melanoma after receiving organ transplants, suggesting that their immunocompetent 




Thomas, 2010). Furthermore, there are melanotic (pigmented) and amelanotic (unpigmented) 
forms of melanoma, which seems to suggest the possibility of both melanocyte (pigmented) and 
McSC (unpigmented) precursor cells. 
 Several recent studies have sought to tackle this controversial cell-of-origin question using 
mouse models. Using TyrCreER to drive mutant BrafV600E and Pten loss-of-function in McSCs and 
their lineage, Moon et al. (2017) demonstrated that McSCs could give rise to melanoma, but to do 
so required their activation. Upon UV exposure and inflammation, transformed McSCs migrated 
to the epidermis where they expanded and generated down-growing melanomas. The authors claim 
that SC quiescence is tumor suppressive in this context. In a back-to-back report, Köhler et al. 
(2017) approached a similar question using this mouse model, but focused on the tail, where 
amelanotic and mature epidermal melanocytes reside (Glover et al., 2015). Their evidence suggests 
that melanocytes can give rise to melanomas, but that they undergo transcriptional reprogramming 
to dedifferentiate during this process. Analogous to the results of Moon et al. in qMcSCs, the 
quiescent amelanotic population of cells in the tail appear refractory to melanomagenesis. Later, 
using a new c-Kit-CreER driver to more specifically transform the SC compartment, Sun et al. 
(2019) further substantiated and extended evidence suggesting that McSCs can serve as the 
melanoma cell-of-origin. Outside of cutaneous skin, the palms and soles of feet lack HFs but are 
also common sites for melanoma. Given their ability to divide and migrate to the epidermis upon 
oncogenic stress, the immature and slow-cycling lineage cells that reside in the secretory portion 
of sweat glands are intriguing candidates for acral melanoma tumor-initiators (Okamoto et al., 
2014). At this point, there is compelling evidence in mice that melanomas can originate from either 







 Melanoblasts, tissue McSCs, and their melanocyte progeny have been an attractive model 
system with which to approach myriad questions, ranging from those pertaining to basic genetics 
to embryonic development to mechanisms of migration and proliferation to organelle biogenesis 
and trafficking. In my thesis research, I have harnessed the tractable model of the mouse skin and 
HF to elucidate the molecular mechanisms that underlie McSC quiescence, their transition to 
activation and proliferation, and their complete differentiation into pigment-producing cells. A 
more thorough understanding of this lineage and how in functions normally in vivo is a critical 
parallel to studies being conducting in abnormal cell states like melanoma and vitiligo. Such 
studies may not only inform our understanding of disease, but may have broader implications 
across other types of adult tissue SCs, especially those that cycle between quiescent and activated 
states to generate transit amplifying progeny in response to periodic tissue demands. For the 
McSCs and their lineage, there is still much to learn about how the differentiation process is 
accomplished, especially with regard to the intermediate transit-amplifying stages and how 
different signaling inputs are integrated. To unearth new insights, I sought temporal and single 
cell-level information about transcription and chromatin states, prioritizing experiments that could 








































CHAPTER 2:   
ELUCIDATING THE TRANSCRIPTIONAL DYNAMICS OF MELANOCYTE 

























 McSCs move from quiescence to activation and differentiation in step with hair cycle 
progression. Given its predictability and ease of manipulation, the murine HF is an attractive model 
system with which to interrogate McSC behavior. While elegant functional studies in mice have 
yielded important discoveries regarding the specific pathways involved in McSC lineage 
progression, unbiased approaches like high throughput sequencing provide an opportunity to 
uncover novel insights about complex biological processes. Previous studies have used single-cell 
qPCR of qMcSCs, melanocytes, and embryonic melanoblasts (Osawa et al. 2005), bulk RNA-
sequencing of McSCs (Joshi et al., 2019; Moon et al., 2017; Zhang et al., 2020) or single-cell 
comparisons of McSCs and melanoma using 10X Genomics (Sun et al., 2019).   
 In my investigation of this lineage, I also wanted to start with a more global vantage point 
with which I could establish my own datasets and address gaps in our understanding. Broadly, I 
hypothesized that distinct transcriptional programs fueled by specific TFs drive quiescence, 
activation, and differentiation. In my approach, I wanted to have single cell resolution that would 
allow me to delineate the intermediate and likely heterogenous activation and differentiation steps. 
To best accomplish this, I also needed a sequencing method that would afford high depth of 
coverage to discern maximal transcriptional differences between these related cell types.  
 To this end, I implemented transgenic mice expressing fluorescent proteins in the 
melanocyte lineage and characterized the activity and localization of McSCs and their progeny 
throughout hair cycling. I then designed fluorescence-activated cell sorting (FACS) strategies to 
isolate lineage cells from the skin at three discrete time points and performed single cell RNA-seq 




obtained high quality transcriptional data with which to perform comparative gene expression and 
pathway analyses, illuminating both expected and novel insights into this differentiation process.  
 
2.2 Results 
2.2.1 Characterizing McSC lineage activity during hair cycling in the mouse skin  
To facilitate the visualization and FACS-based isolation of McSCs and their progeny, I 
took advantage of the Dct-eGFP mouse strain (Gong et al., 2003). DCT is a melanogenic enzyme 
and ubiquitous lineage marker expressed by approximately E10.5. in mice (Mort et al., 2015). 
Using immunofluorescence (IMF) analysis of the skin, I confirmed that eGFP expression 
overlapped with endogenous DCT and was present in both McSCs in the bulge region and in their 
differentiating progeny in the anagen hair bulb (Fig. 2.1 A). In second telogen, or approximately 
postnatal day 60 (P60), qMcSCs in the bulge region were the only melanocyte lineage present in 
the skin (Fig 2.1 A, left). To assess the timing of peak McSC proliferation and enable isolation of 
aMcSCs, I measured incorporation of 5-ethynyl-2-deoxyuridine (EdU) within a 24 hour pulse at 
time points spanning from late first telogen through early anagen progression (P20-23) in Dct-
eGFP mice (Fig. 2.1 B-C). Quantification of EdU+ endogenous DCT+ cells indicated that McSC 
proliferative activity peaked during anagen I-II, which occurred at P21 in males of this background 
strain (Fig. 2.1 C-D). At this point, morphologically, HG expansion and DP engulfment was 
minimal in HFs, and the majority of aMcSCs had not yet become spatially segregated from the 
bulge region. Later on in anagen III, HGs had developed into hair bulbs distanced from the bulge, 
which allowed for evaluation McCP behavior during differentiation (Fig. 2.1 C, E). At P23, 
approximately 30% of DCT+ cells in the hair bulbs were proliferating, suggesting continued 






Figure 2.1 Characterization of McSC activity and differentiation into melanocytes 
throughout the hair cycle reveals time points at which to capture different cellular states. (A) 
IMF images of qMcSCs (left, 2nd telogen (telo) ~P60), aMcSCs (middle, anagen II (ana II) at 
P21), and hair bulb McSC progeny (right, anagen VI at P10); red dashed box indicates enlarged 
areas below. (B) Experimental schematic used to assess proliferation of McSCs and McCPs 
through EdU incorporation over 24 hours. (C) Representative IMF images of HFs at P21 and P23. 
Minimum value displayed was adjusted for DCT channel to reduce background. (D) Quantification 
of percent EdU+ McSCs. (E) Percent of HFs counted that had developed hair bulb-associated 
McCPs with corresponding (F) percent EdU+ McCPs in the developing hair bulb. [P20 n=53 HFs; 
P21 n=63 HFs; P22 n=36 HFs; P23 n=48 HFs (P20 n=1 mouse; P21-23 n=2 mice)]. For all IMF, 





By full anagen (anagen VI), differentiating pigment-producing melanocyte progeny were 
present in the hair bulb. However, both McSCs and their progeny express Dct-eGFP, so to 
distinguish these differentiating cells from their SCs using FACS, an additional fluorescent marker 
was necessary. For this purpose, I crossed Dct-eGFP mice to lymphoid enhancer factor 1(Lef1)-
RFP mice that express RFP in the WNT-responsive differentiating melanocytes but not in McSCs 
(Fig. 2.1 A, right) (Rendl et al., 2005). In full anagen hair bulbs at P10, Lef1-RFP was expressed 
in melanocyte lineage cells and the DP, but melanocytes could be distinguished by co-expression 
of Dct-eGFP. By characterizing McSC lineage activity in the mouse skin, I could then use these 
time points and fluorescent proteins as the basis upon which to develop cell isolation protocols.   
 
2.2.2 McSCs can be purified from mouse skin  
 
 Having established the optimal time points and fluorescent markers with which to label 
qMcSCs, aMcSCs, and their differentiating progeny (including mature melanocytes), I next 
designed FACS strategies to isolate these populations. Using well-established protocols from the 
Fuchs Lab, I mechanically and chemically digested dissected mouse back skin according to the 
hair cycle stage to generate a single cell suspension (Fig. 2.2 A). For all purification schemes, I 
used antibodies against cell surface markers of contaminating cell types in the skin, including 
endothelial (CD31+), immune (CD45+), fibroblast, platelet, and adipocyte (CD140a+), epidermal 
and HF infundibulum (Sca-1+) and bulge HFSC (CD34+) cells. After gating against these cell 
types, qMcSCs from second telogen skin were defined as Dct-eGFP+ integrin α-6medium-low cells; in 
anagen I-II (P21), I collected Dct-eGFP+ integrin α-6all cells, in case changes in integrin expression 
occurred during this dynamic and heterogeneous activation state (Fig. 2.2 B, top). Finally, in 
anagen VI (P10), differentiating lineage cells were identified as Dct-eGFP+, Lef1-RFP+, and c-KIT 




 For initial validation of these strategies, I used RT-qPCR followed by bulk RNA-
sequencing of the “bookend” populations of telogen qMcSCs and anagen VI differentiating McSC 
progeny. These RNA-seq data showed high reproducibility between biological replicates, and 
compared to published HFSC RNA-seq data, there was robust expression of known lineage 
markers including Dct, Sox10, and c-Kit (Fig. 2.2 C). Differential gene expression analysis with 
DESeq2 (Love et al., 2014) revealed thousands of significant transcriptional differences between 
qMcSCs and their differentiating progeny (2,385 genes up in qMcSCs; 2,819 up in differentiating 
progeny, padj≤0.001, log2fold≥1) (Fig. 2.2 D; see also Table S1 of Infarinato et al., 2020). Notably, 
these included several previously described population-specific gene expression differences, 







Figure 2.2 McSCs and their differentiating progeny can be isolated from mouse skin. (A) 
Experimental approach used to isolate McSC lineage and perform transcriptional profiling. (B) 
FACS purification schemes for McSCs (top) and differentiating hair bulb McSC progeny (bottom). 
(C) Validation of sorting strategies by bulk RNA-seq. Bar graph shows Transcripts Per Million 
(TPM) mean values relative to HFSCs. Error bars represent standard deviation (HFSCs n=2, 
qMcSCs n=2, hair bulb McSC progeny n=3). (D) Mean average plot of differentially expressed 
genes between qMcSCs (negative fold change) and their differentiating progeny (positive fold 
change). (E) Correlation matrix illustrating Euclidean distances between biological replicates 
(prog.=differentiating McSC progeny). 
 
 While these data provided a solid foundation for my study and showed good correlation 
between biological replicates (Fig. 2.2 E), I suspected that even in these carefully purified 
populations, there might be transcriptional heterogeneity due to intermediate transition steps in the 
lineage and asynchrony of cells passing through each stage, as well as some degree of 




be especially critical at the activation and transit-amplifying steps, where my IMF analyses 
indicated the presence of non-cycling and cycling McSCs and early McCP populations in the hair 
bulb (Fig. 2.1 C-F). To both capture this heterogeneity and ensure high purity, we performed 
scRNA-seq with Smart-Seq2, which provides higher depth of coverage than Drop-seq or 10X 
Genomics (Picelli et al., 2013) on telogen qMcSCs, anagen I-II aMcSCs, and anagen VI 
differentiating progeny (Fig. 2.2 A). To minimize the capture of non-lineage cells for this purpose, 
I also implemented more stringent FACS gating. 
 
2.2.3 McSCs and their progeny exhibit distinct transcriptional signatures throughout lineage 
progression in vivo 
 
Single cell mRNA libraries were prepared according to the Smart-Seq2 protocol (Picelli et 
al., 2013; Picelli et al., 2014) and subjected to sequencing. Prior to comparative analyses, a variety 
of quality control tests and filtering parameters were performed (Fig. 2.3). External RNA (ERCC) 
spike-ins were implemented to discern technical noise associated with library preparation and 
sequencing from biological variability (Fig. 2.3 A) (Brennecke et al., 2013). To eliminate low 
quality libraries from further analysis, cells with transcript reads from <1,250 genes were removed. 
Any Dctlow (logTPM+1<6) or  Krt15+ (logTPM+1>6) cells were assumed to be non-melanocyte 
lineage cells and were also eliminated from further analysis. The retained cells had an average of 
1x105 reads/cell, with few reads from the full datasets mapping to the mitochondrial genome, 
suggesting good cell viability (Fig. 2.3 B). Libraries were processed in multiple rounds of 
sequencing, so to determine the impact of batch effect, cells were visualized according the 
biological replicate (mouse) from which they originated (Fig. 2.3 C, left and middle). McSCs 
from telogen and anagen I-II exhibited strongly overlapping profiles; for anagen VI differentiating 




transcriptional profiles, cells from individual mice were still most closely related to each other and 
showed a considerably degree of overlap. Finally, telogen qMcSCs displayed the least complex 
transcriptome (Fig. 2.3 B, middle and C, right), consistent with a previous report by Osawa et al. 
(2005) using single cell RT-qPCR. Furthermore, this low complexity transcriptome was also 
observed in a fraction of the anagen I-II McSCs, where a subset of cells are expected to remain 
quiescent during SC activation.  These results suggest that reduced transcription is likely a genuine 
feature of qMcSCs, similar to what been described for several other types of quiescent SCs (van 







Figure 2.3 scRNA-seq data from purified cells are of high quality. (A) Technical noise tests 
relative to ERCC spike-ins detects biologically variable genes for each population. (B) Quality 
control tests showing log number of counts, genes detected per cell, and percentage of 
mitochondrial reads for unfiltered datasets. (C) Unsupervised k-NN based clustering of 
melanocyte lineage cells colored by group identity (left), individual mouse (middle), and number 
of genes detected per cell (right). 
 
 
Principle component analysis (PCA) with uniform manifold approximation and projection 
(UMAP) (Becht et al., 2019) coupled with k-Nearest Neighbors (k-NN) based community 
detection (Blondel et al., 2008) was used to visualize these datasets. Cells segregated into three 
distinct clusters, all of which showed robust expression of lineage markers such as Dct and Mitf 




C2) were more similar to one another than to the anagen VI differentiating progeny (C3). To first 
understand what are the major transcriptional differences driving this separation and define 
features of stemness versus differentiation, differential gene expression and gene ontology (GO) 
analyses were performed on the combined cells of C1 and C2 versus C3 (Fig. 2.4 B; Table 2.1; 
see also Table S2 of Infarinato et al., 2020).  
In this comparison, McSCs showed selective upregulation of transcripts for genes with 
known importance in stemness, such as Bcl2 (Nishimura et al., 2005) and Pax3 (Lang et al., 2005; 
Potterf et al., 2000). Unexpectedly, activator protein-1 (AP-1) family TFs (Fosb, Fos, Junb, Jun) 
featured prominently. At the same time, McSCs showed a striking upregulation of 
immunomodulatory genes (Socs3, Stat3, Stat5a, Il6st). Among these genes was Cd274, encoding 
programmed death-ligand 1 (PD-L1), an immune checkpoint protein that binds to PD1 receptor on 
T cells to inhibit their activation.  
On the other side, the differentiating progeny of C3 showed robust upregulation of genes 
involved in melanogenesis including key melanin production enzymes (Tyrp1, Tyr) and 
melanosome proteins (Pmel, Gpr143, Oca2) and transporters (Rab38). Transcripts from well-
known melanocyte differentiation pathways were also enriched, including SCF/c-KIT (Kitl) 
(Botchkareva et al., 2001; Liao et al., 2017), MC1R/α-MSH/ASIP (Mc1r) (Enshell-Seijffers et al., 
2010), and WNT signaling (Lef1) (Rabbani et al., 2011). Consistent with their increased activity 
compared to SCs, differentiating progeny showed upregulation of several genes encoding enzymes 
involved in multiple forms of cellular metabolism as well as genes involved in semaphorin-plexin 







Figure 2.4 McSCs and their progeny exhibit distinct transcriptional signatures. (A) UMAP 
representation and unsupervised k-NN based clustering of single cell data. Each dot represents a 
cell colored by its cluster (“C”) and known cell identity. For FACS cell identity, pink dots are 
telogen “qMcSCs” (n=104 cells, n=3 mice), gold are anagen I-II “aMcSCs” (n=193 cells, n=3 
mice), and light blue are anagen VI “hair bulb McSC progeny” (n=308 cells, n=2 mice). Below, 
expression plots for the lineage markers, Dct and Mitf, across all three melanocyte populations. 
(B) Heatmap illustrating select differentially expressed genes between McSCs (C1 and C2) and 
McSC progeny (C3). 
 
 
2.2.4 Transcriptional heterogeneity increases throughout differentiation  
 
Having established the key transcriptional features that broadly define stemness and 
differentiation, I next turned to investigating the presence of intrapopulation heterogeneity, a 
concept that had received little attention in the McSC and melanocyte field. This was achieved 
through further sub-clustering of the original three clusters, maintaining conservative parameters 
so as to break down clusters based on the most prominent transcriptional differences. This analysis 
detected the presence of six distinct subpopulations and suggested that transcriptional 




remained as one cluster, C2 split into C2a and C2b, and C3 broke into C3a, C3b, and C3c (Fig. 
2.5 A).  
To understand the features of these six sub-clusters, the stemness and differentiation 
signature genes in the initial comparison of C1 and C2 versus C3 were used to generate global 
scoring system (Fig. 2.5 B). Consistent with my IMF characterization of the lineage throughout 
the hair cycle (Fig. 2.1), these six sub-clusters could be delineated on the basis of differences in 
proliferation and melanogenesis gene expression. Therefore, a group of proliferation genes was 
also used to establish an overall score (Fig. 2.5 C, left). These analyses indicated that C1 had the 
highest stemness score, and C2 sub-clusters showed marked differences, where C2a was more 
stem-like than C2b. Consistently, a fraction of the C2b cells had positive differentiation scores, 
which were all high in the C3 clusters, especially in C3b and C3c. Global proliferation scoring 
provided further insight, suggesting that sub-cluster C2a was less quiescent than C1, but sub-
clusters C2b and C3a were particularly enriched for cell cycling transcripts. Cell phase scoring 
provided further resolution, indicating signatures for G1/S, S, G2/M, and M stages (Fig. 2.5 C).  
Some cell cycle transcripts remained elevated in the more differentiated C3b and C3c sub-clusters, 
but overall, these were substantially lower than in C3a. At the same time, C3c expressed the highest 
levels of melanin biosynthetic and melanosome organization pathway genes, marking these as the 
most mature melanocytes in the dataset (Fig. 2.6 A-C).  Based on these stemness, proliferation, 
and differentiation gene expression patterns, as well as the hair cycle stage at which they were 
isolated, it was possible to delineate these sub-clusters as qMcSCs (C1), aMcSCs (C2a), a 
transitional state from aMcSCs to early McCP (C2b), later McCP of the hair bulb (C3a), and 
differentiated melanocytes (C3b, c) (Fig. 2.6D). This provided high resolution with which to 






Figure 2.5 Transcriptional heterogeneity increases throughout lineage progression. (A) Sub-
clustering of each original cluster from Fig. 2.4 A. (B) Violin and UMAP plots depicting global 
stemness and differentiation scores throughout the six sub-clusters.  (C) Violin plot of proliferation 






Figure 2.6 Melanogenesis, cell cycling genes, and GO analysis further delineate sub-cluster 
identities. (A) Heatmap of select proliferation and melanogenesis mRNAs. (B) Expression plots 
of example proliferation genes and (C) melanogenesis genes. (D) Selected GO terms for each sub-






2.2.5 Analysis of signaling pathways and biological processes associated with each sub-
cluster 
 
 As a next step to understand the biological features of these distinct sub-clusters, GO 
analysis was implemented. Sub-clusters were compared against one another using differential gene 
expression analysis, and the resulting gene lists were subject to GO term processing using 
PANTHER (Mi et al., 2019; Thomas et al., 2006) and DAVID 6.8 (Huang et al., 2009a; Huang et 
al., 2009b) (Fig. 2.6 D, select PANTHER terms with FDR; see also Table S3-6 of Infarinato et al., 
2020). When qMcSCs (C1) were compared to all anagen I-II McSCs/early McCPs (C2), expected 
pathways such as Notch (Moriyama et al., 2006) and TGF-βR signaling (Nishimura et al., 2010) 
were enriched. Genes and processes involved in “negative regulation of cell proliferation” (1.1E-
7) and “autophagy” (p=1.7E-5) (DAVID 6.8) were also detected, consistent with the “common 
quiescence signature” that has been described for other types of tissue SCs (van Velthoven and 
Rando, 2019). In line with their transition to an activated state, C2 was dominated by cell division 
terms, and a few melanogenesis genes were significantly increased, including Oca2, Mc1r, and 
Rab32. To delineate the cellular processes that change as aMcSCs become early McCP, C2a was 
compared to C2b. This highlighted elevated nuclease activity and regulation of cell migration in 
C2a, while C2b showed enrichment of cell cycling and DNA replication and repair pathways, 
characteristic of a transit-amplifying cell population.  
 To dissect the differences between the three sub-clusters of McSC differentiating progeny 
in the anagen VI hair bulb, differential gene expression was performed on C3a late McCP versus 
C3c highly differentiated melanocytes and C3b melanocytes versus C3c. In both analyses, melanin 
biosynthesis and related processes comprised the top terms for C3c. C3a, the late McCP, showed 
upregulation of an intriguing number of cell signaling pathways, and C3b showed enrichment of 




2.2.6 BMP and WNT signaling gene expression increases through differentiation  
 
Turning to genes and pathways likely to be involved in lineage commitment and 
progression, I focused on cohorts of genes that robustly changed in expression during the less 
understood transitional stages of differentiation. Subdividing the McSC lineage into six 
transcriptionally distinct sub-clusters now revealed with higher resolution when specific signaling 
pathways became activated. 
An interesting feature that became apparent was that WNT signaling and response were 
particularly elevated at the juncture between the anagen I-II C2b McCP and the anagen VI late 
McCP (C3a) in the hair bulb (Fig. 2.7 A, top). This marked transition was also reflected by the 
significantly enriched (FDR=1.7E-5) “canonical WNT signaling pathway” GO term in sub-cluster 
C3a when compared to C3c melanocytes (Fig. 2.6 D). Of further intrigue was a similar dramatic 
elevation of bone morphogenetic protein (BMP) pathway response genes at this same juncture 
(Fig. 2.7 A, bottom), and also the significant (FDR=1.5E-2) term “positive regulation of BMP 
signaling pathway” in the C3a McCP sub-cluster analysis (Fig. 2.6 D). Probing deeper into WNT 
pathway activation throughout the lineage revealed elevated levels of genes such as Lef1, Wif1, 
Me1 and Wnt5a within the McCP/melanocyte populations (Fig. 2.7 B). Similarly, there was robust 
upregulation of BMP target genes Id1/2 and Msx1/2 and ligands Bmp2/7 in these differentiating 
populations (Fig. 2.7 C-D), consistent with their BMP receptor expression (Fig. 2.7 D-E).  
WNT activity drives McSC expansion and downstream melanocyte differentiation 
(Rabbani et al., 2011). BMPs have been reported to elicit ligand and context-specific effects on 
melanin production in cultured cells (Bilodeau et al., 2001; Hsu et al., 2005; Jin et al., 2001; 
Kawakami et al., 2008; Park et al., 2009; Singh et al., 2012; Yaar et al., 2006; Yang et al., 2014). 







Figure 2.7 WNT and BMP signaling increase during melanocyte differentiation. (A) Violin 
plots of canonical WNT and BMP target gene pathway scores in each sub-cluster. (B) Expression 
plots of WNT and (C) BMP pathway genes. (D) Heatmap of BMP ligand, receptor, and 
transcriptional effectors over differentiation. (E) Expression plots of BMP receptors.   
 
might engage with crosstalk with other niche signaling components was not well understood. 
Therefore, I endeavored to investigate the role of BMP signaling in melanocyte lineage 






 In harnessing an unbiased approach and profiling cells from their native niche throughout 
lineage progression, this study represents a significant advance in our understanding of the 
transcriptional underpinnings of McSC quiescence, activation, and differentiation. It revealed the 
presence of six distinct transcriptional profiles, suggesting that the lineage increases in complexity 
as cells progress through differentiation. Further studies will be necessary to delineate whether 
these different profiles, especially those three sub-clusters in the differentiating C3 cluster, 
represent a continuum of states through which all cells pass, or perhaps also indicate differences 
in spatial organization within the HF and hair bulb niche, resulting in different extracellular cues 
and cell-cell adhesion. For example, cells in more direct contact with the DP might receive 
different levels of signals from the mesenchyme than those further out and closer to matrix TACs.  
 One significant argument for studying the dynamic developmental trajectory of this lineage 
is to gain insight into how normal features might be exploited or perturbed in disease. In this 
regard, several aspects of the McSC signature underscore the concept that melanomas harness SC 
programs. AP-1 factors regulate several cellular processes, but the particular upregulation in SCs 
was intriguing in light of their implications in cancer. For instance, in melanoma, c-JUN and MITF 
are thought to act antagonistically (Riesenberg S et al., 2015), and FOSL1 has been shown to 
induce melanocyte reprogramming and transformation, also downregulating MITF (Maurus et al., 
2017). Given these striking parallels and the paucity of information regarding their role in the 
normal physiological context, AP-1 family TFs in the McSC lineage merit further study. 
 Furthermore, the upregulation of immune-related genes in McSCs might also suggest that 
the ability of melanoma to modulate and evade immune detection is rooted in a physiological SC 




advantage of studying adult tissue McSCs versus embryonic melanoblasts is understanding these 
SCs in the context of an immune-competent niche. Curiously, work by Riesenberg et al. (2015) 
suggest that dedifferentiated MITFlow melanoma cells have higher expression of inflammatory 
genes. In this regard, the selective upregulation of Cd274 (encoding PD-L1) in McSCs in my 
dataset was particularly striking. PD-L1 is upregulated on melanoma cells to protect against 
immune attack, and targeting this interaction with immunotherapy has revolutionized melanoma 
treatment (Sharma and Allison, 2015). It is tempting to speculate that McSCs might harness 
molecules like PD-L1 to protect themselves from immune attack in situations when the protective 
HF niche might be compromised (i.e. wounding, inflammation) or during migration out of the 
follicle and into the epidermis. Indeed, McSC crosstalk with the immune system is an area of 
emerging study. Harris et al. (2018) demonstrated that MITF suppresses interferon signature genes. 
My data appear to be consistent, as qMcSCs with lower levels of MITF protein, show upregulation 
of many immune-related genes relative to their differentiating progeny, which accumulate nuclear 
MITF. Overall, these results add to the body of literature that report shared molecular features of 
McSCs and melanoma, and point to genes whose role in normal and transformed cells could be 
elucidated in future functional studies. 
 Considering such interactions raises further questions regarding how transcriptional 
changes in the McSC lineage impacts other cell types in the surrounding microenvironment, 
especially HFSCs and their lineage. Numerous studies have described mechanisms through which 
HFSCs and their HF lineage cells dictate the behavior of McSCs and melanocytes, but whether the 
reverse scenario is true (outside of providing UV protection) is not well understood. Given that 
hair growth is not dependent on functional McSCs or their progeny (white hair can grow), the 




data provide a list of candidate factors that could serve as a starting point for such investigations. 
Conversely, it still remains to be determined which components of the bulge and HF niche are 
triggering these gene expression changes in the McSC lineage, as opposed to those that are 
intrinsically controlled.  
 Finally, in their cyclic quiescence, activation, transit amplification, and differentiation, 
McSCs mirror the developmental trajectory of HFSCs. Hsu et al. (2014) demonstrated that HF 
matrix TACs signal back to quiescent SCs via Sonic hedgehog (SHH) signaling to induce their 
self-renewal. This begs an intriguing question:  do McSC TAC progeny (McCP) provide feedback 
to their parent SCs in the way that HFSCs do? Based on the timing of this signaling for matrix 
TACs, the data obtained from aMcSCs and early McCPs in anagen I-II might present clues. Indeed, 
to create banded patterns in feathers, it is believed that mature melanocytes engage in a negative 
feedback loop, signaling back to undifferentiated proliferative progenitor cells to stop their 
progression and achieve cyclic maturation and pigmentation (Inaba and Chuong, 2020). 
 In summary, these new data contribute a more complete and high resolution picture of 
McSC transcription throughout differentiation. Notably, this dataset affords a high depth of 
coverage to discern maximal differences between cell types, and it includes intermediate stages of 
lineage progression, namely aMcSCs and McCP. Recently, Smart-Seq2 data has been generated 
for human melanocytes isolated from different patient ages and body sites (Belote et al., 2020). 
Future cross-species analyses will likely provide useful new insights for the field’s understanding 
of this lineage. 
 However, transcription is just one level of regulation impacting cellular dynamics; global 
proteomic and epigenetic studies at the single cell level will provide further insight into how these 




intersect. This work would inform questions concerning whether some qMcSCs, while appearing 
transcriptionally homogeneous, are actually poised for activation, while another pool is more 
deeply quiescent. These differential gene expression and pathway analyses implicated both known 
and novel genes and biological processes at each stage, allowing me to form more specific 
hypotheses about how McSCs pass through activation and differentiation, which is the subject of 
Chapter 3 and centers on BMP and WNT signaling (Chapter 2.2.6). At the same time, this body 
of work raises several diverse hypotheses, and will hopefully form the foundation for future studies 



























































BMP SIGNALING DRIVES FULL DIFFERENTIATION OF MELANOCYTES 

























 By performing high sensitivity scRNA-seq on McSC lineage cells at multiple 
developmental time points, I gained temporal insight on not only the gene expression changes 
during lineage progression, but also when signaling pathways seem to become activated. In 
narrowing the focus of my project to study the pathways and downstream TFs that were likely to 
impact lineage progression and differentiation, both BMP and WNT signaling featured 
prominently (Chapter 2.2.6). When compared to the most highly differentiated melanocytes in 
the dataset (C3c), the later McCP of the anagen VI hair bulb (C3a) showed significant upregulation 
of genes involved in both pathways. This was intriguing given the essential role of WNT signaling 
in McSC activation and downstream melanocyte maturation (Rabbani et al., 2011), and also given 
reports of both cooperative and antagonistic effects of WNT and BMP pathways in SC biology. 
 Simply described, canonical WNT signaling occurs through the binding of WNT ligands 
to frizzled (FZD) and lipoprotein receptor-related protein (LRP) receptors, disrupting the 
cytoplasmic β-catenin degradation complex.  Stabilized β-catenin can then translocate to the 
nucleus and bind with TCF/LEF family TFs to regulate gene expression (Nusse and Clevers, 
2017). WNT plays an essential role in the melanocyte lineage, from embryonic specification of 
melanoblasts, where it appears to act antagonistically with BMP signaling (Hari et al., 2002; Hari 
et al., 2012; Jin et al., 2001), to activation of HF McSCs and downstream proliferation and 
differentiation of melanocytes in the hair bulb (Rabbani et al., 2011). 
BMP signaling occurs through the binding of BMP ligands to complexes of BMP type I 
and type II cell surface receptors, triggering their serine/threonine kinase-mediated 
phosphorylation of SMAD1/5/9 proteins. Phosphorylated SMAD1/5/9 then bind SMAD4 and 




manipulation of Bmpr1a (ALK3), the Fuchs Lab has shown that this pathway is critical for HF 
lineage regulation. BMP signaling both maintains HFSCs in quiescence and promotes the 
differentiation of HF TACs (Genander et al., 2014; Kobielak et al., 2007). However, the role of 
BMP signaling in McSC lineage commitment was not well understood, with most insights resting 
on cell culture studies (Bilodeau et al., 2001; Jin et al., 2001; Kawakami et al., 2008; Park et al., 
2009; 2005; Singh et al., 2012; Yaar et al., 2006; Yang et al., 2014); the few studies in mice made 
the precise contributions of this pathway difficult to interpret (Han et al., 2012; Sharov et al., 2005).   
 Given the highly context-dependent roles of this pathway, which stem from promiscuity of 
ligand binding, differential receptor expression and complex combinations, and expression of 
positive and negative pathway regulators (Wang et al., 2014), I wanted to gain a deeper understand 
about how BMP works in the lineage in the native tissue microenvironment. Therefore, in my 
thesis research, I posed the following hypotheses:  1)  BMP (BMPR1a) signaling promotes McSC 
lineage progression and melanocyte differentiation, and 2) BMP signaling coordinates with WNT 
signaling in the differentiation process. To test these hypotheses, I harnessed genetic mouse 






3.2.1 Cocommitant activity of WNT and BMP signaling in the lineage  
 
 At the transcript level, there is evidence of increasing WNT and BMP signaling at the late 
McCP stage. To confirm the acitivty of these pathways at the protein level, I performed IMF 
analysis of the skin throughout hair cycling. To assay for WNT activity, I interrogated the TF 




transitioned to the McCP/melanocyte stages in anagen (Fig. 3.1 A). While inner bulge HFSCs 
showed robust BMP signaling through pSMAD1/5/9, neighboring McSCs lacked nuclear signal 
in both their quiescent and activated states. However, as differentiation progressed, 
McCP/melanocytes in the hair bulb became strongly pSMAD1/5/9+, and this was maintained 
throughout anagen (Fig. 3.1 B). Together, these RNA and protein analyses were consistent with 
the hypothesis that BMP signaling acts during differentiation. Furthermore, the concomitant timing 
of pSMAD1/5/9 and LEF1 nuclear accumulation in McCP/melanocytes in anagen HFs were in 
agreement with a degree of convergent signaling. On this basis, I proceeded to employ loss-of-
function mouse models to investigate the role of BMP signaling in lineage progression and how it 





Figure 3.1 WNT/LEF1 and BMP/SMAD signaling is activated in McCP/melanocytes. (A) 
IMF images showing LEF1 protein expression in the melanocyte lineage throughout hair cycling. 
Nuclear LEF1 (red) indicated by yellow arrows. (B) pSMAD1/5/9 (BMP signaling) is absent in 





3.2.2 Perturbed WNT signaling in mice results in reduced hair pigmentaiton 
 
 To understand the importance of LEF1 in the lineage, I first revisted Lef1 full body KO 
mice (Kratochwil et al., 1996; van Genderen et al., 1994). These mice had less pigmented hair 
compared to their littermates (Fig. 3.2 A). Due to their lack of most HFs, there is abnormal 
localization of melanocytes in KO skin, including pigmented melanocytes in the dermis and some 
follicles containing fewer melanocytes. However, in the follicles that did contain DCT+ cells in 
their anagen HFs, hair bulbs and hairs still appeared less pigmented, suggesting that loss of LEF1 
impaired melanocyte differentiation (Fig. 3.2, right).  
 I then used a second, more specific approach to conditionally ablate β-catenin (Ctnnb1) in 
the lineage by generating TyrCreER Ctnnb1floxed R26-YFPfloxed mice (Bosenberg et al., 2006; Brault 
et al., 2001; Srinivas et al., 2001). This model is similar to that used by Rabbani et al. (2011) to 
demonstrate that WNT signaling plays key roles in McSC activation and downstream proliferation  
and differentiation of melanocytes in the hair bulb. Upon tamoxifen treatment, TyrCreER drives 
expression in both McSCs and their differentiating progeny (Bosenberg et al., 2006). At P21, mice 
were treated with seven consecutive doses of tamoxifen (Fig. 3.2 B). Consistent with the results 
of Rabbani et al. (2011), by second telogen, Ctnnb1 conditional KO (cKO) mice had hairs with 
reduced pigmentation relative to control (Fig. 3.2 C). I then wanted to interrogate the status of 
BMP signaling in the absence of functional WNT/β-catenin signaling. To analyze the McSC 
lineage during differentiation, I waxed tamoxifen-treated second telogen mice to induce 
synchronous hair growth and analyzed tissues one week later in anagen (Fig. 3.2 B). Nuclear 
pSMAD1/5/9 was still present in Ctnnb1 null McSC progeny in the hair bulb, indicating that BMP 





Figure 3.2 WNT mutant mice have reduced pigmentation. (A) Left, phenotype of Lef1 KO 
mice at P13, when hair on the skin surface has emerged in KO (control littermate:  female, Lef1 
KO:  male). Middle, IMF for LEF1 in control and Lef1 KO skin at P0. Right, brightfield images 
of P8 anagen HFs. (B) Experimental schematic for conditionally ablating β-catenin (WNT) in the 
melanocyte lineage in vivo. (C) Phenotype of tamoxifen-treated TyrCreER Ctnnb1floxed 
R26YFPfloxed mice at 2nd telogen. (D) IMF of Ctnnb1 cKO and control skin 1 week after waxing. 










3.2.3 Loss of BMP signaling through BMPR1a leads to hair graying  
 
 To interrogate the role of BMP signaling in McSC lineage progression, I generated a strain 
of conditional lineage-specific Bmpr1a KO mice, TyrCreER Bmpr1afloxed R26YFPfloxed (Bosenberg 
et al., 2006; Mishina et al., 2002; Srinivas et al., 2001). BMPR1a is a type I receptor 
serine/threonine kinase whose loss extinguishes downstream signaling through the pathway. I 
treated these mice with tamoxifen at P21 and allowed them to progress to second telogen. 
Strikingly, by this point, Bmpr1a cKOs exhibited gray hair, while Bmpr1a heterozygotes 
(TyrCreER+ Bmpr1a fl/+) showed no phenotype relative to controls (TyrCreER- or TyrCreER+ 
Bmpr1a+/+) (Fig. 3.3 A). To observe the McCP/melanocyte populations in hair bulb compartment, 
tamoxifen-treated second telogen mice were waxed, and anagen skin was collected after one week 
of hair growth. As measured by optical density, there was significantly reduced pigmentation in 
Bmpr1a cKO hair bulbs (Fig. 3.3 A-B).  
Gray hair phenotypes can occur due to defects in the McSC compartment, including 
apoptosis, ectopic proliferation and differentiation, or migration out of the niche (Nishimura et al., 
2011). Alternatively, abnormalities may occur downstream at other points in differentiation (Fig. 
1.2). To ascertain the cause of the gray hair in Bmpr1a cKO mice, I waxed second telogen mice to 
trigger hair growth and McSC activation and differentiation, then analyzed McSCs after one week 
using IMF. McSCs numbers per HF were comparable between Bmpr1a cKO mice and controls  
(Fig. 3.3 C) and seemed to return to quiescence normally after activation, as measured by EdU 
incorporation during a 4 hour pulse (Fig. 3.3 D). To more conclusively rule out McSC dysfunction, 
I challenged the SC pool by performing serial waxing. The anterior back skin of second telogen 
mice was waxed five times in total every three weeks, by which time the waxed region appeared 





Figure 3.3 Conditional ablation of Bmpr1a in the lineage results in gray hair without 
compromised McSCs. (A) Representative phenotype of TyrCreER Bmpr1afloxed R26YFPfloxed mice 
tamoxifen-treated mice in 2nd telogen. Scale bars=25µm. (B) Quantification of pigment content 
in hair bulbs measured by optical density. [****p<0.0001, Mann-Whitney test; Control n=80 HFs 
(n=4 mice); Bmpr1a cKO n=43 HFs, (n=3 mice)]. (C) Quantification of McSCs numbers per 
anagen HF 1 week after waxing [*p=0.0184, Mann-Whitney test; Control n=76 HFs (n=5 mice); 
Bmpr1a cKO n=45 HFs (n=4 mice)]. (D) Quantification of EdU+ McSCs per HF 1 week after 
waxing [(ns=not significant, Mann-Whitney test; Control n=61 HFs (n=3 mice); Bmpr1a cKO 
n=45 HFs (n=4 mice)] (E) Phenotype of control and Bmpr1a cKO mice after 4 rounds of waxing 
on the anterior portion of the back skin, 3 weeks apart. Note that a small skin biopsy was taken 
from the posterior midline near the time of initial waxing of the anterior. (F) Quantification of 
McSCs per HF after 5 rounds of depilation, quantified in anagen 1 week after the fifth wax [(Mann-







exacerbation of hair graying (Fig. 3.3 E). Anagen skin was collected one week after the fifth wax 
for IMF, and I found no significant difference in number of McSCs per HF between control and 
Bmpr1a  cKO  mice  (Fig. 3.3 F).   These  results  suggested  that  McSCs were intact and functional 
upon Bmpr1a loss and were consistent with my scRNA-seq (Fig. 2.7) and IMF data (Fig. 3.1 B), 
which both indicated that this pathway is not activated until the McCP stage. 
I therefore turned my attention to identifying defects downstream in the lineage. In Bmpr1a 
cKO mice, DCT+ cells populated the McCP/melanocyte compartment of the hair bulb. By IMF, 
these cells showed loss of nuclear pSMAD1/5/9 as well as pP38, indicating ablation of canonical 
and non-canonical pathways downstream of BMPR1a, respectively (Fig. 3.4 A-B). To rule out the 
possibility that hair bulbs were less pigmented because cells were simply delayed in 
differentiation, I analyzed skin further into anagen. Indeed, 12 days after waxing, Bmpr1a cKO 
hair bulbs were still poorly pigmented (Fig. 3.4 C). These data suggested that without BMP 
signaling, McSC quiescence and activation were not impacted, but lineage progression and 







Figure 3.4 McSCs in TyrCreER+ Bmpr1afl/fl R26YFP mice give rise to differentiating progeny 
that populate the hair bulb. (A) IMF showing loss of BMP-SMAD signaling through 
pSMAD1/5/9 and (B) MAPK through pP38 in Bmpr1a null DCT+ cells in the hair bulb. (C) Bright 
field images of control and Bmpr1a cKO hair bulbs 12 days after waxing. Scale bars=25µm 
 
 
3.3.4 ScRNA-seq and pseudotime analysis of Bmpr1a null cells in vivo suggests a block in 
differentiation between early McCP and mature melanocyte  
 
 Given that my in vivo results suggested a defect downstream in differentiation, I sought to 
gain further mechanistic insights using a cultured melanocyte mouse cell line, Melan-a2 
(Sviderskaya, et al., 1995). To minimize variability, I first generated a clonal parental line from 
Melan-a2, then using CRISPR/Cas9, I generated and validated Bmpr1a KO and control cloncal 
cell lines (Fig. 3.5 A). However, while loss of the receptor in culture led to reduced pSMAD1/5/9 
upon BMP2 stimulation, signaling was not completely abolished, and BMP6-induced 
pSMAD1/5/9 signaling was not affected in Bmpr1a KO cells (Fig. 3.5 B). At the same time, no 





Figure 3.5 FACS purification of in vivo Bmpr1a null cells preserves the molecular profile that 
results from the dynamic and complex microenvironment. (A) Validation of CRISPR KO of 
Bmpr1a using Cas-analyzer tool on rgenome.net, using MiSeq results. (B) Western blot analysis 
of pSMAD1/5/9 signaling in control and KO Melan-a2 cell lines after 1 hour BMP stimulation 
(0.5% serum, CT-free media during treatment). (C) IMF images of skin at different stages of hair 
cycling. Bu=bulge, HB=hair bulb. Scale bars=50µm. (D) FACS purification schemes for YFP+ 
populations. (E) Quality control metrics showing log number of counts, genes/cell, and percentage 
of mitochondrial genes for unfiltered datasets. (F) Unsupervised k-NN based clustering of control 
(heterozygous, Het and wild-type, WT) and Bmpr1a null cells colored by known identity (left) and 
individual mouse (“M”) (right). For cell identity, purple are WT, (TyrCreER+ Bmpr1a+/+, n=205 
cells, n=1 mouse), blue are Het, (TyrCreER+ Bmpr1a+/fl, n=304 cells, n=2 mice) and green are 
Bmpr1a null (TyrCreER+ Bmpr1afl/fl, n=421 cells, n=2 mice). 
 
accurately recapitulated in vitro. This was not surprising given the complexity and context-
dependent behavior of this pathway. BMP/TGF-β receptor superfamily members (i.e. activin 
receptors) can dimerize in multiple combinations and yield signaling responses that differ 
depending upon the specific ligand, receptors, and intra- and extracellular regulator molecules 




provided a plausible explanation for the context-dependent behaviors described in this lineage in 
the literature (Bilodeau et al., 2001; Han et al., 2012; Jin et al., 2001; Kawakami et al., 2008; Park 
et al., 2009; Sharov et al., 2005; Singh et al., 2012; Yaar et al., 2006; Yang et al., 2014). These 
findings underscored the importance of taking in vivo approach where possible to study this 
signaling pathway and specific receptor’s function.  
Therefore, I focused on methods that enabled me to study the effect of BMPR1a loss in 
mice. To this end, I turned again to FACS purification and scRNA-seq. Bmpr1a control (Bmpr1a 
heterozygous +/fl and WT +/+) and cKO mice were treated with tamoxifen at P21, allowed to 
progress to second telogen, then waxed to induce anagen. At one week post-waxing, HFs were in 
anagen IV, an ideal time point at which to capture differentiating McCP in the hair bulb when 
BMP signaling becomes activated (Fig. 3.5 C). Using a digestion protocol to preferentially release 
cells from the dermis of the skin including hair bulb cells, I FACS purified YFP+ cells, gating 
against CD31, CD45, CD140a, Sca-1 and CD34+ cells (Fig. 3.5 D) and again performed scRNA-
seq. Again, this approach afforded many advantages, including the ability to discern any YFP+ 
cells captured that were not actually Bmpr1a null (which were consequently clustered 
appropriately with control cells). ScRNA-seq data were subject to quality control analyses and 
filtering parameters, where any Dctlow and Krt15+ cells were again excluded from further analysis. 
Overall, cells displayed a similar depth of sequencing with approximately 5,000 genes per cell 
(consistent with increased transcriptional activity occurring during differentiation), and few reads 
mapped to mitochondrial transcripts (Fig. 3.5 E). Furthermore, independent replicates exhibited 
similar clustering (Fig. 3.5 F).  
PCA with UMAP and k-NN clustering of these data revealed the presence of two major 




these two clusters, while Bmpr1a null cells formed the second cohort, indicating their unique 
transcriptome (Fig. 3.6 A). Consistently, expression of direct BMP target genes Id2 and Id3 were 
dramatically downregulated in this Bmpr1a null cluster (Fig. 3.6 B). To understand what other 
transcriptional differences were driving this separation, differential gene expression analysis was 
performed on the control versus Bmpr1a null cluster. This indicated that 80 genes were 
significantly (q≥0.05) downregulated and 346 genes were upregulated in the absence of Bmpr1a 
(Fig. 3.6 C-D; Table 3.1-3.2; see also Table S9 of Infarinato et al., 2020). Strikingly, Bmpr1a null 
cells showed diminished expression of genes involved in melanogenesis and melanosome 





Figure 3.6 Bmpr1a null cells downregulate melanogenesis, melanosome, and transport genes. 
(A) UMAP representation and unsupervised k-NN based clustering of control and Bmpr1a null 
cells colored by cluster identity. (B) Expression plots of Id2 and Id3 in YFP+ populations. (C) 
Heatmap of top differentially expressed genes for Bmpr1a null versus stage-matched controls and 
(D) selected GO terms (DAVID 6.8) with (p-values). See also Table 3.1-3.2. (E) RT-qPCR 
expression of genes from scRNA-seq list isolated 12 days post waxing [(****p<0.0001 Bmpr1a; 
**p=0.0035 Lef1; *p=0.0269 Eps8; *p=0.0148 Vimentin; ***p=0.0010 Pax3, Unpaired t-test; 




showed elevated transcripts of genes involved in stemness (Pax3, Vim), migration and cellular 
projections (Enpp2, Tubb2b), and cell adhesion (Cspg4, Adgrg1). To test whether these trends 
persisted further into anagen, bulk YFP+ cells were FACS purified 12 days after waxing for RT-
qPCR, which produced similar results for several genes (Fig. 3.6 E).  
These intriguing results begged another question:  if integrated into the original WT McSC 
lineage dataset (Chapter 2), how would the Bmpr1a null cells compare? Pseudotime algorithms 
can be implemented on scRNA-seq data to gain temporal information about a biological process 
such as SC differentiation, ordering individual cells in a dataset along an inferred trajectory. 
Therefore, these experimental datasets were integrated with the six WT lineage sub-clusters 
(qMcSCs, aMcSCs, early and late McCP, and differentiated melanocytes) and UMAP-based 
dimensionality reduction and clustering was performed (Fig. 3.7 A). One-third of Bmpr1a null 
cells clustered with early McCP (C2b), suggesting their transcriptional similarity (Fig. 3.7 B, left).  
Next, the collective dataset was subject to pseudotime analysis using Monocle3 (Cao et al., 
2019), a relatively unbiased method to map differentiation in which all biologically significant 
genes are considered. As expected based on the hair cycle time point from which cells were 
isolated and the differentiatial gene expression analyses between sub-clusters (Fig. 3.7 B), 
qMcSCs (C1) were placed at the start or “root” of the trajectory, followed by aMcSCs, then McCP, 
with the most differentiated melanocytes (C3c) forming the end point of the “branch.” As 
expected, Monocle3 also indicated that Bmpr1a control cells collected from anagen IV hair bulbs 
were earlier in the differentiation process than all WT McCP/melanocyte (C3) sub-cluster cells 
isolated from anagen VI hair bulbs. Bmpr1a null cells however were placed after early McCP 
(C2b) from anagen I-II HFs and their stage-matched controls, as well as all other anagen VI 




Their placement in the pseudotime map suggested that Bmpr1a null cells were blocked in 
their differentiation trajectory. To further explore this idea, the expression of established 
“stemness” and “differentiation” signature genes (Fig. 2.5 B) was analyzed relative to the WT 
lineage sub-clusters (Fig. 3.7 C). Bmpr1a null cells showed reduced expression of genes involved 
in melanogenesis as compared to the WT McCP/melanocytes (C3), as well as genes involved in 
BMP and WNT signaling pathways, with elevated expression of stemness genes. This is visualized 
through the global scoring system in the expression plots in Fig. 3.7 D, where levels of stemness 
and differentiation gene scores can also be compared to a small number of YFP+ McSCs collected 
from both Bmpr1a control and null groups, which have the highest stemness and lowest 
differentiation scores. Overall, these analyses suggested that Bmpr1a null cells share many 
transcriptional similarities with early McCP but have elevated melanogenesis and differentiation-
associated gene expression, underscoring that these cells are arrested just downstream of the 







Figure 3.7 Pseudotime analysis of the Bmpr1a null cells suggests a block at the juncture after 
early McCP. (A) Unsupervised k-NN based clustering of original melanocyte lineage populations 
with Bmpr1a null and control cells, colored by sub-cluster identity. (B) Pseudotime analysis of 
combined datasets colored by pseudotime clusters (left) and pseudotime order (right). Cells are 
colored by progression through pseudotime with dashed red arrow to indicate direction of 
progression. (C) Heatmap showing expression of key signature genes in Bmpr1a null cells relative 
to WT sub-clusters. (D) Expression plots of global stemness and differentiation scores for Bmpr1a 
null and control cells. 
 
 
3.3.5. Bmpr1a null cells in the hair bulb exhibit signs of immaturity 
 
 My transcriptional data suggested that Bmpr1a null lineage cells were blocked in 
differentiation. Therefore, I performed tissue analyses to test for feautres of melanocyte 
immaturity. To test for proliferation, I treated mice with tamoxifen at P21, waxed their backskin 




with their transcriptional similarities to aMcSCs and early McCP, Bmpr1a null cells in the hair 
bulb showed increased EdU incorporation relative to control (Fig. 3.8 A). I confirmed these results 
in another experiment, where I counted DCT+ cells in the hair bulb and found cell numbers to be 
significantly increased in Bmpr1a cKOs (Fig. 3.8 B). This suggested that surprisingly, the reduced 
pigmentation in the cKO hair bulbs was not due to reduced numbers of McCP/melanocytes. This 
contrasted from the effect of loss of WNT/β-catenin signaling, which results in reduced 
proliferation in both the McSC and hair bulb compartments (Rabbani et al., 2011). At the same 
time, Bmpr1a null cells in the hair bulb exhibited increased expression of the McSC signature gene 
vimentin at the protein level, further indicating their immaturity (Fig. 3.8 C).  
 
 
Figure 3.8 Bmpr1a null cells in the anagen hair bulb exhibit signs of immaturity. (A)  4 hour 
EdU pulse experiment with representative IMF images and quantification [****p<0.0001, Mann-
Whitney test; control n=50 HFs (n=2 mice); Bmpr1a cKO n=75 HFs (n=3 mice)]. Yellow arrow 
heads indicate proliferating (EdU+) DCT+ cells. (B) Quantification of DCT+ cells per hair bulb 1 
week after waxing [****padj<0.0001, *padj=0.0103, Kruskal-Wallis test, Dunn’s multiple 
comparisons test; TyrCreER- control n=70 HFs (n=3 mice); Het control n=63 HFs (n=3 mice); 
Bmpr1a cKO n=62 HFs (n=4 mice)]. (C) IMF expression of vimentin (red); yellow dashed area 
encircles DCT+ cell area. Scale bars=25µm 
 
 Given the presence and increased number of McSC differentiating progeny in Bmpr1a cKO 
hair bulbs, I next tested for the protein expression of the three key melanogenic enzymes:  DCT, 




data indicating that these enzymes are upregulated earlier on in differentiation, DCT, TYR, and 
TYRP1 (which was in fact reduced in Bmpr1a null cells at the transcript level) were all present by 
IMF in Bmpr1a null cells in the hair bulb (Fig. 3.9 A-B), suggesting that the defect in pigmentation 
was unlikely attributable to loss of any one critical component of melanin production. Instead, I 
turned to assessing melanosomes. While PMEL, a structural component of melanosomes involved 
in organelle maturation, was expressed in Bmpr1a null cells, it exhibited a more perinuclear 
localization compared to control cells, where labeling was seen throughout the cell body and 
dendritic processes (Fig. 3.9 B, right). This suggested a perturbation in melanosome biogenesis 
or localization, which was reinforced by the reduced expression of melanosome organization genes 
seen by scRNA-seq (Fig. 3.6 C-D).  
 Melanosome biogenesis proceeds through four distinct phases of maturation that are well-
defined at the ultrastructural level. Stage I melanosomes largely resemble endosomal 
multivesicular bodies, stage II melanosomes exhibit parallel intralumenal striations, stage III 
melanosomes show thickening and darkening of these striations as melanin is deposited, and stage 
IV mature melanosomes ultimately become opaque (Marks and Seabra, 2001). To investigate the 
status of melanosomes in Bmpr1a null cells, back skin was waxed and collected one week later in 
anagen for electron microscopy (EM) of lineage cells in the hair bulb. Quantification of total and 
mature (stage IV) melanosome area densities revealed similarities between control and Bmpr1a 
null cells, but Bmpr1a null cells displayed a significantly higher density of immature (stage I-III) 
melanosomes  (Fig. 3.9 C).   Together,  these  results  suggest  that  in  the  absence  of  BMPR1a 
signaling, McSC progeny are suspended in a partially differentiated state characterized by 







Figure 3.9 Bmpr1a null cells are intermediately differentiated. (A) IMF images showing 
expression of early melanogenic enzymes in control and Bmpr1a null cells in the hair bulb. (B) 
IMF image showing expression pattern of PMEL. Area within yellow dashed box is enlarged to 
the right, with yellow arrows to indicate perinuclear localization of signal. All IMF scale 
bars=25µm. (C) EM images of silver sections with melanocyte lineage cells outlined in green. 
Dashed box insets are enlarged. Red arrows indicate immature melanosomes. Scale bar=1µm. 
Lower graphs show quantification of number of melanosomes divided by melanocyte lineage cell 
area. Left – total melanosomes/µm2, middle – mature melanosomes/µm2, right – immature 
melanosomes/µm2 [****p<0.0001, Mann-Whitney test; Control n=66 areas (3 mice); Bmpr1a 






3.3.6 BMP-regulated Lef1 may cooperate with MITF to drive full melanocyte differentiation 
 
Given the newfound role of BMPR1a signaling at the juncture downstream of McSC 
activation/early McCP and upstream of melanocyte differentiation (Fig. 3.10 A), I sought further 
insight into how this signaling cascade is transmitted to regulate genes involved in differentiation 
and melanosome organization. My overarching hypothesis for my thesis work was that distinct 
transcriptional programs are fueled by specific TFs that drive dynamic cellular states throughout 
differentiation. Therefore, I turned my attention to TFs that were downregulated in Bmpr1a null 
cells by scRNA-seq. Intriguingly, WNT mediator Lef1 showed a trending downregulation by 
scRNA-seq (Fig. 3.10 B, left) and RT-qPCR (Fig 3.6 E). Consistently, Bmpr1a null cells exhibited 
reduced nuclear LEF1 levels by IMF (Fig. 3.10 B, right).  
Probing for further changes in TFs, I interrogated MITF, the master regulator of the 
melanocyte lineage that is often regulated at the post-transcriptional level (Goding and Arnheiter, 
2019). MITF coordinates myriad lineage processes in development, differentiation, and 
melanoma, including survival, proliferation, and pigment production (Goding and Arnheiter, 
2019). Carreira et al. (2006) proposed that in melanoma, MITF functions according to a “rheostat 
model,” where low MITF promotes stemness, intermediate MITF induces proliferation, and high 
MITF drives differentiation and melanogenesis. While Mitf levels were unchanged at the transcript 
level in Bmpr1a null cells relative to control, interestingly, nuclear MITF protein was reduced by 
IMF (Fig. 3.10 C).  
Given the numerous differentiation and pigmentation defects that stem from perturbations 
or loss of MITF, reduced nuclear MITF in Bmpr1a null cells alone might largely explain the block 
in melanocyte differentiation and resulting gray hair phenotype. However, MITF is known to 




Figure 3.10 Nuclear LEF1 and MITF are reduced in differentiating Bmpr1a null cells. (A) 
Model of McSC lineage progression with the proposed timing of the differentiation block without 
BMP signaling. (B) Lef1 mRNA expression (left) with IMF (right) in control and Bmpr1a null 
cells. Yellow arrows indicate presence and white arrows indicate reduction/absence of nuclear 
LEF1. (C) IMF images depicting MITF in control and Bmpr1a null cells in anagen 1 week after 
waxing. Enlarged areas show reduction (white arrows) of nuclear MITF in transduced (YFP+) vs. 
un-transduced (YFP-) as an internal control. (D-E) IMF images illustrating MITF levels in hair 
bulb McSC progeny of (D) control and Lef1 KO (P4) mice and (E) Ctnnb1 cKO and control mice 
whose HFs were analyzed 1 week post-waxing. Yellow arrows indicate presence and white arrows 
indicate reduction/absence of nuclear MITF. IMF scale bars=25µm. 
 
2019). Therefore, given that Bmpr1a null cells also showed reduced LEF1, I wanted to investigate 
the link between BMPR1a signaling, WNT/LEF1, and MITF. Moreover, previous reports have 
indicated that LEF1 can physically interact with and regulate MITF (Dorsky et al., 2000; Saito et 
al., 2002, Takeda et al., 2000; Yasumoto et al., 2002).  
To ask whether such an interaction might be occurring, I first examined McSC progeny in 




Figure 3.11 BMP-stimulated cells upregulate Lef1/LEF1. (A) Id2 and Lef1 mRNA levels by 
RT-qPCR after 30 hours of stimulation with 10 ng/mL recombinant BMP2 and BMP4 ± 250 nM 
ALK inhibitor (ALKi) [(BMP2 graphs:  Id2, ****padj=0.0001, **padj=0.0084; Lef1, 
***padj=0.0001) (BMP4 graphs:  Id2, ****padj=0.0001, Lef1, ****padj=0.0001, *=0.0111 by 
ordinary one-way ANOVA, Dunnett’s multiple comparisons test)]. (B) pSMAD1/5/9 and LEF1 
protein levels by western blot after 48 hour treatment. (C) Expression plot of Mitf levels in control 
and Bmpr1a null cells. (D) Mitf levels by RT-qPCR after 30 hours of stimulation with 10 ng/mL 
recombinant BMP2 ± 250 nM ALKi, with MITF protein levels by western blot after 48 hour 
treatment.  
 
diminished nuclear MITF (Fig. 3.10 D-E), further suggesting a link between these signaling 
pathways and TFs. While cell culture experiments were limiting overall (see Chapter 3.3.4.), I 
did find that upon BMP2/4 stimulation (ligands that are expressed in anagen skin in vivo), Lef1 
was upregulated. LEF1 protein levels were also increased at 48 hours of treatment with BMP2, as 




(ALK) inhibitor K02288 (Fig. 3.11 A-B). While Mitf mRNA was not changed during 
differentiation (Fig. 3.11 C) or upon BMP stimulation in culture (Fig 3.11 D, left), in vivo, there 
was increased MITF protein upon intact BMPR1a signaling (Fig. 3.10 C). However, in Melan-a2 
cells, MITF levels were already high in untreated cells and did not change further upon BMP2 
stimulation or K02288 inhibitor treatment (Fig. 3.11 D, right), again underscoring the importance 
of studying this signaling cascade in the lineage in the physiological context.  
To further investigate the possibility of such pathway intersection, genes with reduced 
expression in Bmpr1a null cells relative to control by scRNA-seq were scanned for TF motifs 
within their putative promoter regions (within 2.5 kb upstream of the transcription start site, TSS). 
To assess interplay between MITF and BMP-regulated LEF1 TFs, genes were classified as 
containing a MITF motif only, a LEF1 motif only, or both. In another analyses, to assess MITF 
and BMP-mediated pSMAD1/5/9 cooperation, genes were binned as containing a MITF motif 
only, a SMAD motif only, or both. These analyses revealed that genes with promotors harboring 
both MITF and LEF1 sites showed significantly lower expression than those with MITF alone; 
this preferential downregulation was not seen in genes with MITF and SMAD relative to MITF 
alone (Fig. 3.12 A). Analyses of genes increased in Bmpr1a null cells did not indicate any 
enrichments (Fig. 3.12 B). Strikingly, the BMP-regulated genes with both MITF and LEF1 sites 
(23 genes total) included those specifically involved in transport, transmembrane transport, 
melanin production, and melanosome organization, including Mc1r, Oca2, Trpm1, Rab38, and 
Shroom2 (Table 3.3; see also Table S11 of Infarinato et al., 2020). Together, these results 
suggested that downstream of BMPR1a signaling, LEF1 and MITF accumulate in the nucleus, 
where they may cooperate in the upregulation of differentiation-associated genes, particularly 





Figure 3.12 Motif analyses of putative promoter regions of BMPR1a-sensitive genes suggests 
cooperation between MITF and LEF1. Motif analysis of promotors within genes whose 
expression is either (A) reduced or (B) increased upon Bmpr1a loss. Box and whisker plots 




3.3.7 Chromatin accesibility dynamics during the transition from McSC to melanocyte 
suggests cooperation between LEF1 and MITF in differentiation 
 
 To look for further evidence of that MITF and LEF1 cooperate in melanocyte 
differentiation in vivo, I lastly sought to interrogate the chromatin landscape of the lineage. Recent 
studies have indicated the importance of specific chromatin modifers in regulating McSC behavior 
(Koludrovic et al., 2015; Moon et al., 2017), but again, I wanted to take an unbiased approach to 
survey chromatin in vivo. I hypothesized that chromatin openness would change as McSCs 
underwent differentiation into melanocytes and that regions that gain accessibility during 
differentiation would contain TF binding motifs that play a role in this transition. To assay 
chromatin dynamics in the McSC lineage, I implemented Assay for Transposase-Accessible 





Figure 3.13 qMcSCs and their progeny exhibit differential chromatin accessibility. (A) 
Correlation matrix indicating similarity between biological replicates of ATAC-seq. (B) Location 
of ATAC peaks expressed as percentages. (C) Heatmap of differential peaks in qMcSCs versus 
their differentiating hair bulb progeny (prog.) (Log2FoldChange≥1, p≤0.05). 
 
to insert sequencing adaptors in regions of open chromatin that is suitable for low cell number 
input (≥10,000 cells) (Buenrostro et al., 2013). For this assay, I isolated qMcSCs from the telogen 
bulge and McCP/melanocyte progeny from the anagen VI hair bulbs of Dct-eGFP+ mice to 




These ATAC-seq data showed high reproducibility across biological replicates (Fig. 3.13 
A), with similar percentages of peaks within 50 kilobases (kbs) of canonical TSSs (28.2% for 
peaks increased by log2fold≥1 in qMcSCs; 26.4% for McSC progeny) and similarly distributed 
throughout promoters, gene bodies, and intergenic regions  (Fig. 3.13 B). To ask whether the 
chromatin landscape changes throughout differentiation, differential peak analysis was performed. 
This analysis indicated that indeed qMcSCs and their differentiating progeny exhibit strikingly 
distinct chromatin accessibility profiles (Fig. 3.13C [log2 fold change≥1, p≤0.05], see also Table 
S12 of Infarinato et al., 2020), allowing for examination of chromatin regions containing BMP-
sensitive genes by scRNA-seq as well as TF motifs within these dynamic regions.  
Genes whose expression was diminished in Bmpr1a null cells showed increased 
accessibility in differentiation. Example gene tracks for Gpr143 and Oca2 are shown in Fig. 3.14 
A. Notably, Lef1 seemed to show chromatin remodeling as McSCs became differentiated, and 
some of the peaks that became more open in differentiating progeny contained SMAD motifs (Fig. 
3.14 B), supporting the notion that this TF gene might be a direct BMP target gene. Consistent 
with the timing of BMP signaling activity in the lineage, a number of these differential peaks 
associated with differentiation resided within the promoter/enhancer regions of genes 
downregulated upon Bmpr1a ablation (Fig. 3.14 C). 
To next ask what TFs might bind in these differentially accessible chromatin regions, 
unbiased TF motif analysis was performed for stem and differentiation-enhanced ATAC peaks. 
Strikingly, LEF/TCF and MITF (TFEB, TFE3, TFEC) family factors were the top most enriched 
factors in peaks increased in differentiation (Fig. 3.15 A; see also Table S13 of Infarinato et al., 
2020). Conversely, peaks increased in qMcSCs showed enrichment of SP/KLF and AP-1 family 




Figure 3.14 BMP-sensitive genes show increased accessibility in differentiation. (A) ATAC 
tracks showing differential peaks of select differentiation genes. (B) ATAC track of Lef1 gene 
showing chromatin opening in differentiating progeny in regions with SMAD motifs, indicated by 
dashed red boxes. Merged (mean averaged) of three biological replicates are shown. Zoomed in 
views shown to bottom left within red dashed lines. (C) Number of peaks increased in either 
qMcSCs or their differentiating progeny within 5 or 50kb ± of the TSS of genes (80) whose 
expression is diminished upon loss of BMPR1a signaling by scRNA-seq. 
 
play a role in SC biology, such as PAX3 and RBPJ. Motifs such as SOX10 were present in both 
qMcSC and differentiating progeny peaks, with no significant enrichment in either direction. 
Honing in specifically on the set of genes whose expression was diminished in Bmpr1a null cells, 
another motif analysis was performed on differentiation-enriched ATAC peaks within ±50 kb of 
the TSS for these differentially expressed genes (putative promoter and enhancer regions). Again, 




3.15 B; Table 3.4; see also Table S14 of Infarinato et al., 2020), further highlighting the 
importance of both LEF1 and MITF downstream of BMPR1a signaling in driving differentiation.  
Lastly, to assess how BMP regulation via SMADs might impact chromatin dynamics, all 
differentiating progeny peaks were considered for genes whose expression was reduced in Bmpr1a 
null cells, as analysis of differentiation-enhanced peaks did not yield clear results for SMAD 
factors. In agreement with the predictive motif scanning of putative TSS regions (Fig. 3.12), 
analysis of ATAC peaks in the differentiating progeny suggested that many genes involved in 
melanin biosynthesis, transport, and trafficking (i.e. Mc1r, Rab38, Trpm1, Slc24a4) may require 
cooperation of SMAD as well as MITF and LEF1 in controlling their lineage-specific activation 
(Fig. 3.15 C; see also Table S15 of Infarinato et al., 2020).  Overall, these data suggest that McSCs 
and their differentiating McCP/melanocyte progeny undergo chromatin rearrangement during 
differentiation and provide compelling evidence for not only the master regulator MITF but also 









Figure 3.15 Motif analyses within ATAC peaks suggests cooperation of MITF, LEF1, and 
SMAD TFs at BMP-sensitive genes. (A) Plot expressing enrichment of select motifs in 
differential ATAC peaks between each cell type. Motifs with -Log10(p-value) greater than 300 are 
expressed as a maximum of 300 here. (B) Motif analysis within peaks subset by the following 
parameters:  peaks enriched in differentiating progeny relative to McSCs and 50 kb ± TSS of genes 
downregulated in Bmpr1a null cells. X. *=MITF family, **=LEF/TCF family. See also Table 3.4. 
(C) Motif analysis within differentiating McSC progeny peaks within 50 kb ± TSS of genes whose 
expression is diminished in Bmpr1a null cells. Table highlights LEF1, MITF, and SMAD(2, 3, 





 The temporal nature of my scRNA-seq dataset made it a powerful tool with which to 
elucidate the precise coordination of niche pathways and TF responses that might interact to 
achieve aMcSC and McCP proliferation and final melanocyte differentiation. Intrigued by 
evidence of converging BMP and WNT signaling downstream of McSC activation, I investigated 
the roles and intersection of these pathways in the lineage harnessing genetic mouse models, IMF 
and EM analyses, and scRNA and ATAC-seq. These studies revealed a newfound role for 
signaling through BMPR1a in driving cells past the McCP stage to fully mature melanocytes 
through nuclear accumulation of MITF and LEF1 to upregulate transcription of melanosome 




 Similar to the results of cell culture studies pertaining to BMP signaling, prior reports in 
animals were also difficult to resolve. Mice ectopically expressing the secreted BMP inhibitor 
noggin under the Krt5 epidermal promoter had darker coats due to reduced expression of ASIP, 
which signals through MC1R to promote pheomelanin production (Sharov et al., 2005). At the 
same time, mice with melanocyte-specific deletion of Bmpr2 had no phenotype unless on an 
activin A receptor type 2A (Acvr2a) full body KO background, in which case mice had gray hair 
(Han et al., 2012). In zebrafish, BMP signaling via growth differentiation factor (GDF6, also 
known as BMP13) suppresses melanocyte differentiation during development and in melanoma 
via downregulation of mitfa (an ortholog of Mitf). In implementing a conditional, lineage-specific 
ablation approach to delete Bmpr1a, a type I BMP receptor with preferential BMP ligand 
specificity, my approach allowed me to dissect the contribution of this pathway in lineage 
progression in the mammalian context, allowing for normal melanoblast specification and McSC 
establishment while preserving the native niche microenvironment. In this way, I could clearly 
demonstrate the BMP signaling is critical for normal melanocyte maturation, and in contrast to 
what has been described in zebrafish, promotes nuclear accumulation of MITF, as well as LEF1, 
to do so. 
 McSCs must coordinate their behavior with neighboring HFSCs, so because BMP 
(BMPR1a) signaling maintain HFSC quiescence (Adam et al., 2018; Genander et al., 2014; 
Kobielak et al., 2007), this pathway might have also been predicted to promote a quiescent state 
for McSCs in telogen. Surprisingly however, McSCs appear to be largely refractory to BMP 
signaling, as reflected by the paucity of nuclear pSMAD1/5/9 in these cells throughout the hair 
cycle. In Bmpr1a cKO mice, McSCs still became activated at early anagen, were able to generate 




anagen. There are several possible scenarios that might explain these distinct responses of McSCs 
and HFSCs, from differential receptor expression to ligand availability. It is notable that these SCs 
occupy distinct locales within the niche; quiescent HFSCs flank the BMP-rich inner bulge, while 
qMcSCs reside near the base of the bulge where BMP levels lower (Hsu et al., 2011; Yang et al., 
2017). TGF-β signaling is elevated at the bulge base (Oshimori and Fuchs, 2012), which could 
explain the preferential sensitivity of McSCs to this related signaling pathway during quiescence 
(Nishimura et al., 2010). Another interesting possibility is that in the McSC lineage, TGF-β and 
BMP signaling act in an antagonistic fashion, pushing cells towards stemness/quiescence and 
differentiation, respectively. 
In considering how BMP intersects with WNT, while WNT/β-catenin signaling impacts 
McSC proliferation (Rabbani et al., 2011), BMP signaling functions after initial McCP 
specification, when cells are proliferative but show considerable signs of differentiation.  In 
Ctnnb1 cKO mice, nuclear pSMAD1/5/9 was still seen in McSC hair bulb progeny, suggesting 
that BMP signaling is not dependent on WNT signaling, but nuclear LEF1 was diminished in 
Bmpr1a null cells, suggesting WNT’s reliance on BMP signaling downstream during melanocyte 
maturation. Placing BMP signaling upstream of Lef1 expression and nuclear accumulation of 
LEF1 and MITF provided mechanistic understanding of the detrimental effects of loss of BMPR1a 
on pigment production, as well as their failure to progress appreciably past the immature McCP 
stage. While the “rheostat model” alone might explain why some MITF target genes were still 
expressed in Bmpr1a null cells (i.e. low levels induce expression of genes involved in survival and 
proliferation) and others are diminished (i.e. high levels induce genes involved in differentiation 
such as melanosome biogenesis and transport), these data also suggest cooperation with the TF 




reduced nuclear MITF, the mechanism for how these two TFs might be coordinating their behavior 
it is not yet clear.  
While some of BMP’s effect on the lineage appear to be indirect, motif analysis of 
differentiating melanocyte ATAC peaks provides insight into genes that might be direct SMAD 
targets, such as Slc45a2 and Tyrp1 (SMAD sites only), but further studies are required to 
demonstrate such regulation. More interesting however was the reduced transcription of genes 
with both LEF1 and MITF in their putative promoter regions in Bmpr1a null cells, and the 
importance of these factors was reinforced by chromatin accessibility profiling of McSCs versus 
their differentiating progeny. These ATAC data also revealed that regions within the Lef1 gene 
locus with SMAD motifs show enhanced accessibility upon differentiation, corroborating the 
finding that Lef1 mRNAs are downregulated upon Bmpr1a ablation and suggesting that Lef1 is 
likely a direct BMP target gene.  Together, these data provide new insights into how BMP signals 
in this lineage, supporting a model whereby signaling through BMPR1a upregulates Lef1, and 
LEF1 then promotes nuclear accumulation of and cooperates with MITF to govern a critical cohort 





































































4.1 Summary:  new insights into McSC lineage progression and a key role for BMP signaling 
in melanocyte differentiation in the HF niche 
 
 Dissecting the molecular mechanisms that drive adult tissue SC behavior is of fundamental 
importance for our understanding of how the body maintains and replenishes itself. These same 
mechanisms can be disrupted in aging and disease. In my thesis research, I sought deeper 
understanding of McSCs and their dynamic lineage, generating a high-resolution characterization 
of the transcriptional programs that accompany lineage progression. Importantly, this work has 
yielded insight into the intermediate stages of McSC activation and McCP maturation and has 
uncovered that transcriptional heterogeneity increases over the course of the differentiation 
trajectory (Chapter 2). Using conditional lineage-specific ablation in mice, I have demonstrated 
a role for BMPR1a signaling in driving complete differentiation, clarifying a role for this pathway 
in regulating McSC lineage progression in the HF niche that was not well appreciated or 
understood. Using single cell transcriptional profiling coupled with pseudotime analysis, I have 
unearthed the complex gene regulation downstream of this receptor and pinpointed where 
signaling acts in differentiation. Curiously, Bmpr1a null cells retain stemness markers, show 
elevated proliferation, and have a higher density of immature melanosomes. Importantly, BMPR1a 
signaling is necessary for the nuclear accumulation of master regulator MITF and WNT mediator 
LEF1. Investigating the substantial chromatin rearrangements that take place as cells transition 
from SCs to differentiated melanocytes, motif analyses further pointed to cooperation between 
MITF and LEF1 near BMP-sensitive genes (Chapter 3). Altogether, my data support a model 
wherein McSCs are refractory to BMP until the McCP stage, when signaling promotes nuclear 
accumulation of MITF and SMAD-mediated upregulation of Lef1/LEF1; these two key TFs 
regulation transcription of genes required for terminal differentiation, involving the upregulation 




 In considering how these pathways fit into the broader field, McSCs seem to fall within the 
ranks of other tissue SC types such as HF, mesenchymal, and intestinal SCs, which also use the 
BMP pathway to coordinate differentiation (Adam et al., 2018; Beumer and Clevers, 2021; Chen 
et al., 2012; Genander et al., 2014; He et al., 2004). For instance, to promote differentiation and 
restrain proliferation, intestinal SCs undergo a switch from WNT to BMP signaling (Beumer and 
Clevers, 2021; He et al., 2004), whereas in McSCs, BMP seems to both promote differentiation, 
suppress proliferation, but also enhance WNT signaling through LEF1. Interestingly, in 
hippocampal neural SCs, BMP and WNT signaling also seem to converge at the level of LEF1 
(Armenteros et al., 2018). These similarities raise questions about the role of other more universal 
signaling pathways associated with SC differentiation, particularly SHH signaling. 
 
4.2 Outstanding questions:  unraveling the complex mechanisms up- and downstream of 
BMPR1a in the tissue microenvironment 
 
 My results suggest that signaling downstream of BMPR1a leads to SMAD-mediated 
upregulation of Lef1 mRNA and nuclear accumulation of LEF1 protein. While MITF is critical in 
promoting differentiation and appears to cooperate with LEF1 to do so, given that Mitf mRNA is 
not affected in Bmpr1a null cells, it is still not clear how BMP signaling induces accumulation of 
nuclear MITF post-transcriptionally. This is somewhat surprising, as LEF1 has been reported to 
activate transcription of Mitf-M in human cultured melanocytes (Takeda et al., 2002). In any case, 
in Lef1 null cells, nuclear MITF is diminished, supporting interplay between these two factors. 
Previous studies have provided some possible avenues for how this coregulation might occur. For 
instance, LEF1 (but not TCF1) can physically interact with MITF/TFE3 TFs (Yasumoto et al., 
2002). Perhaps such interactions might induce stabilization and nuclear localization of MITF. 




shown to stabilize MITF, driving upregulation of genes involved in multivesicular body 
biogenesis. These bodies further enhance WNT by sequestering β-catenin destruction complex 
proteins (Ploper et al., 2015).  
 Furthermore, BMPR1a phosphorylation can trigger both canonical and noncanonical 
signaling cascades, with different BMP ligands and receptor combinations activating different 
downstream mediators. It seems likely that in vivo, both arms are this cascade are stimulated 
simultaneously. While Lef1 upregulation appears to occur through canonical BMP-SMAD 
signaling, MITF levels might be controlled via SMAD-independent noncanonical pathways, such 
as p38-MAPK, which can phosphorylate MITF in osteoclasts (Mansky et al., 2002). In cultured 
human melanocytes, BMP6 signals through p38 to induce melanogenesis (Singh et al., 2012). At 
the same time, this paper also demonstrated that BMP4 reduces melanin production, making it 
difficult to predict what the role of this signaling pathway would be in the native HF niche and 
highlighting the importance of complementary in vivo studies.  
 Reflecting further on the report by Singh et al. (2012) demonstrating the anti-melanogenic 
effect of BMP4 in culture, it is intriguing that I find that BMP4 (and BMP2) both induce 
upregulation of Lef1. While WNT signaling is critical for melanocyte differentiation (Rabanni et 
al., 2011), it is not yet completely clear to what extent reduced nuclear LEF1 drives the BMPR1a 
loss-of-function phenotype. While LEF1/TCF family motifs are enriched in differentiation-
enhanced ATAC peaks (Fig. 23A-B), it is possible that other TCF factors may be able to act in a 
functionally redundant manner. The Lef1 KO mice do appear to have reduced hair pigmentation, 
but a conditional lineage-specific ablation approach would be ideal. To this end, I have been 
generating a TyrCreER Lef1floxed (Zhou and Xue, 2012) R26YFPfloedx strain to investigate whether 




with IMF, and YFP+ cells can be FACS purified to assess changes in transcription. To more 
conclusively define LEF1 targets, future ChIP-seq studies performed in vivo with techniques 
optimized for low cell input such as CUT&RUN (Skene and Henikoff, 2017) would be 
informative. One possibility to explore would be that LEF1 mediates target genes involved in 
proliferation. This fits with the finding that BMP4 (which in my hands upregulates Lef1) in 
downregulated during UV exposure (Singh et al., 2012). Perhaps this signal restrains proliferation 
in the HF bulb, but is downregulated upon UV in the epidermis to allow melanocytes to both 
proliferate and continue to produce melanin.  
 Finally, there is the question of which cells in the HF niche are providing the BMP ligands 
that McCP and melanocytes respond to during anagen. Autocrine signaling may be occurring, as 
McCP and melanocytes express Bmp2 and Bmp7 by scRNA-seq (Fig. 8C-D), preferential ligands 
of BMPR1a (Wang et al., 2014). However, the skin is rich in BMPs emanating from several 
compartments. One immediate possible source is the HF matrix TACs, which would make sense 
in terms of coordinating the differentiation of these two SCs compartments so that pigment could 
be transferred to hair cells at the appropriate time. BMP also directly regulates a cohort of hair-
specific genes in the proliferative progenitors of the hair shaft (Adam et al., 2018; Genander et al., 
2014). Another candidate would be the Krox20+ cells specifically, as these also provide SCF to 
promote melanocyte maturation and maintenance (Liao et al., 2017). BMPs also appear to be 
elevated at the apical region of the DP where proliferative precursors of both the hair shaft and the 
melanocytes reside (Yang et al., 2017). While it seems most likely that BMPs acting on the 
melanocyte lineage come from within the HF, other conceivable sources include the dermis, which 
exhibits cyclic expression of BMP2 and BMP4 or the adipose tissue that expresses BMP2 (Plikus 




several niche cell types producing different BMPs and extracellular regulators and the convergence 
of both canonical and noncanonical pathways with players like WNT converge to determine the 
outcome of BMPR1a signaling in the native microenvironment. 
 
4.3 Future Directions  
 
 Studies investigating both specific pathways using genetic mouse models and global 
profiling methods in the melanocyte lineage in the HF have been critical for unraveling how 
McSCs transition through different cellular states in homeostasis. These in turn raise intriguing 
questions about how these genes and pathways act in phenotypic variation, aging, and diseases 
such as cancer. Pathways that regulate SC behavior often come into play in contexts outside of 
normal tissue regeneration. For example, the critical differentiation-promoting pathways MC1R 
and WNT/β-catenin are also necessary for McSC migration out of the HF niche to the epidermis 
during wounding (Chou et al., 2013; Sun et al., 2018). In melanoma, variants in MC1R, especially 
those resulting in fair skin and red hair, are associated with greater risk of developing cancer due 
not only to reduced pigmentation and UV-protection, but also because pheomelanin itself has 
carcinogenic properties (Mitra et al., 2012). Similarly, while its impacts on melanoma appear to 
be highly context-dependent, WNT/β-catenin is also a key player in melanoma (Gajos-
Michniewicz and Czyz, 2020). Aging encompasses cumulative stress, injury, and inflammation 
over the course of an organism’s lifetime, on top of homeostatic tissue demands. Here, I discuss 
three exciting avenues of inquiry that stem from my thesis work, exploring the possible roles of 







4.3.1 Potential mediators of phenotypic diversity in hair pigmentation and patterning 
 
 The gray hair phenotype elicited by loss of Bmpr1a (Fig. 3.3 A) raises the question of 
whether this pathway might be altered in nature to achieve different skin and coat colors or 
contribute to pattern formation. In HFs, this could be accomplished through downregulation of 
BMPR1a cell surface expression during differentiation and or by differential ligand or inhibitor 
(i.e. noggin) production in the microenvironment. Whether BMPR1a signaling might affect 
melanoblast migration during embryonic development in some species, thus affecting 
pigmentation and patterning (as in SCF/c-KIT and EDN3/EDNRB mutant mice), is another 
possibility. Indeed, several of the genes upregulated in Bmpr1a null cells were related to migration 
and cell adhesion (Fig. 3.6 B-C). At the same time, migration to the epidermis in adult mice in 
response to wounding or UV exposure is dependent on MC1R (Chou et al., 2013), which is 
downregulated in Bmpr1a cKO mice. Therefore, there are several potential mechanisms by which 
BMP could elicit phenotypic diversity in hair, fur, skin, and feathers. 
 While thoroughly investigating the status of epidermal melanocytes in the Bmpr1a cKO 
mice was beyond the scope of my study, I did not observe overt phenotypic differences in the ears, 
feet, or tail where these populations reside. There is reason to believe that such effects might only 
be seen upon UV exposure to enhance their basal activity. Singh et al. (2012) showed that upon 
UV exposure, human cultured melanocytes upregulate Bmpr1a, Bmpr1b, Bmpr-II, and Bmp6. 
Furthermore, their work suggests that different classes of BMPs can have opposing effects on 
melanogenesis, again highlighting the possibility of differential regulation of this pathway to 








4.3.2 Elevated BMP levels in aging skin and potential implications for hair graying 
 
 This deeper understanding of the role of BMP signaling in McSC differentiation into 
melanocytes in the HF raises an intriguing question: could perturbed BMP signaling occur 
throughout aging and contribute to hair graying? This is especially interesting in light of previous 
work in Fuchs Lab demonstrating that the production of BMPs in the skin increases with age in 
mice (Keyes et al., 2013). For aged HFSCs in the bulge, this results in increased pSMAD1/5/9 
activity and longer periods of quiescence, leading to reduced hair growth (Keyes et al., 2013). 
Given this changing microenvironment and the importance of BMPR1a signaling in promoting 
melanocyte lineage differentiation under normal conditions, it is tempting to speculate that BMP 
might contribute to age-related hair graying. Indeed, while limited, there is some evidence linking 
increased WNT/β-catenin signaling in the skin to hair graying in mice (Zhang et al., 2017). These 
findings further suggest that pathways that normally regulate McSC lineage progression can be 
disrupted in age.   
 Hair graying can result from depletion or dysfunction of McSCs or McCP/melanocyte in 
the hair bulb. In actuality, a combination of issues might come into play as the long-lived McSCs 
and surrounding HF and skin microenvironment change during aging. In the case of BMP 
signaling, one might hypothesize that age-related hair graying might result from 1) increased BMP 
signaling causing ectopic activation of this pathway in bulge McSCs, driving their depletion and 
subsequent loss of their differentiating progeny, and or from 2) the impaired ability of McSC 
progeny to respond to BMP signaling, resulting in their failure to fully differentiate into pigment-
producing cells, causing loss of color in the growing hair. These mechanisms could be investigated 
in mice, who like humans, exhibit age-associated hair graying; Zhang et al., (2017) observed 




McSCs might result in pSMAD+ DCT+ McSCs and or differentiated (melanogenic) melanocytes 
in the bulge area. Impaired ability of differentiating progeny in aging follicles might elicit a 
phenotype reminiscent of Bmpr1a cKO mice, where anagen follicles with gray/white hair show 
DCT+ differentiating progeny in the hair bulb without nuclear pSMAD1/5/9, LEF1, or MITF. Cells 
from both conditions could be FACS purified to assess changes in receptor, BMP ligand, and 
downstream target gene expression in aged versus young adult mice. 
 Such studies in McSCs and their lineage and their response to BMPs throughout aging 
might shed light on disruptions that occur in other tissue SC types where BMP signaling is active. 
Furthermore, age-related deterioration of melanocyte function lessens their ability to produce 
melanin and provide UV protection, promoting epidermal aging and increasing the risk of skin 
cancer, rendering such investigations all the more important. If elevated BMP signaling in age 
does negatively impact McSCs (as has been shown for HFSCs), one could conceive of potentially 
using topical BMP inhibitors or intradermal injection of recombinant protein inhibitors as an anti-
aging strategy to boost both hair growth and pigmentation.  
 
4.3.3 BMPR1a as a possible switchboard for melanoma cells 
 
 Arguably one of the most exciting avenues opened up by this work are questions pertaining 
to how BMP might impact transformed cells of this lineage:  melanoma. Not surprisingly, both 
pro- and anti-tumorigenic effects of this pathway have been described, but BMP has often been 
linked to melanoma invasiveness and migration (Braig and Bosserhoff, 2013; Gramann et al., 
2019; Hsu et al., 2005; Rothhamer et al., 2005; Sinnberg et al., 2018; Venkatesan et al., 2018). For 
example, BMP2 is highly expressed in invasive melanoma cell lines, is thought to promote 




(Sinnberg et al., 2018). Intriguingly, recent work in zebrafish melanoma has indicated that ligand-
activated BMP signaling actually inhibits differentiation and cancer cell death (Venkatesan et al., 
2018). This group further demonstrated that GDF6 is expressed in melanoma (but not in normal 
melanocytes) and acts through BMP receptors to maintain a neural crest signature through MITF 
inhibition. Furthermore, GDF6 expression in melanoma is inversely correlated with patient 
survival (Gramann et al., 2019). 
However, my work demonstrates that in the mammalian physiological context, loss of 
BMP signaling suspends the melanocyte lineage in a committed progenitor-like state, where cells 
are proliferative but unable to fully differentiate. Therefore, one might hypothesize that melanoma 
cells could exploit this pathway to progress in malignancy, and that in certain contexts, being 
refractory to BMPR1a signaling could promote activated McSC/McCP-like characteristics. 
Perhaps in premalignant cells or early in tumor initiation, enhanced BMPR1a signaling might help 
to push cells towards a more differentiated (MITFhigh LEF1high) and less proliferative state, blunting 
progression. As the tumor advances, however, cells could downregulate BMPR1a or its activating 
ligands to achieve an MITFlow-medium LEF1low-medium state with less melanin production, more 
proliferation, and enhanced expression of stem and migratory genes. Support for such a scenario 
comes from familial cancer syndromes caused by germline mutations in Bmpr1a, such as Juvenile 
Polyposis and Cowden disease (Hsu et al., 2005; Zhou et al., 2001). These syndromes are 
characterized by benign overgrowths and increased susceptibility to  cancer. Zhou et al. (2001) 
found that many Bmpr1a mutations in these patients were predicted to result in truncated receptors 
and diminished BMP signaling, reminiscent of the over-proliferation of McCP in Bmpr1a cKO 
mice. Therefore, BMPR1a might have both oncogenic and tumor suppressive roles, similar to 




depending on the context (Bilodeau et al., 2001; Han et al., 2012; Jin et al., 2001; Kawakami et 
al., 2008; Park et al., 2009; Sharov et al., 2005; Singh et al., 2012; Yaar et al., 2006; Yang et al., 
2014).  
Indeed, related superfamily member TGF-β can enhance the proliferation of tumor-
initiating cells when signaling is silenced, while simultaneously playing a powerful counter role 
in promoting invasion and metastasis (David et al., 2016; David and Massague, 2018; Guasch et 
al., 2007; Oshimori et al., 2015; Su et al., 2020).  It is tempting to speculate that in melanoma, the 
juncture between immature McCP and differentiated melanocytes might become plastic through 
cells flipping their reliance on BMP signaling, depending on the stage of disease progression and 
particular microenvironment.  
Future studies in mouse models of melanoma (to complement those performed in 
zebrafish) may illuminate whether mechanisms involving BMPR1a might be at work. If so,  
melanoma might conceivably be treated with BMP receptor agonists or antagonists. At the same 
time, in addition to BMPR1a and its downstream signaling, my extensive scRNA-seq of the 
lineage, in particular that of quiescent and activated McSCs and McCP, provides a wide range of 




































































All mice were maintained in The Rockefeller University’s Association for Assessment and 
Accreditation of Laboratory Animal Care (AAALAC)-accredited animal facility, the Comparative 
Bioscience Center. All mouse procedures were performed under Institutional Animal Care and 
Use Committee (IACUC)-approved laboratory protocols.  
Dct-eGFP mice (Tg(Dct-EGFP)NY2Gsat/Mmucd, RRID:MMRRC_032849-UCD) were 
obtained from Mutant Mouse Resource and Research Center (MMRRC) at University of 
California at Davis and was donated to the MMRRC by Dr. Nathaniel Heintz of The Rockefeller 
University (GENSAT) (Gong et al., 2003). Lef1-RFP mice were generated previously in the Fuchs 
Lab by Rendl, et al. (2005). Dct-eGFP (mixed C57BL6/J, JAX#000664) males were crossed to 
CD1 females (CRL, Strain 022) to increase litter size and improve maternal care for mice used in 
qMcSC and aMcSC studies (Dct-eGFP+ only). Background strain was kept as consistent as 
possible in generating Dct-eGFP+ Lef1-RFP+ mice, mating Dct-eGFP (mixed C57BL6/J) males 
with Lef1-RFP (CD1) females. TyrCreER (JAX#012328) (Bosenberg et al., 2006) mice were 
purchased from Jackson Laboratories and mated to in house colonies of Bmpr1a floxed (Mishina 
et al., 2002) R26YFP floxed (JAX#006148) (Srinivas et al., 2001) (mixed C57BL/6) mice. The 
Lef1 KO strain (C57BL/6J) was obtained from Dr. Rudolf Grosschedl (Kratochwil et al., 1996). 
Ctnnb1 floxed (JAX#004152) (Brault et al., 2001) (C57BL/6J) were purchased from Jackson 
Laboratories.  
For RNA and ATAC-seq experiments and IMF quantifications, male mice were used to 
eliminate sex-related differences, minimize variability in the hair cycle, and capture more cells per 
experiment. Male and female mice were used for IMF analysis (sex-matched for comparison), and 




Photographs of the gross phenotypes of mice were taken with iPhone 6, 7 Plus, and 11 Pro Max 
cameras and brightened in Fijj/ImageJ as necessary. Genotyping was performed using the primers 
listed in Table 5.1 below. 
Table 5.1 Genotyping Primer List 
 
Primer Name                Sequence 5’ > 3’ 
β-catenin 1 AAGGTAGAGTGATGAAAGTTGTT 
β-catenin 2 CACCATGTCCTCTGTCCTATTC 
β-catenin 3 TACACTATTGAATCACAGGGACTT 
Bmpr1a Fx2 Forward GCAGCTGCTGCTGCAGCCTCC 




GFPR2 Reverse TAGCGGCTGAAGCACTGCA 
Lef1-RFP Forward CACCCTTGAGTTACCCCTCTG 
Lef1-RFP Reverse CCCTGAAAACTTTGCCCCCTC 
Neo A  TGGAGAGGCTATTCGGCTATGAC 
Neo B AACTCGTCAAGAAGGCGATAGAAG 
TyrCreER Forward CAGGGTGTTATAAGCAATCCC 
TyrCreER Reverse CCTGGAAAATGCTTCTGTCCG 
Rosa26YFP common AAAGTCGCTCTGAGTTGTTAT 
Rosa26YFP mutant AAGACCGCGAAGAGTTTGTC 




 EdU incorporation. To assess McSC proliferation by IMF, two 100 uL doses of 5 mg/mL 
5-Ethynyl-2´-deoxyuridine (EdU) were administered by intraperitoneal injection (IP). Mice were 
euthanized and skin was collected 24 hours after the first dose of EdU. To quantify proliferation 
of McSCs and their differentiating progeny in the hair bulb in TyrCreER Bmpr1afloxed R26YF floxed 
mice one week after waxing, animals were given 100-150 uL EdU by IP 4 hours prior to sacrifice 
and skin collection.  
 Tamoxifen treatment. Starting at P21 (weaning age), TyrCreER Bmpr1afloxed R26YFPfloxed 
and TyrCreER Ctnnb1floxed R26YFPfloxed mice were given 50uL 2% tamoxifen dissolved in Sigma 




isoflurane anesthesia. Buprenorphine was given for pain management, and nails were clipped to 
minimize scratching. To prevent fighting and injury of waxed skin, male mice were singly housed 
after the procedure until the time of euthanasia. 
 
Fluorescence-activated Cell Sorting   
 
To obtain single cell suspensions for FACS purification, mouse back skin was dissected 
and subjected to chemical and mechanical digestion. Telogen (P58-80 for qMcSCs) and anagen I-
II (P21 for aMcSCs) skin was scraped with a dull scalpel to remove excess fat prior to rotating 
incubation in trypsin-EDTA (Gibco) hair side up at 37°C for 45-60 minutes. Skin was then scraped 
with a dull scalpel against the direction of hair growth to release cells in the HFs. Anagen skin 
(P9-10 or 1 week or 12 days post waxing) was digested hair side up in 0.25% collagenase (Sigma) 
in HBSS (Gibco) at 37°C for 25-30 minutes. DNAse (Roche, 1:200) and 5mM MgCl2 was 
sometimes added to anagen skin preparations to minimize cell clumping. The skin was then 
scraped from the dermal side to preferentially release cells in the hair bulb. The suspensions were 
quenched with cold FACS buffer (5% FBS in 1X PBS), filtered, spun down, and incubated for 25 
minutes on ice with primary antibodies. All antibodies used are listed in Table 5.2. For biotin-
conjugated antibodies, cells were washed and incubated with streptavidin secondary antibody for 















Table 5.2 FACS Antibody List 
 
Antibody                  Company, Catalogue #         Dilution 
Ly-6A/E (Sca-1) PerCP-Cy5.5  eBioscience, 45-5981-82 1:1000 
Ly-6A/E (Sca-1) APC-Cy7 BioLegend, 108126 1:1000 
CD34 eFluor660 eBioscience, 50-0341 1:100 
CD49f (α-6) BV421 BioLegend, 313624 1:100 
CD49F (α-6) PE-Cy-7 BioLegend, 313621 1:100 
CD117 (c-KIT) PE-Cy-7 eBioscience, 25-1171-82 1:100 
Biotin-CD140a BioLegend, 135910 
 
1:150 
Biotin-CD31 BioLegend, 102404 1:150 
Biotin-CD45 BD, 553077 1:150 
Streptavidin PE eBioscience, 12-4317 1:1500 
Streptavidin APC-Cy7 BD, 554063 1:500 
 
DAPI was used for live/dead cell exclusion. For bulk RNA-seq and RT-qPCR, cells were 
sorted with a 70 um nozzle directly into TRIzol (ThermoFisher). For scRNA-seq, cells were sorted 
with a 100 um nozzle into 96 well plates, gating more conservatively to minimize the capture of 
contaminating cell types. Cells were sorted by the Flow Cytometry Resource Center of The 
Rockefeller University. Flow cytometry plots were generated using FlowJo to illustrate the 
strategies used to isolate each cell population. Manual compensation was performed for 
presentation of flow plots 
Immunofluorescence 
 
To prepare tissue for IMF analysis, mouse back skin was prefixed in 4% paraformaldehyde 
in PBS immediately after dissection for 30 minutes at room temperature or 1-2 hours at 4°C. Tissue 
was then washed with 1X PBS and incubated while rotating in 30% sucrose in PBS at 4°C 
overnight before embedding in OCT Compound. Frozen blocks were sectioned (10-18µm 
thickness) on a Leica cryostat and mounted on SuperFrost Plus slides (Thermo Fisher). Unstained 




Slides were dried at room temperature before blocking for at least an hour in IMF staining 
buffer consisting of 5% normal donkey serum, 1% bovine serum albumin, 2% fish gelatin and 
0.3% Triton X-100 in PBS. For TYR and MITF IMF, slides were additionally fixed in cold 
methanol at 20°C for 20 minutes before blocking. Slides were incubated with primary antibodies 
diluted in IMF staining buffer (listed in Table 5.3) at 4°C overnight and washed three times with 
PBS prior to incubation with secondary antibodies (Alexa Fluor-RRX, 488, or 647-conjugated, 
Life Technologies at 1:500 dilution) for an hour at room temperature. For EdU, the Click-iT EdU 
Alexa Fluor 647 Imaging Kit (C10340) was used before proceeding to secondary antibody 
staining. Slides were washed another three times before mounting with ProLong Antifade Gold 
with DAPI Mountant (Thermo Fisher). Counterstaining with DAPI in PBS was sometimes 
performed to enhance nuclear signal.  
Table 5.3 Primary Immunofluorescence Antibody List 
 
Antibody            Company, Catalogue #    Dilution 
DCT (TYRP2, D-18) Santa Cruz, sc-10451  1:200-250 
TYRP1 Made by Fuchs Lab 1:100 
Tyrosinase (PEP7) Made by V.J. Hearing 1:750 
CD104 (integrin β-4) BD Pharmingen, #553745 1:100 
PMEL (Anti-Melanoma gp100 [EP4863(2)]) Abcam, ab137078 1:750 
GFP Abcam, ab13970 1:2000 
RFP Made by Fuchs Lab  
Phospho-Smad1 (Ser463/465)/Smad5 
(Ser463/465)/ Smad9 (Ser465/467) (D5B10) 
Cell Signaling, #13820 1:100 
Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) XP Cell Signaling, #4511 1:100 
MITF Abcam, ab122982 1:100 




IMF microscopy images were acquired with an Axio Observer.Z1 epifluorescence 
microscope with a Hamamatsu ORCA-ER camera (Hamamatsu Photonics) and with an 




Differential interference contrast (DIC) brightfield images were taken on the Axio Observer.Z1 
using the Axiocam 305 camera (Zeiss). Images were processed by channel using Fiji/ImageJ using 
Brightness/Contrast where appropriate. Images with Z-stacks were displayed as max intensity 
projections. Optical density (OD) was determined with MetaMorph software (Molecular Devices), 
where OD=log10 (1/transmittance), and transmittance=transmitted light/incident light. 
Measurements were made of a single plane of DIC bright field image with Integrated 
Morphometry Analysis within a freehand drawn region outlining the DCT-stained region (based 
on maximum intensity projection).   
Electron microscopy 
 
Skin samples were fixed in 2% glutaraldehyde, 4% PFA, and 2 mM CaCl2 in 0.1 M sodium 
cacodylate buffer (pH 7.2) at room temperature for >1 hour, post-fixed in 1% osmium tetroxide, 
and processed for Epon embedding. Ultrathin sections (60–65 nm) were counterstained with uranyl 
acetate and lead citrate. Images were taken with a transmission electron microscope (Tecnai G2-
12 FEI) equipped with a digital camera (AMT BioSprint29). For quantification, melanosomes 
were counted within hair bulb McSC progeny areas ≥10um2. These areas were outlined by hand 
by H. Amalia Pasolli, an expert in EM analysis of the skin. Melanosomes were scored as immature 
by the presence of striations/translucency and as mature (stage IV) if opaque. Measurements were 
expressed as melanosome number/cell area captured. 
Cell Culture 
 
The Melan-a2 mouse melanocyte cell line was generated by Sviderskaya, et al. (1995) and 
purchased from the Wellcome Trust Functional Genomics Cell Bank of St George's, University of 
London (http://anatomy.sgul.ac.uk/pages/). Cells were cultured in RPMI 1640 with L-glutamine 




phorbol 12-myristate 13-acetate and grown at 7.5% CO2. Cells were plated for experiments 24 
hours before treatment in normal growth media, then serum starved at 0.5% FBS during the course 
of treatment (10 ng/mL recombinant human/murine/rat BMP2, murine BMP4, or human BMP6 
(Peprotech) and or 250 nM ALK inhibitor K02288 (Tocris) in DMSO). 
 To generate a Bmpr1a KO Melan-a2 cell line with CRISPR, we first made a clonal parental 
cell line from a single Melan-a2 cell to minimize experimental variability. Predesigned gRNA was 
purchased from Integrated DNA Technologies (IDT) (control non-targeting and 
DesignID:Mm.Cas9.BMPR1A.1.AB Bmpr1a, Exon 9, 5’-
CAUGACGCAUUAACACCGUCGUUUUAGAGCUAUGCU-3’). Cells were transfected with 
Lipofectamine RNAiMAX (ThermoFisher) to deliver ribonucleoproteins (RNPs) consisting of 
duplexed gRNA and tracrRNA-Atto550 with Alt-R S.p. Cas9 Nuclease V3 (IDT). Culture media 
was changed 12-24 hours post transfection, and then genomic DNA was extracted with 
QuickExtract (Lucigen). The cut site region was PCR amplified, and cutting efficiency was tested 
by T7 endonuclease assay (New England Biolabs). To generate the Bmpr1a KO cell line, the 
parental clonal cell line was transfected and single cells were sorted into 96 well plates from which 
cell lines were grown. Gene KO was confirmed by MiSeq and the rgenome.net Cas-analyzer tool. 
















Table 5.4 Primers used for Bmpr1a CRISPR KO in Vitro 
 
Primer Name                Purpose                   Sequence 5’ > 3’ 
Sg_Ex9_CutSite_F1 Bmpr1a cut site 
PCR (T7 assay) 
GGACTGTGTCGGATCAGCTAGG 
 
Sg_Ex9_CutSite_R1 Bmpr1a cut site 
PCR (T7 assay) 
TGTGTACCATCACACCCACTCA 
 
BH_Seq_CutSite_F1 MiSeq validation 







BH_Seq_CutSite_R1 MiSeq validation 










Cultured cells were washed with PBS and harvested by resuspending in TRI Reagent LS 
(Sigma); FACS purified cells were sorted directly into TRI Reagent LS. RNA was purified using 
the Direct-zol RNA MicroPrep kit (Zymo Research) according to the kit protocol. cDNA was 
made with the SuperScript VILO cDNA Synthesis Kit (ThermoFisher) and diluted before RT-
qPCR, which was performed using SYBR Green PCR master mix (ThermoFisher). Ppib2 was 


















Table 5.5 RT-qPCR Primer List 
 
Primer Name            Sequence 5’ > 3’ 
Gapdh Forward GTCGTGGAGTCTACTGGTGTCTTCAC 
Gapdh Reverse GTTGTCATATTTCTCGTGGTTCACACCC 
Bmpr1a Forward GCTATTGCTCAGGACACTGC 
 
Bmpr1a Reverse TGGTTTCTCCCTGATCATCTT 
 
Eps8 Forward TCTTCACCACCCTATTCCCAG 
 
Eps8 Reverse CATCTTTCCGATCCAGCACGA 
 
Id2 Forward CTATCGTCAGCCTGCATCAC 
Id2 Reverse ATTCAGATGCCTGCAAGGAC 
Kif26b Forward TACACCATGATCGGAAGGGAC 
 
Kif26b Reverse CTTGAACAGCCAAGAAATAGCAC 
 
Lef1 Forward CGCTAAAGGAGAGTGCAGCTA 
Lef1 Reverse GCTGTCTCTCTTTCCGTGCT 
Mitf Forward ACTTTCCCTTATCCCATCCAC 
Mitf Reverse TGAGATCCAGAGTTGTCGTACA 
Oca2 Forward CCTGAACATACAGAGTTTGGCT 
 
Oca2 Reverse GAGCAGAGGAGTGTCTTCCTTA 
 
Pax3 Forward CCGGGGCAGAATTACCCAC 
Pax3 Reverse GCCGTTGATAAATACTCCTCCG 
Ppib2 Forward GTGAGCGCTTCCCAGATGAGA 
Ppib2 Reverse TGCCGGAGTCGACAATGATG 
Rab38 Forward GGGACATTGCTGGTCAAGAAA 
Rab38 Reverse GGCTTACCATTAGGGAGCGTT 
Slc26a2 Forward AGAGACGGGGCTTTTGATTTC 
 
Slc26a2 Reverse GGCACCAACAGGATACCCAC 
 
Vimentin Forward GAAATTGCAGGAGGAGATGC 
 











Cultured cells were washed in cold 1X PBS, lysed in cold RIPA Buffer (Millipore) 
supplemented with protease and phosphatase inhibitors (Roche), and harvested by scraping. Cells 
were lysed for 30 minutes on ice with vortexing, centrifuged at 4°C for 10 minutes, and supernatant 
lysate was collected. Protein concentration was determined by BCA Assay (Pierce) read on a 
BioTek plate reader using a bovine serum albumin standard curve. Up to 50µg protein was loaded 
on NuPAGE 4-12% Bis-Tris Gels (Invitrogen) and run for 1 hour at 200V in NuPAGE MOPS 
SDS Running Buffer (Invitrogen). Protein was transferred at 30V overnight at 4°C onto PVDF 
membranes in NuPage Transfer Buffer (Invitrogen) with 20% methanol. Membranes were blocked 
in PBS-based blocking buffer (Odyssey) for at least 1 hour at room temperature before incubating 
with primary antibodies overnight at 4°C in blocking buffer supplemented with Tween-20. 
Membranes were washed several times in PBS with 0.1% Tween-20 before incubating with 
fluorescent secondary antibodies in blocking buffer supplemented with Tween-20 and SDS. 
Membranes were washed again before imaging on an Odyssey CLx machine (LI-COR). The 
primary and secondary antibodies and the dilutions used are listed in Table 5.6.   
TABLE 5.6 Immunoblotting Antibody List 
 
Antibody         Company, Catalogue #    Dilution 
Phospho-Smad1 (Ser463/465)/Smad5 
(Ser463/465)/ Smad9 (Ser465/467) (D5B10) 
Cell Signaling, #13820 1:1000 
SMAD1/5/9 Invitrogen, #PA1-41079 1:1000 
LEF1 (C12A5) Cell Signaling, #2230 1:1000 
MITF (D5G7V) Cell Signaling, #12590 1:1000 
α-tubulin Invitrogen, #T5168 1:10,000 
Donkey anti-rabbit 800 (secondary) LI-COR, #926-32213 1:10,000 











Cells were FACS purified into TRI Reagent LS, and total RNA was purified using the 
Direct-zol RNA MicroPrep kit (Zymo Research).  For McSCs, cells from 4 male mice at P60 were 
pooled for Replicate 1, and cells from 4 male mice at P62 were pooled for Replicate 2. For 
differentiating McSC progeny in the hair bulb, cells from male P10 mice were also pooled:  3 mice 
for Replicate 1, 2 mice for Replicate 2, and 4 mice for Replicate 3. The Weill Cornell Medical 
College Genomic Core facility (New York, NY) performed quality control analysis and 
sequencing. Briefly, RNA quality was determined by Agilent 2100 Bioanalyzer, and cDNA 
libraries were prepared using the Illumina TrueSeq mRNA sample preparation kit (non-stranded, 
poly-A selection) and sequenced on an Illumina HiSeq 4000 instrument.  
 
Single cell cDNA synthesis and library preparation 
 
ScRNA-seq libraries were prepared using a slightly modified version of the Smart-seq2 
protocol described by Picelli et al. (2014). Cells were FACS sorted into 96 well plates with 2µL 
lysis buffer containing Triton X-100, RNaseOUT (Invitrogen), Oligo dT30VN, dNTPs, and ERCC 
spike-ins. Plates were flash frozen in liquid nitrogen and stored at -80°C until further processing. 
Plates were then thawed on ice before lysing at 72°C for 3 minutes. The RNA was subject to reverse 
transcription (4U/µL Maxima H- transcriptase), template switching reaction, and whole 
transcriptome amplification. cDNA was purified with 7µL AMPure XP beads per well. To test for 
low quality libraries or empty wells, RT-qPCR for Gapdh was performed before proceeding. 
Illumina sequencing libraries were then prepared using the Nextera XT DNA library preparation 
kit (Illumina). After barcoding, samples were pooled and purified with MinElute PCR Purification 
Kit (Qiagen), then cleaned with 0.9X by volume AMPure XP beads (Beckman Coulter). Libraries 




ATAC library preparation 
 
Cells were FACS purified using an 85µm nozzle for gentler sorting to improve viability. 
qMcSCs were isolated as described in Fig. 2.2 B from Dct-eGFP+ x CD1 2nd telogen skin at P60 
(Replicate 1, cells from 3 male mice pooled) and P80 (Replicates 2 and 3, cells from 4 male mice 
pooled for each); differentiating progeny were isolated from Dct-eGFP+ (C57BL6/J background 
with some CD1) anagen skin at P9 (Replicate 1, cells from 1 male mouse, Replicates 2 and 3, cells 
from 2 male mice pooled for each) using the following FACS strategy:  dump (CD31, CD45, 
CD140a)-, Sca-1-, CD34-, eGFPhigh, CD117+ cells). Library preparation was performed as 
described (Buenrostro et al., 2013) with some modifications. Briefly, sorted cells were washed 
with cold PBS, pelleted, and resuspended in cold lysis buffer  (10 mM Tris-HCl, pH 7.4, 10 mM 
NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630). Buffer was removed after centrifugation, then 
samples were incubated in the transposition reaction at 37°C for 30 minutes (Illumina Nextera 
DNA Preparation Kit, using 10uL TDE1 enzyme). The reaction was terminated by adding 
Tagmentation Clean Up buffer consisting of 300 mM EDTA and 900 mM NaCl. DNA was purified 
with the Qiagen MiniElute PCR purification kit, then PCR amplified with barcode identifiers for 
12-18 cycles, and the products taken at three cycling times were tested by D1000 Tape Station 
(Agilent). Optimal samples were then pooled and bead purified for sequencing on NextSeq High 
Output 75 single read (40 x 40 bp paired end).  
Schematics 
 
Some graphics from SMART Servier Medical Art (https://smart.servier.com) were used to 







Quantification and Statistical Analyses 
 
Statistical tests for microscopy quantifications and RT-qPCR were performed with 
GraphPad Prism 7. Column data was first subject to D’Agostino and Pearson normality testing. 
For data without normal distribution, two-tailed Mann-Whitney test was used to compare two 
groups, and Kruskal-Wallis test with Dunn’s with multiple comparisons was used to compare 
between more than two groups. For RT-qPCR, where n number was too low for normality testing, 
unpaired t test or ordinary one-way ANOVA with Dunnett’s multiple comparison tests were 
performed.  
Bulk RNA-seq analysis 
 
Sequence and transcript coordinates for mouse mm10 UCSC genome and gene models 
were retrieved from the Bioconductor Bsgenome.Mmusculus.UCSC.mm10 (version 1.4.0) and 
TxDb.Mmusculus.UCSC.mm10.knownGene (version 3.4.0) Bioconductor libraries, 
respectively. Read length was 51bp. Transcript expressions were calculated using the Salmon 
quantification software (version 0.8.2)  (Patro et al., 2017) and gene expression levels as TPMs 
and counts were obtained using Tximport (version 1.8.0) (Soneson et al., 2015). Normalization 
and rlog transformation of raw read counts in genes were performed using DESeq2 (version 
1.20.0) (Love et al., 2014). Variability between samples was assessed with hierarchical 
clustering and heat maps of between sample distances implemented in the Pheatmap R package 
(1.0.10) as described by Love et al. (2014), and sample similarity is expressed as Euclidean 
distance. Published HFSC RNA-seq data from Ge et al. (2017) was obtained from Gene 







Single cell RNA-seq analysis 
 
Sequence and transcript coordinates for mouse release M23 (GRCm38.p6) genome and 
gene models were downloaded from GENCODE 
(https://www.gencodegenes.org/mouse/release_M23.html). Adaptors were trimmed from reads 
using Skewer (version 0.2.2). Sequencing reads were aligned to the mouse reference genome 
combined with sequences for ERCC spike-ins as artificial chromosomes using STAR (version 
2.5.2a) (Dobin et al., 2013) with default parameters for paired-end reads. Transcript expressions 
were calculated with Salmon (version 0.14.1) (Patro et al., 2017), and gene expression levels as 
TPMs and counts were obtained with Tximport (version 1.12.3) (Soneson et al., 2015). TPMs were 
transformed to log2(TPM+1). For downstream analyses, cells with <1,250 genes detected per cell 
and genes expressed in <5% of the cell population were removed. Cells expressing lower levels of 
Dct (log2(TPM+1) <6) and or those expressing the HF lineage gene Krt15 (log2(TPM+1) >6) were 
excluded. After filtering, the number of cells in the dataset were as follows: qMcSCs n=104 cells 
(n=3 mice), aMcSCs n=193 cells (n=3 mice), McSC differentiating progeny (McCP/melanocytes) 
n=308 cells (n=2 mice), Bmpr1a WT control n=205 cells (n=1 mouse), Bmpr1a heterozygous 
n=304 cells (n=2 mice), and Bmpr1a null n=421 cells (n=2 mice). 
Analyses and visualization of data were conducted in a Python environment built on the 
Numpy, SciPy, matplotlib, scikit-learn package and pandas libraries (Pedregosa et al., 2011). 
Batch effect variation between sequencing runs and biological replicates was assessed by 
examining the Euclidean distances between replicates within each hair cycle timepoint dataset 
versus across hair cycle timepoints, which showed closer relationships between replicates 
compared with variation between biologically distinct collection timepoints. PCA analysis of the 




biologically relevant differences in gene expression separating these replicates, suggesting that 
these differences likely represent true biological variation between animals in this highly dynamic 
differentiating population, rather than technical batch effects.    
To distinguish biological variability in gene expression from technical noise, a statistical 
model for identifying highly variable genes compared to ERCC spike-ins as described by 
Brennecke et al. (2013) was implemented. A custom script based on the methodology described 
by Brennecke et al., 2013 (in R version 3.6.1) was used to identify those genes with variation at 
least 10% above the technical variation with FDR less than 0.1.  
To visualize the data and identify clusters, the highly variable gene dataset was centered 
and scaled, and PCA was performed. A Jack-straw approach for the first 100 components (based 
on Seurat v3.1.1) (Stuart et al., 2019) was implemented in R to calculate a statistical significance 
for each PC, and components with p<0.05 were retained for downstream analysis. Significant PCs 
were used as input for non-linear dimensionality reduction, performed using UMAP implemented 
in scikit-learn. A graph-based clustering approach based on building a kNN graph and clustering 
with the Louvain algorithm (with k set to 1/5th of the dataset size, and resolution parameter of 1 
x10-4) was implemented. Euclidean distance in PCA space served as input for both UMAP 
generation and Louvain clustering. In second level analysis, the same strategy was used for 
dimensionality reduction, clustering, and visualization, with variable genes and PCs determined 
separately for each of the main cell clusters (C1, C2, C3).  
For pseudotime analysis, the same strategy for dimensionality reduction and clustering of 
each dataset was used, principal graph based on the community analysis was constructed, and a 
pseudotime values for each cell was computed using Monocle 3 (version 0.2.0) (Cao et al., 2019; 




function of Monocle 3 was used to implement Moran’s I test. Genes were considered significantly 
changing here if they had a q-value<1.0x10-4. 
Differential gene expression was used to identify genes up- and downregulated in each 
cluster. Briefly, raw count matrices for the biologically variable genes within each dataset were 
used and applied to the DESeq2 package (version 1.24.0) (Love et al., 2014) using R. A negative 
binomial fit was used to model differential gene expression, the dataset was factored based on 
Louvain cluster assignments, and a threshold of 0.75 was used to construct Wald tests of 
significance. In general, genes were considered to be significantly differentially expressed if their 
log2(fold change) ≥|1| and p-adjusted value (q) ≤0.05. Lowly expressed differential genes 
(baseMean expression ≤5) were discarded from visualization and further analysis. Expression 
levels of specific genes of interest were visualized as log2(TPM+1) values on UMAP plots. The 
“stemness” and “differentiation” signature gene sets used to generate global scores were the top 
100 up- or down-regulated differentially expressed genes between McSCs (C1 and C2) and McSC 
differentiating progeny (C3). The “AddModuleScore” function from Seurat v3.1.1 was used to 
calculate the average expression levels of each gene set on a single cell level, subtracted by the 
aggregated expression of control feature sets, as originally described in Tirosh et al. (2016).  
GO analyses of differentially expressed genes were performed using PANTHER Tools 
Overrepresentation Test (version 14.0), and annotated using the GO Biological Process Complete 
list (Mi et al., 2019; Thomas et al., 2006), with significant associations calculated by the Fisher’s 
Exact test and multiple comparisons corrected for using FDR. Where indicated, GO analyses were 
also annotated using DAVID Bioinformatics Resources 6.8 “Functional Annotation,” “BP Direct” 




Heatmaps were constructed in a Python environment built on the Numpy, SciPy, 
matplotlib, scikit-learn package and pandas libraries (Pedregosa et al., 2011). For specific GO 
annotations, the corresponding Mus musculus gene lists were obtained from AmiGO 2 through the 
Gene Ontology Consortium. Each GO gene list was used to filter the biologically variable genes 
associated with the dataset to generate normalized expression matrices, and genes characteristic of 
cell clusters (expressed in >50% of the cluster cells) were used for visualization. Each expression 
matrix was scaled and centered, and hierarchical linkages between genes was calculated based on 
pairwise correlation distances using the Farthest Point Algorithm. The matplotlib extension 
Seaborn visualization library (version 0.9.1) was used to create heatmaps using the clustermap() 
function with the previously generated gene-based hierarchical linkages fed in. 
BMP or canonical WNT target gene lists were culled from mouse literature (Table S8 of 
Infarinato et al., 2020); to be included, target genes had to be validated as direct targets of the 
signaling pathway in at least two mesenchymal or epithelial tissues, and be expressed in our 
datasets. Cell cycle stage specific gene lists were obtained from Macosko et al. (2015). To generate 
a global proliferation gene set score, an amalgamated list of cell cycle stage-specific genes was 
used. The “AddModuleScore” function from Seurat v3.1.1 was used to calculate the average 
expression levels of each gene set on a single cell level, subtracted by the aggregated expression 
of control feature sets, as originally described in Tirosh et al. (2016). Gene set scores for each cell 
are color-coded on UMAP visualizations of the data or on violin plots binned by sub-cluster cell 
identity. 
Promoter analysis of differentially expressed genes 
 
HOMER genome-wide motif predictions were used to scan for LEF1, MITF, and SMAD 




baseMean≥5 in the Bmpr1a null versus control cluster. Motifs had to be found in at least one TSS 
to be considered positive, then genes were then grouped based on the presence or absence of 
motifs. The difference in fold change between two groups was tested by Wilcoxon test with the 
null hypothesis that there is no difference in the distribution between the test groups. The results 
were plotted with R (3.6.1) and ggplot2. 
ATAC-seq analysis 
 
ATAC-seq reads are aligned to the mm10 genome from the 
Bsgenome.Mmusculus.UCSC.mm10 Bioconductor package (version 1.4.0) using Rsubread's align 
method in paired-end mode with fragments between 1 to 5000 base-pairs considered properly 
paired (Liao et al., 2013). Normalized, fragment signal bigWigs were created using the rtracklayer 
package. Peak calls were made with MACS2 software in BAMPE mode (Feng J et al., 2012; Zhang 
et al., 2008) and sequences under these peaks used with the motifMatcher Bioconductor package 
(Schep et al., 2014) and JASPAR motif database (Fornes et al., 2020) to identify known motifs 
within ATAC-seq peaks. Differential ATAC-seq signal was identified using the DESeq2 package 
(Ross-Innes CS et al., 2012; Love et al., 2014) and enrichment for motifs identified using the 
Limma packages geneSetTest function (Ritchie et al., 2015). Integrative Genomics Viewer (IGV) 
was used for gene track and peak visualization. 
Data Availability 
 
 The bulk and scRNA-seq and ATAC-seq and code generated during this study are available 












Table 2.1 Select List of Differentially Expressed “Stemness” and “Differentiation” Genes from 
DESeq2 Comparison of C1 and C2 vs. C3 cells (see also Table S2 from Infarinato et al., 2020) 
*All values shown to three decimal points, ranked by padj value 
 
"Stemness" Genes     
      
Gene Name baseMean log2FoldChange stat pvalue padj 
Arid5a 55.144 4.415 22.643 1.626E-113 9.691E-111 
Lmna 146.456 3.407 22.635 1.948E-113 1.045E-110 
Socs3 13.928 6.498 22.422 2.401E-111 1.171E-108 
Col12a1 118.818 4.992 22.246 1.240E-109 5.544E-107 
Fosb 150.150 6.711 21.631 9.247E-104 2.918E-101 
Fos 87.376 4.838 20.848 1.586E-96 4.254E-94 
Gab1 25.657 3.804 20.358 3.926E-92 7.799E-90 
Vim 72.713 3.279 20.097 7.909E-90 1.463E-87 
C4b 25.086 7.613 19.317 3.885E-83 5.788E-81 
Junb 27.407 3.956 19.001 1.684E-80 2.293E-78 
Sulf2 20.808 3.583 19.000 1.710E-80 2.293E-78 
Bcl2 10.713 3.669 18.904 1.062E-79 1.390E-77 
Adgrg1 41.006 3.380 18.621 2.181E-77 2.785E-75 
Sbno2 39.072 3.971 18.278 1.244E-74 1.517E-72 
Atf3 28.740 6.009 17.848 2.983E-71 3.266E-69 
Adamtsl4 15.394 4.034 17.785 9.193E-71 9.669E-69 
Jun 66.969 3.507 17.525 9.208E-69 9.319E-67 
Cubn 14.540 4.600 16.826 1.576E-63 1.432E-61 
Nr4a1 80.646 4.142 16.670 2.179E-62 1.948E-60 
Gm37352 40.083 3.819 16.024 8.620E-58 6.889E-56 
Pde1c 10.661 3.741 16.024 8.733E-58 6.889E-56 
Enpp2 55.947 2.522 15.761 5.739E-56 4.160E-54 
Cyp2d22 10.102 5.271 15.700 1.513E-55 1.068E-53 
Gucy1b1 7.253 4.439 15.649 3.374E-55 2.320E-53 
Agrn 31.948 3.033 15.647 3.486E-55 2.367E-53 
H2-Q4 7.623 4.878 15.362 2.928E-53 1.963E-51 
Vmp1 18.806 2.835 15.252 1.593E-52 1.042E-50 
Plagl1 20.224 2.952 15.011 6.193E-51 3.908E-49 
H2-D1 34.118 2.518 14.878 4.582E-50 2.858E-48 
Klf6 27.310 2.574 14.625 1.946E-48 1.200E-46 
H2-K1 11.266 3.541 14.608 2.491E-48 1.519E-46 
Dusp18 16.353 3.537 13.829 1.697E-43 9.100E-42 
Sema5a 14.677 3.207 13.584 4.994E-42 2.601E-40 
AW011738 6.590 4.229 13.497 1.621E-41 8.283E-40 
Arid5b 17.312 2.854 13.422 4.516E-41 2.243E-39 




Prelp 12.471 3.857 13.335 1.457E-40 7.039E-39 
Prex2 15.862 2.491 12.964 1.963E-38 8.925E-37 
Col16a1 10.798 2.714 12.778 2.175E-37 9.484E-36 
Ppp1r15a 10.229 3.946 12.691 6.609E-37 2.859E-35 
Myo10 28.098 1.992 12.504 7.098E-36 2.952E-34 
Auts2 10.411 2.411 12.404 2.498E-35 1.023E-33 
Ahr 6.537 3.711 12.170 4.470E-34 1.725E-32 
Gm37376 58.121 2.074 12.133 7.045E-34 2.699E-32 
Egr1 62.819 3.795 11.999 3.593E-33 1.321E-31 
Pax3 48.077 1.805 11.999 3.596E-33 1.321E-31 
Myadm 30.894 2.455 11.964 5.494E-33 1.978E-31 
4930402H24Rik 18.825 2.335 11.755 6.659E-32 2.304E-30 
Glul 39.453 2.339 11.720 1.009E-31 3.446E-30 
Idh2 15.207 1.945 11.588 4.747E-31 1.602E-29 
Cd274 9.282 4.758 11.414 3.546E-30 1.168E-28 
Rnf144a 7.449 2.695 11.414 3.549E-30 1.168E-28 
Ets1 7.877 2.573 11.407 3.865E-30 1.264E-28 
Igsf3 17.309 2.224 11.380 5.276E-30 1.715E-28 
Arnt2 10.709 2.939 11.361 6.571E-30 2.098E-28 
Pde4b 7.085 4.166 11.282 1.609E-29 5.076E-28 
Irs2 14.342 2.594 11.164 6.135E-29 1.880E-27 
Klf9 6.685 3.033 11.055 2.070E-28 6.168E-27 
Plekhm2 11.478 2.322 10.892 1.254E-27 3.675E-26 
Lpin1 8.887 2.650 10.793 3.714E-27 1.060E-25 
Malat1 502.984 1.825 10.475 1.125E-25 3.010E-24 
Slc27a1 8.518 3.511 10.405 2.362E-25 6.210E-24 
Appl2 16.596 1.974 10.395 2.607E-25 6.788E-24 
Ndrg1 10.186 3.455 10.201 1.968E-24 4.888E-23 
Per1 13.888 2.415 10.155 3.141E-24 7.765E-23 
Ubald1 9.929 2.399 10.101 5.496E-24 1.340E-22 
Ahdc1 7.473 2.794 9.965 2.165E-23 5.208E-22 
Gucy2f 6.645 4.889 9.948 2.575E-23 6.166E-22 
Jmjd1c 23.048 2.013 9.895 4.376E-23 1.030E-21 
Zfp36 13.266 2.802 9.892 4.526E-23 1.060E-21 
Crebrf 7.724 2.661 9.821 9.139E-23 2.113E-21 
Mdfic 8.493 3.271 9.813 9.898E-23 2.279E-21 
Gm42418 1123.306 1.636 9.762 1.645E-22 3.770E-21 
Ahnak 206.591 1.732 9.719 2.493E-22 5.666E-21 
Lgals3 31.405 2.127 9.692 3.252E-22 7.329E-21 
Cyr61 8.873 3.438 9.547 1.333E-21 2.942E-20 
Ripk1 5.918 3.017 9.530 1.580E-21 3.474E-20 
Sox6 14.469 2.013 9.339 9.712E-21 2.067E-19 
Arhgef2 5.694 2.935 9.269 1.877E-20 3.963E-19 




Mylk 6.477 3.079 9.219 2.993E-20 6.271E-19 
Irgm1 6.763 3.368 9.140 6.248E-20 1.289E-18 
B3gnt2 7.552 2.867 9.127 7.027E-20 1.444E-18 
Fscn1 10.000 2.427 9.112 8.090E-20 1.644E-18 
Fam214a 5.715 3.017 9.077 1.120E-19 2.267E-18 
Cpne4 6.191 2.677 8.809 1.264E-18 2.456E-17 
Erbb3 22.192 1.827 8.678 4.029E-18 7.610E-17 
Sertad1 5.273 3.219 8.669 4.367E-18 8.197E-17 
Usp53 5.278 2.413 8.665 4.531E-18 8.468E-17 
Cdh1 17.249 2.097 8.647 5.269E-18 9.813E-17 
Slc4a8 13.716 2.869 8.641 5.591E-18 1.038E-16 
Inf2 12.312 2.138 8.484 2.172E-17 3.989E-16 
Egr2 9.327 3.866 8.423 3.677E-17 6.687E-16 
Pnrc1 5.159 2.176 8.410 4.092E-17 7.390E-16 
Hmcn1 9.112 2.555 8.298 1.060E-16 1.889E-15 
Clasp2 17.863 1.623 8.257 1.488E-16 2.634E-15 
Hspa1b 5.479 3.023 8.218 2.064E-16 3.631E-15 
Myc 11.202 2.442 8.021 1.049E-15 1.809E-14 
Anxa1 10.648 2.033 7.971 1.579E-15 2.715E-14 
Slc5a3 6.741 2.429 7.959 1.733E-15 2.970E-14 
Capn6 7.353 2.810 7.953 1.825E-15 3.107E-14 
Stard13 7.208 2.467 7.919 2.385E-15 4.036E-14 
Myo1b 8.792 1.953 7.869 3.572E-15 6.024E-14 
Rnf213 7.330 3.203 7.856 3.960E-15 6.658E-14 
Zbtb20 22.953 1.899 7.798 6.288E-15 1.044E-13 
Ier2 7.101 2.420 7.767 8.014E-15 1.323E-13 
Klf4 6.010 2.633 7.719 1.175E-14 1.934E-13 
Btg2 7.464 3.094 7.701 1.354E-14 2.214E-13 
Fam102a 9.421 1.907 7.669 1.732E-14 2.815E-13 
Cdc14a 11.719 1.851 7.629 2.357E-14 3.786E-13 
Crip2 8.638 2.539 7.600 2.956E-14 4.719E-13 
Ifrd1 9.497 2.103 7.547 4.462E-14 7.039E-13 
Nfia 8.908 1.888 7.480 7.420E-14 1.154E-12 
Anxa11 5.587 1.984 7.444 9.776E-14 1.516E-12 
Brd2 28.751 1.508 7.435 1.043E-13 1.613E-12 
Stat3 29.849 1.711 6.988 2.792E-12 3.952E-11 
Mafk 5.844 2.550 6.968 3.225E-12 4.540E-11 
Klf7 7.189 2.030 6.951 3.637E-12 5.081E-11 
Ccnl1 10.458 1.676 6.929 4.225E-12 5.872E-11 
Slc6a17 45.641 1.571 6.893 5.453E-12 7.558E-11 
Lbh 21.268 1.417 6.884 5.799E-12 8.017E-11 
Cttnbp2nl 11.579 1.797 6.850 7.367E-12 1.011E-10 
Ncor2 17.038 1.553 6.806 1.003E-11 1.362E-10 




Wee1 5.202 2.350 6.628 3.397E-11 4.477E-10 
Timp2 10.524 1.875 6.487 8.731E-11 1.126E-09 
Txnip 9.183 2.174 6.451 1.109E-10 1.426E-09 
Dnajb1 11.202 1.779 6.412 1.437E-10 1.831E-09 
Gpx3 6.039 3.123 6.193 5.910E-10 7.355E-09 
Prickle1 7.362 1.856 6.190 6.001E-10 7.452E-09 
Cdh3 60.078 1.266 6.170 6.829E-10 8.420E-09 
Stat2 5.309 2.221 6.118 9.458E-10 1.158E-08 
Btg1 7.001 1.619 6.115 9.681E-10 1.183E-08 
Ablim1 12.355 2.270 6.093 1.106E-09 1.342E-08 
Tns2 5.817 2.340 6.067 1.307E-09 1.579E-08 
Dclk2 9.641 1.950 6.024 1.701E-09 2.037E-08 
Igf1r 11.076 1.730 5.911 3.397E-09 3.978E-08 
Helz2 6.337 2.692 5.857 4.726E-09 5.487E-08 
Foxo3 24.108 1.376 5.846 5.025E-09 5.809E-08 
Arhgap39 6.371 1.858 5.841 5.192E-09 5.989E-08 
Olfm1 6.949 1.879 5.839 5.262E-09 6.056E-08 
Clk1 11.442 1.376 5.832 5.469E-09 6.268E-08 
Klf5 6.257 2.215 5.829 5.574E-09 6.375E-08 
Mtss1l 6.919 1.786 5.787 7.150E-09 8.092E-08 
Syne2 14.479 1.781 5.773 7.800E-09 8.789E-08 
Ctdsp2 14.459 1.432 5.740 9.495E-09 1.068E-07 
Daam1 8.305 1.483 5.680 1.349E-08 1.508E-07 
Abl2 6.802 2.083 5.662 1.498E-08 1.660E-07 
Dusp10 6.494 2.063 5.629 1.817E-08 1.997E-07 
Tra2a 6.074 1.552 5.607 2.059E-08 2.254E-07 
Bahcc1 5.375 1.878 5.554 2.787E-08 3.002E-07 
Cspg4 7.698 2.330 5.542 2.998E-08 3.223E-07 
Eng 8.673 1.821 5.529 3.222E-08 3.436E-07 
Osmr 6.130 2.552 5.478 4.307E-08 4.557E-07 
Vamp2 7.659 1.627 5.469 4.532E-08 4.785E-07 
B2m 23.617 1.278 5.468 4.558E-08 4.803E-07 
Filip1l 5.907 1.956 5.397 6.786E-08 7.009E-07 
Zfp521 8.923 1.716 5.351 8.742E-08 8.966E-07 
Kdm6b 7.158 1.666 5.331 9.764E-08 9.938E-07 
Ythdc1 5.326 1.649 5.317 1.053E-07 1.064E-06 
Ankrd28 14.394 1.524 5.274 1.335E-07 1.334E-06 
Rnd3 8.430 1.701 5.171 2.334E-07 2.310E-06 
Fam129b 6.100 1.888 5.169 2.352E-07 2.324E-06 
Rasa3 11.601 1.362 5.081 3.749E-07 3.650E-06 
Eci2 7.965 1.373 5.073 3.907E-07 3.790E-06 
Nfatc1 7.280 1.811 4.963 6.952E-07 6.612E-06 
Slc41a1 8.065 1.898 4.955 7.220E-07 6.855E-06 




Foxk1 7.176 1.524 4.927 8.361E-07 7.895E-06 
Lama3 6.114 2.287 4.920 8.644E-07 8.134E-06 
Foxo4 5.458 1.777 4.905 9.325E-07 8.754E-06 
Ncald 7.217 1.611 4.847 1.254E-06 1.161E-05 
Ski 12.056 1.396 4.797 1.613E-06 1.481E-05 
Nedd9 6.563 1.973 4.787 1.690E-06 1.549E-05 
Sept8 18.038 1.331 4.762 1.917E-06 1.752E-05 
Tor1aip1 5.699 1.584 4.698 2.623E-06 2.376E-05 
Il6st 21.783 1.380 4.697 2.637E-06 2.385E-05 
Slc15a4 8.742 1.445 4.635 3.565E-06 3.187E-05 
Dennd1a 8.696 1.508 4.564 5.023E-06 4.431E-05 
Timp3 14.275 1.844 4.537 5.693E-06 4.965E-05 
Myo1e 8.208 1.457 4.523 6.101E-06 5.287E-05 
Ano1 12.236 1.565 4.473 7.699E-06 6.566E-05 
Itpr3 5.611 1.854 4.469 7.847E-06 6.670E-05 
Dock5 12.603 1.368 4.437 9.116E-06 7.689E-05 
Rnf31 6.219 1.675 4.388 1.142E-05 9.498E-05 
Klhl21 10.514 1.412 4.388 1.144E-05 9.498E-05 
Fosl2 17.573 1.658 4.354 1.337E-05 1.098E-04 
Nr3c1 5.191 1.569 4.341 1.416E-05 1.153E-04 
Akap8l 5.709 1.570 4.337 1.448E-05 1.176E-04 
Chd6 12.734 1.328 4.323 1.542E-05 1.248E-04 
Litaf 18.740 1.307 4.302 1.691E-05 1.364E-04 
Gm47283 6.433 1.381 4.300 1.706E-05 1.374E-04 
Mcl1 11.317 1.318 4.278 1.883E-05 1.514E-04 
Sorbs1 14.388 1.279 4.187 2.830E-05 2.236E-04 
Tnrc18 14.104 1.309 4.170 3.050E-05 2.395E-04 
Rela 6.669 1.430 4.087 4.373E-05 3.366E-04 
Tnrc6c 6.356 1.428 4.082 4.460E-05 3.428E-04 
Srsf7 6.870 1.374 4.073 4.640E-05 3.555E-04 
Mef2d 12.239 1.299 4.049 5.143E-05 3.919E-04 
Eif1a 6.534 1.475 3.992 6.563E-05 4.958E-04 
Zfp592 7.696 1.435 3.990 6.613E-05 4.989E-04 
Ppp1r10 9.347 1.376 3.972 7.119E-05 5.333E-04 
Numa1 15.785 1.224 3.868 1.097E-04 7.963E-04 
Cavin1 8.194 1.474 3.854 1.162E-04 8.415E-04 
Atf4 7.262 1.263 3.788 1.516E-04 1.088E-03 
Prag1 6.107 1.537 3.753 1.751E-04 1.241E-03 
Zc3hav1 12.967 1.283 3.750 1.767E-04 1.251E-03 
Ptprj 33.028 1.145 3.740 1.843E-04 1.299E-03 
Kmt2a 13.513 1.221 3.718 2.005E-04 1.406E-03 
Serinc3 9.546 1.273 3.700 2.159E-04 1.502E-03 
Tmbim1 11.073 1.330 3.699 2.166E-04 1.505E-03 




Hnrnph1 15.127 1.134 3.488 4.858E-04 3.266E-03 
Tcaf1 6.691 1.477 3.485 4.925E-04 3.306E-03 
Rsrp1 21.051 1.157 3.473 5.146E-04 3.442E-03 
Nfat5 15.487 1.245 3.408 6.549E-04 4.342E-03 
Inpp4a 6.688 1.359 3.384 7.140E-04 4.716E-03 
Zfp36l1 16.266 1.154 3.360 7.782E-04 5.115E-03 
Tmem94 10.442 1.263 3.317 9.111E-04 5.938E-03 
Slc39a14 7.862 1.337 3.306 9.452E-04 6.145E-03 
Trp53inp1 6.008 1.486 3.304 9.527E-04 6.187E-03 
Nop58 5.996 1.297 3.303 9.578E-04 6.205E-03 
Cd200 7.151 1.318 3.287 1.012E-03 6.537E-03 
Arhgap21 6.993 1.300 3.281 1.035E-03 6.678E-03 
Srsf5 18.657 1.085 3.264 1.098E-03 7.063E-03 
St5 7.452 1.270 3.263 1.104E-03 7.091E-03 
Ccnl2 16.447 1.134 3.200 1.376E-03 8.674E-03 
Tmem2 7.672 1.473 3.159 1.584E-03 9.847E-03 
Klhl24 8.578 1.203 3.157 1.596E-03 9.906E-03 
Flrt3 6.383 1.445 3.080 2.071E-03 1.273E-02 
Ccnt1 7.306 1.292 3.071 2.132E-03 1.307E-02 
Ak3 14.646 1.119 3.069 2.150E-03 1.316E-02 
Gnb4 5.303 1.280 3.047 2.314E-03 1.406E-02 
Ezh1 5.726 1.302 3.041 2.360E-03 1.430E-02 
Insr 7.007 1.263 3.029 2.457E-03 1.484E-02 
Lrch3 9.251 1.200 3.013 2.587E-03 1.559E-02 
Cic 17.692 1.110 2.961 3.063E-03 1.815E-02 
Nsmf 5.126 1.337 2.917 3.533E-03 2.069E-02 
Emp1 7.833 1.478 2.885 3.916E-03 2.266E-02 
Dclk1 9.563 1.179 2.871 4.089E-03 2.358E-02 
Plp1 29.369 1.143 2.812 4.918E-03 2.810E-02 
Stat5a 7.246 1.260 2.807 4.998E-03 2.849E-02 
Atf7 17.632 1.090 2.767 5.650E-03 3.178E-02 
Stau1 8.643 1.153 2.748 5.993E-03 3.355E-02 
Epc1 6.668 1.167 2.737 6.198E-03 3.452E-02 
Rnf38 12.356 1.085 2.733 6.268E-03 3.486E-02 
Cdk19 6.028 1.246 2.714 6.645E-03 3.671E-02 
Vezf1 7.955 1.094 2.692 7.096E-03 3.912E-02 
Gjc3 10.614 1.225 2.679 7.388E-03 4.060E-02 
Cttnbp2 18.389 1.099 2.662 7.769E-03 4.256E-02 
Gprc5b 5.951 1.276 2.644 8.192E-03 4.461E-02 
Shc1 11.063 1.102 2.622 8.741E-03 4.726E-02 









      
Gene Name baseMean log2FoldChange stat pvalue padj 
Me1 5.949 -5.294 -28.378 3.787E-177 2.031E-173 
Bmp7 7.113 -5.577 -27.983 2.625E-172 7.041E-169 
Rab38 36.135 -4.501 -26.439 4.863E-154 8.695E-151 
Fndc1 9.192 -5.408 -25.460 5.484E-143 7.354E-140 
Krt31 10.680 -6.277 -25.386 3.570E-142 3.830E-139 
Atp6v0d2 9.338 -5.567 -23.772 6.498E-125 5.809E-122 
Tchh 5.797 -5.407 -23.695 4.057E-124 3.109E-121 
Oca2 73.716 -5.738 -23.009 3.827E-117 2.566E-114 
Krt35 7.450 -5.714 -22.051 9.300E-108 3.563E-105 
Mlana 78.767 -3.484 -21.930 1.338E-106 4.784E-104 
S100a1 13.154 -3.692 -21.830 1.205E-105 4.041E-103 
Eps8 16.445 -4.366 -21.599 1.855E-103 5.527E-101 
Krt87 6.819 -5.424 -20.750 1.215E-95 3.104E-93 
Krt33a 5.928 -5.357 -20.731 1.815E-95 4.426E-93 
Slc24a4 54.551 -4.934 -20.699 3.569E-95 7.976E-93 
Col3a1 26.434 -7.492 -20.555 7.012E-94 1.504E-91 
Trpm1 470.363 -3.906 -20.388 2.136E-92 4.407E-90 
Slc24a5 62.002 -3.529 -19.983 7.690E-89 1.375E-86 
Gja1 26.626 -4.017 -19.917 2.908E-88 5.031E-86 
Krt71 6.121 -5.217 -19.713 1.655E-86 2.774E-84 
Scrn1 10.022 -4.123 -19.484 1.491E-84 2.423E-82 
Krtap8-1 5.647 -5.312 -19.471 1.920E-84 3.029E-82 
Col1a1 29.560 -7.414 -19.329 3.076E-83 4.715E-81 
Mc1r 58.927 -3.712 -18.263 1.645E-74 1.961E-72 
Sparc 33.357 -3.393 -18.260 1.720E-74 2.006E-72 
Dsp 10.583 -4.554 -18.124 2.074E-73 2.367E-71 
Gapdh 62.801 -2.257 -18.009 1.664E-72 1.860E-70 
Tyr 327.912 -2.814 -17.829 4.215E-71 4.522E-69 
Krt73 5.689 -5.211 -17.535 7.798E-69 8.044E-67 
Robo1 8.976 -3.526 -17.091 1.721E-65 1.678E-63 
Slc7a8 65.248 -3.265 -17.021 5.784E-65 5.540E-63 
Kif26b 36.268 -3.598 -16.540 1.906E-61 1.649E-59 
Dlx3 5.215 -4.722 -16.402 1.854E-60 1.554E-58 
Gfra1 5.868 -4.122 -16.363 3.524E-60 2.908E-58 
Col1a2 14.692 -6.142 -16.015 1.009E-57 7.840E-56 
Gpr143 14.238 -3.331 -15.747 7.180E-56 5.135E-54 
Nrp2 5.385 -4.903 -15.306 6.981E-53 4.623E-51 
Id2 13.214 -2.803 -15.158 6.689E-52 4.323E-50 
Lama5 5.635 -5.205 -14.368 8.227E-47 4.903E-45 
Ttc3 67.474 -2.118 -14.253 4.289E-46 2.528E-44 




Dsc3 5.922 -4.197 -13.999 1.590E-44 8.990E-43 
Loxl2 20.701 -3.680 -13.998 1.592E-44 8.990E-43 
B3galt5 11.790 -3.401 -13.983 1.971E-44 1.101E-42 
Wfs1 8.342 -3.715 -13.930 4.162E-44 2.302E-42 
4931406C07Rik 13.232 -2.813 -13.831 1.654E-43 8.962E-42 
Egfr 5.205 -4.316 -13.640 2.309E-42 1.214E-40 
Tinagl1 10.895 -3.096 -13.528 1.074E-41 5.540E-40 
Specc1 14.288 -2.797 -13.432 3.927E-41 1.969E-39 
Epdr1 13.579 -2.807 -13.401 5.986E-41 2.946E-39 
Bgn 7.995 -5.474 -13.263 3.806E-40 1.823E-38 
Ctsd 69.512 -2.004 -13.179 1.160E-39 5.506E-38 
Epb41 14.444 -2.665 -13.165 1.404E-39 6.604E-38 
Slc45a2 73.810 -2.445 -13.019 9.590E-39 4.397E-37 
Tyrp1 461.225 -2.095 -12.950 2.353E-38 1.061E-36 
Myef2 12.641 -2.907 -12.942 2.606E-38 1.165E-36 
Smpd1 12.130 -2.938 -12.815 1.352E-37 5.944E-36 
Proser2 7.199 -2.960 -12.547 4.149E-36 1.766E-34 
Eogt 26.872 -2.554 -12.533 4.917E-36 2.077E-34 
Slc7a5 71.064 -2.437 -12.510 6.544E-36 2.742E-34 
S1pr3 8.031 -3.958 -12.336 5.813E-35 2.344E-33 
Ftl1-ps1 8.377 -2.060 -12.326 6.602E-35 2.643E-33 
Psd3 5.579 -3.063 -12.321 6.987E-35 2.776E-33 
Emp3 10.328 -2.378 -12.296 9.522E-35 3.755E-33 
Lef1 6.964 -2.919 -12.255 1.587E-34 6.212E-33 
Sema6d 24.896 -2.906 -12.222 2.384E-34 9.268E-33 
Trp63 5.212 -4.120 -12.130 7.339E-34 2.792E-32 
Mcc 9.669 -2.838 -12.118 8.457E-34 3.195E-32 
Fstl1 5.362 -4.553 -12.040 2.192E-33 8.165E-32 
Lpl 6.379 -3.075 -11.904 1.125E-32 4.023E-31 
Aldoa 47.755 -2.082 -11.884 1.437E-32 5.070E-31 
Ero1l 10.928 -2.852 -11.717 1.039E-31 3.527E-30 
Calm1 36.639 -1.935 -11.560 6.588E-31 2.209E-29 
Ccnd2 20.798 -2.467 -11.555 6.974E-31 2.324E-29 
B4galt6 8.246 -2.522 -11.373 5.723E-30 1.849E-28 
Pmel 828.372 -2.105 -11.137 8.312E-29 2.533E-27 
Gne 13.552 -2.593 -11.135 8.428E-29 2.554E-27 
Ctsh 9.624 -2.715 -11.134 8.583E-29 2.586E-27 
mt-Nd1 223.043 -1.550 -11.093 1.363E-28 4.085E-27 
Perp 9.169 -3.038 -10.982 4.661E-28 1.374E-26 
Ptgds 168.727 -2.040 -10.882 1.401E-27 4.085E-26 
Eno1 26.851 -2.102 -10.842 2.166E-27 6.246E-26 
Rab32 8.393 -2.419 -10.774 4.572E-27 1.298E-25 
Cd63 67.943 -1.663 -10.675 1.329E-26 3.676E-25 




Adam10 28.836 -1.944 -10.441 1.605E-25 4.240E-24 
Fbn1 11.778 -3.565 -10.399 2.515E-25 6.580E-24 
Scd2 50.704 -2.024 -10.340 4.646E-25 1.192E-23 
Atp6v0c 54.411 -1.601 -10.333 4.972E-25 1.270E-23 
Pgam1 23.938 -1.956 -10.321 5.676E-25 1.443E-23 
Pgk1 11.107 -2.153 -10.319 5.773E-25 1.461E-23 
Txn1 10.913 -1.831 -10.217 1.669E-24 4.164E-23 
Sfn 10.965 -3.161 -10.154 3.186E-24 7.840E-23 
Trim29 6.449 -3.280 -10.128 4.167E-24 1.021E-22 
Col6a3 7.149 -5.552 -9.998 1.558E-23 3.781E-22 
G6pdx 7.145 -2.375 -9.940 2.786E-23 6.641E-22 
Apold1 9.352 -2.445 -9.845 7.215E-23 1.683E-21 
Car13 7.446 -2.520 -9.823 8.963E-23 2.081E-21 
Ednrb 160.843 -1.774 -9.753 1.797E-22 4.103E-21 
Soat1 8.138 -2.511 -9.693 3.233E-22 7.318E-21 
Slc26a2 18.917 -2.334 -9.636 5.622E-22 1.251E-20 
Mknk2 22.897 -1.958 -9.596 8.346E-22 1.850E-20 
Gpr155 6.808 -2.788 -9.520 1.726E-21 3.778E-20 
Bop1 15.551 -2.052 -9.439 3.765E-21 8.144E-20 
Cyb5a 21.648 -1.749 -9.416 4.701E-21 1.013E-19 
Ldha 43.659 -1.825 -9.289 1.556E-20 3.299E-19 
Gstp1 103.798 -1.575 -9.115 7.839E-20 1.599E-18 
Nckap5l 15.147 -1.938 -8.987 2.545E-19 5.074E-18 
Emc8 9.628 -2.107 -8.974 2.850E-19 5.640E-18 
Creg1 10.504 -2.168 -8.966 3.081E-19 6.076E-18 
Igfbp4 5.085 -4.113 -8.955 3.386E-19 6.654E-18 
Slc3a2 83.950 -1.639 -8.707 3.107E-18 5.889E-17 
Prelid1 16.312 -1.704 -8.669 4.370E-18 8.197E-17 
Lrp1 12.162 -3.558 -8.635 5.886E-18 1.089E-16 
Npy 10.879 -2.297 -8.447 2.986E-17 5.448E-16 
Pgam1-ps2 6.857 -2.107 -8.227 1.918E-16 3.384E-15 
Nkd1 9.290 -2.237 -8.102 5.403E-16 9.349E-15 
Lss 8.077 -2.181 -7.929 2.217E-15 3.763E-14 
Ltbp4 5.401 -3.258 -7.840 4.497E-15 7.538E-14 
Gng12 24.117 -1.614 -7.802 6.096E-15 1.016E-13 
Fdps 9.143 -1.860 -7.650 2.012E-14 3.250E-13 
Tfeb 17.831 -1.915 -7.592 3.146E-14 4.992E-13 
Tnfrsf19 14.755 -2.019 -7.521 5.427E-14 8.536E-13 
Postn 7.107 -3.890 -7.381 1.568E-13 2.389E-12 
Met 31.235 -1.834 -7.376 1.632E-13 2.480E-12 
mt-Nd2 39.935 -1.301 -7.275 3.461E-13 5.201E-12 
Prdx1 27.925 -1.370 -7.219 5.242E-13 7.762E-12 
mt-Nd5 205.636 -1.218 -7.205 5.815E-13 8.569E-12 




Pkm 29.267 -1.517 -7.092 1.318E-12 1.905E-11 
Tnxb 5.156 -5.057 -7.021 2.202E-12 3.150E-11 
Slc6a8 6.586 -1.954 -7.019 2.238E-12 3.193E-11 
Adi1 16.713 -1.644 -7.006 2.454E-12 3.492E-11 
Spg21 19.176 -1.521 -6.986 2.835E-12 4.002E-11 
Jup 14.395 -2.011 -6.964 3.317E-12 4.658E-11 
Ccser2 21.049 -1.657 -6.950 3.662E-12 5.102E-11 
Lgals1 6.284 -1.812 -6.820 9.083E-12 1.237E-10 
Ccnd1 6.354 -2.042 -6.801 1.041E-11 1.410E-10 
Ptprf 10.028 -2.358 -6.798 1.060E-11 1.432E-10 
Plxna1 21.205 -1.631 -6.769 1.294E-11 1.722E-10 
Ptprs 37.029 -1.638 -6.702 2.051E-11 2.724E-10 
Tacc1 62.024 -1.356 -6.679 2.407E-11 3.188E-10 
Adgrl2 13.760 -1.639 -6.567 5.119E-11 6.730E-10 
Fdft1 8.117 -1.868 -6.549 5.802E-11 7.573E-10 
Atp5g3 12.941 -1.392 -6.507 7.650E-11 9.911E-10 
Ago2 51.360 -1.372 -6.444 1.160E-10 1.489E-09 
Tpi1 10.961 -1.542 -6.319 2.628E-10 3.325E-09 
Acat2 5.603 -1.848 -6.310 2.788E-10 3.518E-09 
mt-Nd4 83.133 -1.123 -6.180 6.400E-10 7.928E-09 
Dpp7 11.172 -1.664 -6.084 1.175E-09 1.423E-08 
Ctsb 55.171 -1.295 -6.065 1.320E-09 1.592E-08 
Mylip 12.773 -1.708 -5.978 2.266E-09 2.677E-08 
Naa60 6.304 -1.671 -5.960 2.520E-09 2.964E-08 
Hr 5.416 -2.044 -5.891 3.843E-09 4.491E-08 
Selenop 127.818 -1.279 -5.806 6.383E-09 7.269E-08 
Cotl1 10.640 -1.551 -5.803 6.514E-09 7.403E-08 
Atp6v1b2 46.930 -1.372 -5.800 6.615E-09 7.501E-08 
Gjb2 11.511 -1.873 -5.636 1.743E-08 1.920E-07 
Etv5 7.721 -1.741 -5.622 1.892E-08 2.076E-07 
Atp6v1a 15.943 -1.463 -5.595 2.210E-08 2.409E-07 
Mboat2 6.299 -1.677 -5.541 3.013E-08 3.232E-07 
Akr1a1 45.817 -1.198 -5.539 3.038E-08 3.253E-07 
Cux1 21.847 -1.447 -5.478 4.304E-08 4.557E-07 
Cyfip2 8.078 -1.751 -5.460 4.754E-08 4.980E-07 
Calr 34.881 -1.320 -5.419 5.980E-08 6.229E-07 
Mmp2 5.926 -2.063 -5.411 6.258E-08 6.506E-07 
Serp1 12.474 -1.477 -5.407 6.398E-08 6.638E-07 
Nhs 7.542 -1.756 -5.378 7.539E-08 7.762E-07 
mt-Co3 44.223 -1.716 -5.328 9.922E-08 1.008E-06 
Uqcrq 5.475 -1.439 -5.236 1.645E-07 1.637E-06 
Mapk6 13.518 -1.407 -5.223 1.757E-07 1.742E-06 
Atp13a2 10.091 -1.578 -5.132 2.867E-07 2.816E-06 




Ctsl 21.312 -1.445 -5.013 5.360E-07 5.153E-06 
Npc1 22.438 -1.301 -4.979 6.404E-07 6.112E-06 
Mfsd14b 15.041 -1.405 -4.970 6.687E-07 6.371E-06 
Dhcr24 16.468 -1.418 -4.946 7.581E-07 7.184E-06 
Nfatc2 7.994 -1.763 -4.863 1.154E-06 1.071E-05 
Acaca 10.710 -1.522 -4.823 1.417E-06 1.304E-05 
Gdi2 22.631 -1.222 -4.693 2.692E-06 2.427E-05 
Ndufa4 5.170 -1.279 -4.571 4.858E-06 4.293E-05 
Hmga1 10.756 -1.465 -4.562 5.073E-06 4.461E-05 
Fn1 9.239 -2.358 -4.554 5.257E-06 4.608E-05 
Plxna4 6.144 -1.731 -4.535 5.759E-06 5.006E-05 
Tpp1 21.024 -1.229 -4.489 7.147E-06 6.134E-05 
Ptprg 11.195 -1.473 -4.487 7.234E-06 6.183E-05 
Ttyh3 5.029 -1.635 -4.462 8.133E-06 6.892E-05 
Gabarap 21.998 -1.116 -4.427 9.567E-06 8.043E-05 
Mdh1 6.828 -1.360 -4.426 9.615E-06 8.071E-05 
Nadk 11.516 -1.393 -4.412 1.026E-05 8.588E-05 
Igsf8 17.897 -1.310 -4.373 1.225E-05 1.011E-04 
Anxa2 29.325 -1.236 -4.367 1.258E-05 1.035E-04 
Mtpn 21.234 -1.236 -4.354 1.339E-05 1.098E-04 
Cox6b1 5.866 -1.234 -4.351 1.353E-05 1.106E-04 
Efnb1 5.009 -2.022 -4.334 1.467E-05 1.190E-04 
Cox5b 8.944 -1.204 -4.253 2.111E-05 1.690E-04 
Itm2c 7.761 -1.370 -4.239 2.244E-05 1.791E-04 
Tspan10 32.480 -1.390 -4.166 3.103E-05 2.433E-04 
Peg3 8.251 -2.372 -4.125 3.715E-05 2.892E-04 
Fads1 10.290 -1.381 -4.070 4.706E-05 3.601E-04 
Sec14l1 12.947 -1.382 -4.054 5.034E-05 3.841E-04 
Ssbp4 8.985 -1.330 -3.959 7.529E-05 5.609E-04 
Mgll 68.724 -1.176 -3.928 8.574E-05 6.326E-04 
Plxna2 7.974 -1.610 -3.927 8.613E-05 6.347E-04 
Pdia3 24.662 -1.209 -3.909 9.280E-05 6.810E-04 
Pfn1 35.810 -1.125 -3.908 9.323E-05 6.831E-04 
App 22.469 -1.140 -3.778 1.582E-04 1.133E-03 
Flnb 9.753 -1.431 -3.767 1.652E-04 1.175E-03 
Gpi1 19.997 -1.159 -3.758 1.714E-04 1.218E-03 
Abhd2 18.951 -1.304 -3.745 1.803E-04 1.274E-03 
Gpr137b 11.732 -1.257 -3.740 1.838E-04 1.298E-03 
Bzw1 9.641 -1.240 -3.715 2.031E-04 1.422E-03 
Aars 7.855 -1.290 -3.700 2.158E-04 1.502E-03 
Frmd4a 24.534 -1.182 -3.606 3.109E-04 2.130E-03 
Celsr2 6.953 -1.415 -3.510 4.481E-04 3.027E-03 
Morf4l2 16.372 -1.181 -3.475 5.103E-04 3.417E-03 




Zfp266 11.279 -1.234 -3.337 8.460E-04 5.534E-03 
Lpp 18.800 -1.131 -3.230 1.238E-03 7.857E-03 
Krt5 5.730 -1.678 -3.209 1.330E-03 8.412E-03 
Cdc42 22.128 -1.042 -3.205 1.353E-03 8.546E-03 
Ddah1 11.903 -1.220 -3.168 1.535E-03 9.575E-03 
Mfsd12 7.110 -1.314 -3.136 1.711E-03 1.059E-02 
Gspt1 6.550 -1.201 -3.073 2.121E-03 1.302E-02 
Slc39a10 8.785 -1.389 -3.062 2.202E-03 1.344E-02 
Cfap54 17.314 -1.230 -3.036 2.401E-03 1.454E-02 
Insig1 17.378 -1.217 -3.007 2.641E-03 1.588E-02 
Otub1 7.441 -1.171 -2.995 2.745E-03 1.649E-02 
Slc25a39 15.061 -1.144 -2.987 2.816E-03 1.684E-02 
Cs 21.474 -1.082 -2.928 3.408E-03 2.006E-02 
Pcdhgc3 10.486 -1.216 -2.893 3.813E-03 2.213E-02 
Rab1 18.843 -1.044 -2.844 4.454E-03 2.555E-02 
Mif 8.297 -1.107 -2.806 5.018E-03 2.857E-02 
Syt4 18.630 -1.244 -2.799 5.119E-03 2.909E-02 
Bsg 24.524 -1.010 -2.633 8.472E-03 4.604E-02 
Plekha8 6.048 -1.246 -2.632 8.499E-03 4.614E-02 
Gns 21.955 -1.066 -2.617 8.883E-03 4.794E-02 



























Table 3.1:  Select List of Differentially Expressed Genes for Bmpr1a Null vs. Control 
Differentiating Progeny Cells from DESeq2 (see also Table S9 from Infarinato et al., 2020) 
*All values shown to three decimal points, ranked by padj value 
 
Control Genes     
      
Gene Name baseMean log2FoldChange stat pvalue padj 
Id2 7.898 -2.607 -20.584 3.800E-94 4.750E-91 
Itgb3 9.372 -3.995 -18.555 7.370E-77 3.070E-74 
Kif26b 22.271 -2.274 -15.807 2.770E-56 5.780E-54 
Atp6v0d2 12.111 -3.226 -15.632 4.400E-55 7.330E-53 
B3galt5 7.955 -2.442 -15.612 6.000E-55 9.370E-53 
Slc24a4 50.652 -2.280 -14.714 5.270E-49 7.330E-47 
Slc37a2 8.526 -2.720 -14.670 9.980E-49 1.310E-46 
Rab38 21.841 -1.725 -14.252 4.380E-46 5.480E-44 
Parm1 2.326 -3.240 -13.491 1.770E-41 1.930E-39 
Ephx1 5.849 -2.623 -13.370 9.020E-41 9.020E-39 
Fam129a 5.488 -2.425 -13.018 9.660E-39 9.290E-37 
Oca2 69.508 -1.912 -12.831 1.100E-37 9.840E-36 
Sfrp4 4.848 -3.244 -12.337 5.710E-35 4.600E-33 
Hhipl1 1.524 -3.046 -12.206 2.900E-34 2.190E-32 
Epdr1 13.772 -1.658 -11.832 2.680E-32 1.810E-30 
Egfl6 2.722 -2.916 -11.491 1.460E-30 8.920E-29 
Apold1 13.615 -1.661 -11.442 2.590E-30 1.500E-28 
Ttll7 2.910 -2.638 -11.292 1.440E-29 8.160E-28 
Gpr143 14.902 -1.508 -11.177 5.310E-29 2.890E-27 
Wfs1 5.356 -2.360 -10.721 8.080E-27 4.210E-25 
Id3 5.860 -2.191 -10.518 7.100E-26 3.350E-24 
Pla2g15 4.387 -1.887 -9.574 1.030E-21 4.210E-20 
Smpd1 12.327 -1.580 -9.510 1.900E-21 7.540E-20 
Plxna4 1.222 -3.025 -8.667 4.440E-18 1.530E-16 
Rnf144b 2.481 -2.257 -8.467 2.510E-17 7.950E-16 
Nr4a3 6.251 -1.794 -8.377 5.420E-17 1.670E-15 
Trpm1 410.843 -1.289 -8.343 7.230E-17 2.200E-15 
Me1 2.851 -1.923 -8.307 9.830E-17 2.960E-15 
Tmem47 1.496 -2.443 -8.257 1.500E-16 4.390E-15 
Eps8 24.224 -1.461 -8.256 1.510E-16 4.390E-15 
Ptprs 37.340 -1.272 -8.218 2.070E-16 5.890E-15 
Scrn1 8.310 -1.468 -7.804 5.970E-15 1.610E-13 
Ctsd 92.539 -1.118 -7.748 9.330E-15 2.460E-13 
Ogdhl 0.879 -2.868 -7.593 3.120E-14 7.640E-13 
Tmem151a 0.765 -2.899 -7.473 7.850E-14 1.900E-12 
Calm1 37.219 -1.060 -7.457 8.850E-14 2.130E-12 




Pgm2l1 1.171 -2.379 -7.126 1.030E-12 2.260E-11 
Tubb3 2.056 -1.950 -6.838 8.030E-12 1.660E-10 
Amd1 10.791 -1.243 -6.828 8.600E-12 1.760E-10 
Ero1l 10.216 -1.436 -6.756 1.420E-11 2.800E-10 
Lgals3 15.866 -1.342 -6.461 1.040E-10 1.900E-09 
Loxl2 17.896 -1.599 -6.382 1.740E-10 3.140E-09 
Ninj1 4.505 -1.285 -6.330 2.450E-10 4.350E-09 
Sec14l1 7.433 -1.351 -6.214 5.170E-10 8.970E-09 
Plekha8 6.285 -1.364 -6.185 6.210E-10 1.060E-08 
Emc8 11.706 -1.156 -5.923 3.160E-09 5.030E-08 
Frmd4a 21.442 -1.087 -5.778 7.550E-09 1.170E-07 
Shroom2 8.931 -1.218 -5.597 2.190E-08 3.230E-07 
Slc45a2 78.717 -1.037 -5.559 2.720E-08 3.980E-07 
Ddah1 2.459 -1.605 -5.493 3.950E-08 5.610E-07 
Gpr137b 16.132 -1.182 -5.281 1.290E-07 1.750E-06 
Tacc1 43.830 -0.995 -5.028 4.960E-07 6.110E-06 
Mc1r 53.287 -1.080 -4.878 1.070E-06 1.250E-05 
Skil 4.166 -1.332 -4.876 1.080E-06 1.260E-05 
4930523C07Rik 10.536 -1.705 -4.761 1.920E-06 2.170E-05 
Plxnd1 5.716 -1.286 -4.735 2.190E-06 2.440E-05 
Akap6 1.449 -1.764 -4.691 2.710E-06 2.990E-05 
Mtss1 5.542 -1.230 -4.689 2.750E-06 3.010E-05 
Gsn 11.730 -1.243 -4.617 3.890E-06 4.140E-05 
Npy 9.681 -1.182 -4.522 6.140E-06 6.290E-05 
Xpo6 9.495 -1.097 -4.464 8.040E-06 8.100E-05 
Fabp5 4.452 -1.220 -4.421 9.810E-06 9.690E-05 
Asah1 14.842 -1.045 -4.395 1.110E-05 1.079E-04 
Adam10 26.366 -1.012 -3.933 8.400E-05 7.371E-04 
Slc26a2 9.977 -1.155 -3.914 9.090E-05 7.915E-04 
Nav2 54.383 -0.994 -3.813 1.375E-04 1.146E-03 
Ftl1 179.829 -0.879 -3.559 3.727E-04 2.958E-03 
Slc7a11 4.459 -1.454 -3.547 3.894E-04 3.081E-03 
Enpep 3.716 -1.274 -3.514 4.420E-04 3.431E-03 
Tbx1 0.518 -1.854 -3.491 4.806E-04 3.697E-03 
D7Ertd443e 2.432 -1.322 -3.311 9.304E-04 6.861E-03 
Smchd1 8.656 -1.048 -3.239 1.200E-03 8.670E-03 
Padi2 1.569 -1.592 -3.160 1.578E-03 1.108E-02 
Insig1 18.165 -1.022 -3.161 1.575E-03 1.108E-02 
Fech 8.357 -0.986 -3.105 1.904E-03 1.319E-02 
Tyrp1 474.390 -0.927 -3.104 1.912E-03 1.320E-02 
S1pr3 27.483 -1.061 -3.058 2.231E-03 1.503E-02 
Tmem132d 0.499 -1.836 -2.800 5.108E-03 3.201E-02 
Pitpnm2 3.461 -1.127 -2.686 7.239E-03 4.361E-02 




Bmpr1a Null Genes     
      
Gene Name baseMean log2FoldChange stat pvalue padj 
Vim 41.870 2.468 22.621 2.690E-113 6.730E-110 
Car14 5.486 3.521 20.562 6.070E-94 5.060E-91 
Cdh1 23.571 2.339 18.910 9.470E-80 5.920E-77 
Sulf2 15.571 2.393 18.618 2.280E-77 1.140E-74 
Cspg4 5.915 4.153 18.240 2.470E-74 8.830E-72 
1700086L19Rik 5.761 4.086 17.620 1.720E-69 5.360E-67 
Col12a1 13.728 4.599 17.317 3.510E-67 9.760E-65 
C4b 13.450 6.092 16.789 2.940E-63 7.350E-61 
Dbpht2 3.081 4.278 16.684 1.710E-62 3.890E-60 
Phgdh 5.198 2.552 15.764 5.540E-56 1.060E-53 
Sema5a 4.369 3.898 15.759 5.910E-56 1.060E-53 
Agrn 12.374 2.483 15.389 1.940E-53 2.850E-51 
Idh2 12.882 1.618 13.927 4.340E-44 5.170E-42 
Capn6 6.652 2.577 13.651 1.990E-42 2.260E-40 
Adamtsl4 7.509 2.420 13.395 6.440E-41 6.710E-39 
Abca1 5.798 2.886 12.965 1.940E-38 1.800E-36 
Acvr1c 11.597 2.719 12.583 2.610E-36 2.250E-34 
Itpr3 3.253 2.570 12.469 1.110E-35 9.230E-34 
Enpp2 21.418 1.761 12.292 1.000E-34 7.850E-33 
Rnf144a 4.315 2.100 12.142 6.300E-34 4.630E-32 
Lama3 7.727 2.372 12.124 7.840E-34 5.600E-32 
Hs3st1 2.320 3.097 12.097 1.090E-33 7.600E-32 
Txnip 3.631 3.026 11.614 3.510E-31 2.310E-29 
Rnf213 4.482 3.008 11.551 7.290E-31 4.670E-29 
Hmgcs2 3.685 3.816 11.502 1.280E-30 8.010E-29 
Nfia 5.247 1.887 11.454 2.250E-30 1.340E-28 
Wscd1 3.625 2.521 11.241 2.580E-29 1.430E-27 
Auts2 7.103 1.747 10.769 4.830E-27 2.570E-25 
Rapgef3 1.315 3.088 10.708 9.300E-27 4.750E-25 
Gab1 4.366 2.226 10.692 1.110E-26 5.560E-25 
Kcnn4 0.913 3.109 10.616 2.520E-26 1.240E-24 
Maob 3.121 2.768 10.594 3.180E-26 1.530E-24 
Prex2 11.572 1.642 10.382 3.000E-25 1.380E-23 
Erbb3 14.885 1.701 10.381 3.030E-25 1.380E-23 
Cubn 5.085 2.195 10.219 1.620E-24 7.250E-23 
Filip1l 4.492 2.053 10.141 3.650E-24 1.600E-22 
Pde4b 2.728 2.453 10.014 1.320E-23 5.710E-22 
Gsta4 2.230 2.260 9.895 4.370E-23 1.850E-21 
Vcan 2.847 3.315 9.627 6.150E-22 2.560E-20 
Adgrg1 13.468 2.053 9.564 1.130E-21 4.560E-20 




Fscn1 2.341 2.787 9.307 1.310E-20 5.040E-19 
Wnk4 1.664 2.555 9.242 2.420E-20 9.180E-19 
Afap1l2 1.410 3.000 9.164 5.000E-20 1.870E-18 
Rnase4 2.219 3.543 9.114 7.940E-20 2.920E-18 
Gm47865 4.150 1.794 9.072 1.170E-19 4.220E-18 
Klf5 1.468 2.426 9.054 1.380E-19 4.920E-18 
Serpinb1a 1.311 2.555 8.710 3.030E-18 1.070E-16 
Gucy2f 2.720 2.998 8.666 4.480E-18 1.530E-16 
Ctdsp2 7.578 1.483 8.662 4.640E-18 1.570E-16 
Sema3a 1.531 2.664 8.606 7.570E-18 2.520E-16 
Arhgef10l 1.448 2.774 8.554 1.190E-17 3.910E-16 
Fam102a 5.116 1.656 8.509 1.760E-17 5.710E-16 
Bcl9l 3.033 1.910 8.489 2.080E-17 6.660E-16 
Hspa1b 3.275 3.321 8.404 4.320E-17 1.350E-15 
Zfhx3 1.342 2.645 8.305 1.000E-16 2.980E-15 
Plk2 2.921 1.940 8.220 2.030E-16 5.850E-15 
Plec 17.394 1.500 8.051 8.200E-16 2.300E-14 
Gjb2 5.957 1.687 8.021 1.050E-15 2.920E-14 
Tcf7l2 1.123 2.041 7.892 2.990E-15 8.200E-14 
Pde1c 5.223 1.853 7.856 3.960E-15 1.080E-13 
Col1a1 4.946 3.267 7.778 7.380E-15 1.960E-13 
Ptk7 2.567 2.004 7.718 1.180E-14 3.070E-13 
Fbln2 2.507 2.198 7.699 1.380E-14 3.550E-13 
Ahr 2.459 2.028 7.692 1.440E-14 3.690E-13 
Card10 1.526 2.520 7.679 1.600E-14 4.050E-13 
Pmp22 4.151 1.786 7.657 1.900E-14 4.760E-13 
Pde3a 5.504 1.539 7.615 2.640E-14 6.540E-13 
Appl2 8.504 1.380 7.420 1.170E-13 2.780E-12 
Celsr2 3.589 1.761 7.411 1.250E-13 2.960E-12 
Iqgap2 4.866 1.548 7.367 1.740E-13 4.080E-12 
Gad1 0.817 3.027 7.362 1.810E-13 4.190E-12 
Lpin1 3.601 1.675 7.322 2.440E-13 5.590E-12 
H2-K1 5.397 1.619 7.218 5.270E-13 1.190E-11 
Timp3 2.150 2.474 7.172 7.380E-13 1.650E-11 
Cdk6 1.303 2.592 7.150 8.700E-13 1.920E-11 
Ifitm3 1.573 1.984 7.100 1.250E-12 2.720E-11 
Tnfrsf21 0.991 3.194 7.047 1.830E-12 3.950E-11 
Prickle1 4.690 1.708 6.984 2.870E-12 6.120E-11 
Arsi 0.796 3.002 6.981 2.930E-12 6.210E-11 
Ahnak 72.999 1.350 6.881 5.940E-12 1.250E-10 
Notch1 14.054 1.435 6.852 7.280E-12 1.520E-10 
St5 6.023 1.386 6.811 9.670E-12 1.970E-10 
Dsp 1.614 3.327 6.788 1.140E-11 2.290E-10 




Hspg2 8.690 1.654 6.771 1.280E-11 2.540E-10 
Prelp 5.479 1.617 6.708 1.970E-11 3.850E-10 
Igfbp4 1.270 3.135 6.704 2.030E-11 3.930E-10 
Abcg1 1.003 2.785 6.688 2.260E-11 4.340E-10 
Shisa2 0.884 2.233 6.682 2.360E-11 4.510E-10 
Fam129b 1.931 1.852 6.664 2.660E-11 5.030E-10 
Dhrs3 1.341 2.399 6.637 3.200E-11 6.020E-10 
Zbtb20 10.713 1.444 6.563 5.280E-11 9.860E-10 
Crybg1 1.260 2.835 6.510 7.540E-11 1.400E-09 
Lrp1 3.141 2.712 6.476 9.420E-11 1.730E-09 
Fgfr1 1.882 2.001 6.423 1.340E-10 2.420E-09 
Nfib 5.165 1.346 6.359 2.030E-10 3.620E-09 
Trdmt1 1.488 1.774 6.271 3.580E-10 6.300E-09 
Hspa1a 3.635 2.941 6.244 4.260E-10 7.450E-09 
Igf1r 2.761 1.636 6.211 5.280E-10 9.100E-09 
Dcn 1.150 2.938 6.205 5.470E-10 9.370E-09 
Ucp2 3.658 2.103 6.173 6.720E-10 1.130E-08 
Jup 4.439 1.844 6.124 9.100E-10 1.530E-08 
Gm47316 2.082 1.671 6.048 1.470E-09 2.440E-08 
Cd82 1.799 1.710 6.031 1.630E-09 2.700E-08 
Junb 3.315 1.945 6.014 1.810E-09 2.980E-08 
Rnase1 1.255 2.319 6.012 1.830E-09 2.990E-08 
Ptprf 1.632 2.933 5.991 2.080E-09 3.380E-08 
Ehd2 1.041 2.368 5.964 2.470E-09 3.980E-08 
Pik3ip1 0.891 2.176 5.959 2.530E-09 4.060E-08 
Krt5 1.009 3.083 5.907 3.490E-09 5.520E-08 
Col3a1 3.896 2.566 5.846 5.040E-09 7.920E-08 
A230050P20Rik 1.318 2.087 5.802 6.560E-09 1.030E-07 
Sgsh 0.813 2.365 5.782 7.360E-09 1.140E-07 
Bmp1 2.241 1.655 5.765 8.150E-09 1.250E-07 
Nfix 0.649 2.230 5.758 8.500E-09 1.300E-07 
Arrb1 0.907 2.675 5.744 9.260E-09 1.400E-07 
Rnd3 2.944 1.609 5.701 1.190E-08 1.800E-07 
AW011738 2.570 1.708 5.648 1.620E-08 2.430E-07 
Igsf3 7.390 1.242 5.601 2.130E-08 3.170E-07 
Zfp469 1.559 2.047 5.561 2.680E-08 3.930E-07 
Pax3 34.639 1.058 5.553 2.820E-08 4.090E-07 
Gucy1b1 1.986 1.937 5.542 2.990E-08 4.320E-07 
Perp 1.134 2.988 5.537 3.080E-08 4.430E-07 
Tnrc18 6.437 1.283 5.532 3.160E-08 4.510E-07 
Sox6 8.240 1.215 5.422 5.880E-08 8.300E-07 
H2-T23 1.079 1.969 5.399 6.700E-08 9.410E-07 
Egfr 1.329 3.040 5.375 7.650E-08 1.070E-06 




Zfp36 2.569 1.793 5.317 1.060E-07 1.460E-06 
Bgn 0.903 2.570 5.314 1.070E-07 1.470E-06 
Myh14 1.230 1.826 5.295 1.190E-07 1.630E-06 
Syne2 4.936 1.554 5.267 1.380E-07 1.870E-06 
Phip 3.318 1.433 5.265 1.410E-07 1.890E-06 
Wdr6 13.267 1.180 5.256 1.470E-07 1.960E-06 
Thbs2 1.044 2.780 5.256 1.470E-07 1.960E-06 
Krt17 1.184 3.411 5.245 1.560E-07 2.070E-06 
Coq8a 2.480 1.579 5.236 1.650E-07 2.160E-06 
H2-Q4 1.545 2.170 5.227 1.720E-07 2.260E-06 
Olfml1 0.744 2.515 5.222 1.770E-07 2.300E-06 
Zbtb44 1.564 1.683 5.214 1.850E-07 2.390E-06 
Gas1 1.382 1.697 5.190 2.100E-07 2.710E-06 
Col1a2 3.420 1.829 5.171 2.330E-07 2.980E-06 
Inf2 6.419 1.256 5.165 2.400E-07 3.060E-06 
Abca8a 1.121 2.029 5.160 2.470E-07 3.130E-06 
Pik3c2b 0.682 2.381 5.156 2.520E-07 3.180E-06 
Sfn 1.514 2.551 5.144 2.690E-07 3.380E-06 
Dgka 0.803 2.101 5.121 3.040E-07 3.800E-06 
Fos 18.196 1.695 5.109 3.240E-07 4.030E-06 
Trim29 1.652 2.913 5.064 4.100E-07 5.080E-06 
Slc43a3 0.748 2.049 5.013 5.370E-07 6.580E-06 
Cntn1 0.766 2.492 5.011 5.410E-07 6.600E-06 
Arnt2 6.599 1.223 5.009 5.460E-07 6.630E-06 
Myo1b 7.567 1.148 4.969 6.740E-07 8.090E-06 
Boc 1.485 1.724 4.968 6.750E-07 8.090E-06 
Phldb1 1.890 1.791 4.968 6.770E-07 8.090E-06 
Neo1 6.366 1.195 4.960 7.050E-07 8.400E-06 
Gm37376 22.131 1.169 4.941 7.770E-07 9.210E-06 
Arhgef2 1.857 1.853 4.901 9.520E-07 1.120E-05 
Rarg 1.540 1.721 4.894 9.900E-07 1.160E-05 
Nrbp2 1.800 1.593 4.858 1.190E-06 1.370E-05 
Tgfbr3 2.008 1.709 4.838 1.310E-06 1.510E-05 
Pde1b 1.026 2.124 4.772 1.820E-06 2.090E-05 
Arsg 1.175 1.780 4.762 1.920E-06 2.170E-05 
Hspb1 0.910 2.550 4.764 1.900E-06 2.170E-05 
Pxdn 1.176 2.322 4.753 2.000E-06 2.260E-05 
Efnb1 0.988 2.375 4.739 2.150E-06 2.410E-05 
Dlx3 0.990 2.884 4.734 2.200E-06 2.450E-05 
Atf3 1.229 2.598 4.724 2.310E-06 2.550E-05 
Itgb4 0.936 3.059 4.662 3.130E-06 3.420E-05 
Myc 5.541 1.408 4.657 3.200E-06 3.480E-05 
Frmd4b 1.996 1.667 4.635 3.570E-06 3.860E-05 




Serping1 0.955 2.701 4.630 3.660E-06 3.930E-05 
Ppp1r9a 0.977 1.923 4.620 3.830E-06 4.090E-05 
Sdc4 0.632 2.288 4.603 4.160E-06 4.410E-05 
Crip2 1.287 1.627 4.580 4.640E-06 4.890E-05 
Myo10 13.135 1.069 4.576 4.730E-06 4.970E-05 
Fstl1 0.889 2.478 4.575 4.760E-06 4.980E-05 
Col16a1 5.658 1.221 4.561 5.080E-06 5.270E-05 
Kcna2 8.441 1.239 4.562 5.060E-06 5.270E-05 
Trp63 1.044 3.010 4.555 5.230E-06 5.400E-05 
Zfp618 0.644 2.098 4.547 5.430E-06 5.590E-05 
Chd6 6.379 1.146 4.518 6.240E-06 6.370E-05 
Pdzd2 0.878 2.447 4.496 6.920E-06 7.030E-05 
Car5b 0.703 1.922 4.476 7.610E-06 7.700E-05 
Bcl2 3.493 1.368 4.447 8.730E-06 8.760E-05 
Cdc42ep1 0.712 2.309 4.444 8.840E-06 8.840E-05 
Wdfy3 4.590 1.200 4.439 9.040E-06 8.970E-05 
Col6a3 1.955 2.344 4.439 9.040E-06 8.970E-05 
Col5a1 1.274 2.929 4.416 1.010E-05 9.900E-05 
Per1 4.734 1.310 4.412 1.020E-05 1.000E-04 
Sema3c 3.993 1.345 4.412 1.020E-05 1.000E-04 
Cxcl14 0.907 1.858 4.391 1.130E-05 1.094E-04 
Grik1 1.148 1.786 4.357 1.320E-05 1.274E-04 
Plxna2 1.857 1.839 4.335 1.460E-05 1.399E-04 
Rin3 1.342 1.570 4.325 1.530E-05 1.462E-04 
Usp53 1.490 1.520 4.310 1.630E-05 1.557E-04 
Pde7b 4.820 1.334 4.269 1.960E-05 1.866E-04 
Coro2a 0.615 2.450 4.262 2.030E-05 1.922E-04 
Nfkbiz 1.765 1.658 4.252 2.120E-05 1.997E-04 
Cd200 2.346 1.417 4.248 2.160E-05 2.030E-04 
Emp2 2.380 1.498 4.207 2.580E-05 2.410E-04 
Dixdc1 0.560 2.044 4.208 2.580E-05 2.410E-04 
Gng7 2.028 1.403 4.206 2.590E-05 2.411E-04 
Casz1 1.083 2.853 4.200 2.670E-05 2.469E-04 
Ece1 0.841 1.939 4.195 2.730E-05 2.516E-04 
Arrdc3 1.975 1.511 4.191 2.780E-05 2.557E-04 
Plxnb1 0.888 2.870 4.165 3.120E-05 2.855E-04 
Ets1 3.729 1.222 4.128 3.660E-05 3.338E-04 
Dock3 1.299 1.997 4.103 4.080E-05 3.705E-04 
Eng 7.938 1.132 4.096 4.200E-05 3.809E-04 
Clasp2 11.676 1.030 4.055 5.020E-05 4.528E-04 
Epha2 1.162 1.864 4.053 5.070E-05 4.555E-04 
Dapk1 0.640 2.095 4.040 5.350E-05 4.798E-04 
Gas7 0.890 2.507 4.018 5.860E-05 5.236E-04 




Zfp704 6.247 1.105 4.016 5.910E-05 5.243E-04 
Dpysl3 1.330 1.674 4.008 6.130E-05 5.412E-04 
Irf6 0.576 2.247 3.972 7.130E-05 6.278E-04 
Usp54 3.861 1.222 3.927 8.590E-05 7.511E-04 
Cyp2d22 1.062 2.640 3.910 9.230E-05 8.015E-04 
Prkd3 7.108 1.037 3.900 9.610E-05 8.291E-04 
Tnik 4.403 1.156 3.900 9.620E-05 8.291E-04 
Lama5 0.998 2.887 3.894 9.850E-05 8.460E-04 
Ivns1abp 16.971 1.001 3.892 9.960E-05 8.524E-04 
Fchsd2 2.839 1.248 3.887 1.017E-04 8.675E-04 
Tet3 6.900 1.085 3.861 1.131E-04 9.617E-04 
Oplah 0.791 1.788 3.853 1.167E-04 9.887E-04 
Sox4 1.997 1.284 3.851 1.177E-04 9.945E-04 
Ip6k3 0.630 2.396 3.850 1.182E-04 9.953E-04 
Fat2 1.182 3.613 3.842 1.218E-04 1.022E-03 
Bmp7 0.671 2.267 3.840 1.228E-04 1.027E-03 
Heg1 0.797 2.365 3.805 1.420E-04 1.180E-03 
Cpne4 7.224 1.149 3.783 1.551E-04 1.284E-03 
Lrrtm2 2.306 1.416 3.764 1.670E-04 1.378E-03 
Aldh1a3 1.047 2.794 3.715 2.034E-04 1.673E-03 
Itga4 0.834 1.812 3.710 2.074E-04 1.700E-03 
Stard9 1.665 1.562 3.680 2.328E-04 1.902E-03 
S100a6 0.445 1.932 3.668 2.445E-04 1.991E-03 
Erich3 0.527 1.955 3.667 2.453E-04 1.991E-03 
Ltbp4 0.855 2.221 3.659 2.531E-04 2.048E-03 
Lama1 3.146 1.288 3.638 2.747E-04 2.215E-03 
Hap1 1.389 1.511 3.625 2.885E-04 2.319E-03 
Capn5 0.694 1.774 3.616 2.987E-04 2.393E-03 
Plpp3 1.069 1.602 3.614 3.010E-04 2.404E-03 
Arid5b 3.077 1.252 3.596 3.230E-04 2.571E-03 
Jarid2 5.474 1.111 3.538 4.038E-04 3.185E-03 
Dsg3 0.822 3.107 3.535 4.078E-04 3.206E-03 
Irf2bpl 6.785 1.077 3.532 4.123E-04 3.231E-03 
Med12 9.431 1.008 3.515 4.398E-04 3.429E-03 
Plekhn1 1.322 1.441 3.515 4.402E-04 3.429E-03 
Malat1 234.342 1.048 3.510 4.481E-04 3.458E-03 
Cobll1 1.808 1.353 3.510 4.478E-04 3.458E-03 
P3h2 0.973 1.680 3.482 4.975E-04 3.815E-03 
Xdh 0.523 1.908 3.480 5.007E-04 3.828E-03 
Mmp14 8.685 1.013 3.476 5.093E-04 3.870E-03 
Jag1 0.641 1.791 3.476 5.089E-04 3.870E-03 
Xylt1 1.369 1.472 3.463 5.350E-04 4.053E-03 
Gm9920 1.225 1.493 3.458 5.435E-04 4.105E-03 




Krt75 0.991 3.367 3.390 6.986E-04 5.245E-03 
Col6a1 0.784 2.762 3.384 7.134E-04 5.340E-03 
Lad1 0.765 2.575 3.356 7.902E-04 5.897E-03 
Hmcn1 6.280 1.175 3.352 8.019E-04 5.966E-03 
Fancc 1.078 1.329 3.327 8.766E-04 6.503E-03 
Jun 20.871 1.346 3.319 9.048E-04 6.693E-03 
Cavin2 6.634 1.076 3.308 9.398E-04 6.910E-03 
2610035D17Rik 0.431 1.722 3.297 9.789E-04 7.176E-03 
Gm10800 0.857 1.684 3.291 9.992E-04 7.304E-03 
Tns4 0.742 2.800 3.276 1.053E-03 7.675E-03 
Numa1 7.433 1.021 3.272 1.067E-03 7.757E-03 
Dsc3 0.769 2.654 3.265 1.095E-03 7.938E-03 
Fcgrt 0.481 2.007 3.223 1.267E-03 9.127E-03 
Nr1d1 1.525 1.359 3.218 1.289E-03 9.253E-03 
Rab11fip5 1.006 1.540 3.218 1.292E-03 9.253E-03 
Dclk2 4.867 1.194 3.189 1.426E-03 1.019E-02 
Sipa1l3 5.703 1.052 3.185 1.448E-03 1.030E-02 
Ica1 1.668 1.227 3.185 1.450E-03 1.030E-02 
Maml3 2.888 1.162 3.167 1.540E-03 1.088E-02 
Bambi 1.182 1.359 3.167 1.540E-03 1.088E-02 
Prag1 2.685 1.203 3.156 1.598E-03 1.119E-02 
Tram2 1.341 1.337 3.144 1.665E-03 1.162E-02 
Adgra2 1.976 1.276 3.141 1.686E-03 1.174E-02 
Col18a1 0.591 1.939 3.115 1.838E-03 1.276E-02 
Gria4 0.971 1.694 3.098 1.946E-03 1.340E-02 
Col14a1 0.656 2.324 3.089 2.010E-03 1.380E-02 
Fn1 1.860 1.667 3.076 2.100E-03 1.438E-02 
Klk1b22 0.481 1.737 3.075 2.106E-03 1.438E-02 
Ogt 18.022 0.960 3.070 2.141E-03 1.459E-02 
Tspan2 1.448 1.666 3.066 2.172E-03 1.476E-02 
Fnbp1l 2.091 1.206 3.061 2.210E-03 1.497E-02 
Slc39a14 2.910 1.176 3.059 2.223E-03 1.502E-02 
Tubb2b 6.655 1.100 3.035 2.406E-03 1.617E-02 
Insr 3.991 1.091 3.015 2.571E-03 1.723E-02 
Egr3 0.632 2.215 3.012 2.597E-03 1.736E-02 
Mpzl1 8.840 0.975 2.998 2.719E-03 1.813E-02 
Obsl1 0.824 1.512 2.989 2.799E-03 1.861E-02 
Zfp783 0.719 1.669 2.987 2.818E-03 1.869E-02 
Rasgef1b 0.555 1.940 2.972 2.959E-03 1.952E-02 
Col6a2 0.679 2.449 2.972 2.959E-03 1.952E-02 
Bcam 0.542 2.339 2.969 2.989E-03 1.966E-02 
Lifr 1.360 1.610 2.961 3.064E-03 2.011E-02 
Axl 0.660 2.065 2.941 3.273E-03 2.142E-02 




Arhgap32 8.589 1.002 2.921 3.487E-03 2.270E-02 
Plp1 20.265 1.008 2.897 3.766E-03 2.445E-02 
Unc5b 0.854 1.735 2.883 3.937E-03 2.550E-02 
Efemp1 0.468 2.179 2.879 3.986E-03 2.575E-02 
Sned1 0.669 1.879 2.864 4.184E-03 2.696E-02 
Nfat5 6.552 1.022 2.854 4.315E-03 2.773E-02 
Dock6 2.177 1.195 2.852 4.341E-03 2.783E-02 
Slc15a2 0.680 1.604 2.848 4.397E-03 2.811E-02 
Ablim1 4.048 1.379 2.846 4.430E-03 2.825E-02 
Pkp1 0.490 2.192 2.844 4.456E-03 2.834E-02 
Ahdc1 3.183 1.098 2.828 4.684E-03 2.972E-02 
Notch2 11.131 0.982 2.823 4.750E-03 3.006E-02 
Ndrg1 1.265 1.698 2.816 4.869E-03 3.074E-02 
Gm44005 1.562 1.276 2.814 4.899E-03 3.085E-02 
Fndc1 0.913 2.698 2.803 5.059E-03 3.178E-02 
Dnm1 0.447 1.688 2.798 5.141E-03 3.213E-02 
Sdc1 0.477 1.810 2.790 5.278E-03 3.284E-02 
Wnt5a 0.597 2.262 2.789 5.281E-03 3.284E-02 
Kmt2a 7.219 0.985 2.782 5.406E-03 3.354E-02 
Gpc3 0.438 2.000 2.776 5.496E-03 3.401E-02 
Frem2 0.929 1.581 2.772 5.576E-03 3.442E-02 
Plcl1 0.638 1.574 2.765 5.688E-03 3.502E-02 
Socs3 1.099 2.002 2.753 5.907E-03 3.629E-02 
Olfm1 9.519 1.039 2.748 6.003E-03 3.670E-02 
Arhgap21 3.441 1.049 2.748 6.004E-03 3.670E-02 
Nup210 2.267 1.313 2.745 6.046E-03 3.687E-02 
Klhl24 5.210 1.038 2.740 6.149E-03 3.740E-02 
Nfic 11.088 0.941 2.725 6.437E-03 3.906E-02 
Adamts1 2.871 1.337 2.720 6.529E-03 3.952E-02 
Bahcc1 2.694 1.117 2.706 6.802E-03 4.107E-02 
Per3 1.616 1.258 2.684 7.284E-03 4.377E-02 
Emp1 1.130 1.410 2.681 7.335E-03 4.397E-02 
Runx1 0.398 1.759 2.677 7.432E-03 4.434E-02 
Spint2 0.362 1.823 2.677 7.427E-03 4.434E-02 
Rassf2 0.613 1.472 2.674 7.490E-03 4.458E-02 
Unkl 1.250 1.294 2.663 7.742E-03 4.597E-02 
Btg2 0.493 1.946 2.661 7.782E-03 4.610E-02 
Col4a1 0.688 2.453 2.659 7.833E-03 4.630E-02 
Padi3 0.618 2.388 2.644 8.197E-03 4.833E-02 
Vangl2 3.541 1.068 2.633 8.455E-03 4.974E-02 






Table 3.2:  DAVID GO terms from Gene Lists in Table 3.1 (see also Table S9 from Infarinato et 
al., 2020) 
 
DAVID GO Term Analysis Output:  Statistical enrichment, GO Biological Process 
Complete 
     
Control List     
     
Term Count % P-Value Benjamini 
melanin biosynthetic process 4 5 1.90E-05 1.30E-02 
melanosome organization 4 5 2.40E-05 8.50E-03 
negative regulation of sequence-specific DNA 
binding transcription factor activity 4 5 3.00E-03 5.00E-01 
vagus nerve morphogenesis 2 2.5 8.30E-03 7.70E-01 
positive regulation of keratinocyte apoptotic process 2 2.5 1.20E-02 8.30E-01 
pigmentation 3 3.8 1.50E-02 8.30E-01 
cellular protein modification process 3 3.8 1.60E-02 8.00E-01 
visual perception 4 5 1.80E-02 8.00E-01 
axon guidance 4 5 2.40E-02 8.50E-01 
muscle organ development 3 3.8 2.80E-02 8.70E-01 
cellular aromatic compound metabolic process 2 2.5 2.90E-02 8.50E-01 
regulation of axon extension involved in axon 
guidance 2 2.5 2.90E-02 8.50E-01 
semicircular canal morphogenesis 2 2.5 2.90E-02 8.50E-01 
epithelial cell differentiation 3 3.8 3.20E-02 8.50E-01 
cerebral cortex development 3 3.8 3.20E-02 8.30E-01 
positive regulation of feeding behavior 2 2.5 3.30E-02 8.10E-01 
positive regulation of ryanodine-sensitive calcium-
release channel activity 2 2.5 3.30E-02 8.10E-01 
transport 14 17.5 3.60E-02 8.20E-01 
inner ear morphogenesis 3 3.8 3.60E-02 8.00E-01 
response to endoplasmic reticulum stress 3 3.8 4.00E-02 8.10E-01 
regulation of cell migration 3 3.8 4.10E-02 8.00E-01 
positive regulation of smooth muscle cell 
proliferation 3 3.8 4.40E-02 8.10E-01 
branchiomotor neuron axon guidance 2 2.5 4.50E-02 8.00E-01 
semaphorin-plexin signaling pathway involved in 
axon guidance 2 2.5 5.30E-02 8.40E-01 
lens fiber cell differentiation 2 2.5 5.30E-02 8.40E-01 
multicellular organism development 9 11.2 6.30E-02 8.70E-01 
cell proliferation 4 5 6.30E-02 8.70E-01 
barbed-end actin filament capping 2 2.5 6.40E-02 8.60E-01 
transmembrane transport 5 6.2 6.50E-02 8.50E-01 
angiogenesis 4 5 7.70E-02 8.90E-01 
developmental pigmentation 2 2.5 8.00E-02 8.90E-01 




extracellular matrix organization 3 3.8 8.10E-02 8.80E-01 
tissue regeneration 2 2.5 8.70E-02 8.90E-01 
positive regulation of angiogenesis 3 3.8 9.00E-02 8.90E-01 
middle ear morphogenesis 2 2.5 9.50E-02 9.00E-01 
actin filament polymerization 2 2.5 9.50E-02 9.00E-01 
endothelial cell migration 2 2.5 9.90E-02 9.00E-01 
     
Bmpr1a Null List     
     
Term Count % P-Value Benjamini 
cell adhesion 36 10.7 1.00E-12 2.30E-09 
positive regulation of transcription from RNA 
polymerase II promoter 46 13.7 3.60E-09 4.10E-06 
positive regulation of transcription, DNA-templated 32 9.5 2.60E-08 2.00E-05 
skin development 10 3 6.50E-07 3.70E-04 
wound healing 12 3.6 7.00E-07 3.20E-04 
positive regulation of cell proliferation 28 8.3 9.90E-07 3.70E-04 
angiogenesis 18 5.4 1.00E-06 3.30E-04 
cell migration 16 4.8 1.30E-06 3.70E-04 
neural tube development 9 2.7 2.50E-06 6.30E-04 
single organismal cell-cell adhesion 12 3.6 2.80E-06 6.40E-04 
canonical Wnt signaling pathway 11 3.3 3.30E-06 6.70E-04 
blood vessel development 10 3 3.70E-06 7.00E-04 
negative regulation of cell proliferation 22 6.5 3.90E-06 6.90E-04 
negative regulation of transcription from RNA 
polymerase II promoter 32 9.5 4.30E-06 7.00E-04 
regulation of cell migration 10 3 7.30E-06 1.10E-03 
axon guidance 13 3.9 1.20E-05 1.60E-03 
skeletal muscle cell differentiation 8 2.4 4.40E-05 5.90E-03 
intracellular signal transduction 20 6 7.70E-05 9.70E-03 
endodermal cell differentiation 6 1.8 9.00E-05 1.10E-02 
blood vessel remodeling 7 2.1 9.30E-05 1.00E-02 
response to mechanical stimulus 8 2.4 1.10E-04 1.20E-02 
glycosaminoglycan biosynthetic process 6 1.8 1.10E-04 1.10E-02 
negative regulation of neuron projection 
development 8 2.4 1.20E-04 1.20E-02 
organ morphogenesis 10 3 1.20E-04 1.10E-02 
cAMP catabolic process 5 1.5 1.40E-04 1.20E-02 
extracellular matrix organization 10 3 1.70E-04 1.50E-02 
heart development 15 4.5 2.00E-04 1.70E-02 
response to cAMP 7 2.1 2.40E-04 2.00E-02 
multicellular organism development 35 10.4 2.50E-04 1.90E-02 
protein heterotrimerization 5 1.5 2.80E-04 2.10E-02 
semaphorin-plexin signaling pathway 6 1.8 2.80E-04 2.00E-02 




transforming growth factor beta receptor signaling 
pathway 8 2.4 3.20E-04 2.20E-02 
positive regulation of BMP signaling pathway 6 1.8 3.70E-04 2.40E-02 
cell-matrix adhesion 8 2.4 4.10E-04 2.60E-02 
positive regulation of mesenchymal cell proliferation 6 1.8 4.20E-04 2.60E-02 
cell motility 5 1.5 4.20E-04 2.60E-02 
cell cycle arrest 8 2.4 5.20E-04 3.00E-02 
collagen fibril organization 6 1.8 5.40E-04 3.10E-02 
skeletal system development 9 2.7 5.60E-04 3.10E-02 
regulation of transcription from RNA polymerase II 
promoter 18 5.4 6.10E-04 3.30E-02 
regulation of cell proliferation 13 3.9 6.40E-04 3.40E-02 
circadian regulation of gene expression 7 2.1 6.50E-04 3.40E-02 
keratinocyte differentiation 8 2.4 6.90E-04 3.50E-02 
epidermis development 7 2.1 7.10E-04 3.50E-02 
positive regulation of catenin import into nucleus 4 1.2 7.70E-04 3.70E-02 
post-anal tail morphogenesis 5 1.5 8.50E-04 4.00E-02 
negative regulation of axon extension involved in 
axon guidance 5 1.5 9.90E-04 4.60E-02 
regulation of embryonic development 4 1.2 1.00E-03 4.60E-02 
semaphorin-plexin signaling pathway involved in 
axon guidance 4 1.2 1.30E-03 5.80E-02 
negative regulation of fibroblast growth factor 
receptor signaling pathway 4 1.2 1.30E-03 5.80E-02 
cardiac septum morphogenesis 4 1.2 1.30E-03 5.80E-02 
regulation of angiogenesis 5 1.5 1.30E-03 5.70E-02 
ureteric bud development 6 1.8 1.40E-03 6.00E-02 
lung development 9 2.7 1.50E-03 6.10E-02 
branching involved in salivary gland morphogenesis 4 1.2 2.00E-03 8.20E-02 
negative regulation of apoptotic process 21 6.2 2.20E-03 8.70E-02 
in utero embryonic development 14 4.2 2.30E-03 8.90E-02 
nervous system development 16 4.8 2.60E-03 9.70E-02 
protein phosphorylation 21 6.2 2.70E-03 1.00E-01 
positive regulation of epithelial to mesenchymal 
transition 5 1.5 2.70E-03 1.00E-01 
positive regulation of neuron projection 
development 9 2.7 2.90E-03 1.00E-01 
desmosome organization 3 0.9 2.90E-03 1.00E-01 
negative regulation of vascular endothelial growth 
factor signaling pathway 3 0.9 2.90E-03 1.00E-01 
hemidesmosome assembly 3 0.9 2.90E-03 1.00E-01 
positive regulation of cell migration 11 3.3 3.00E-03 1.00E-01 
neuron projection development 9 2.7 3.00E-03 1.00E-01 
hair follicle morphogenesis 5 1.5 3.10E-03 1.00E-01 
branching morphogenesis of an epithelial tube 5 1.5 3.40E-03 1.10E-01 




digestive tract morphogenesis 4 1.2 3.50E-03 1.10E-01 
bone remodeling 4 1.2 3.50E-03 1.10E-01 
coronary vasculature development 5 1.5 3.80E-03 1.20E-01 
response to toxic substance 7 2.1 3.80E-03 1.20E-01 
retinal blood vessel morphogenesis 3 0.9 4.30E-03 1.30E-01 
collagen biosynthetic process 3 0.9 4.30E-03 1.30E-01 
odontogenesis of dentin-containing tooth 6 1.8 4.70E-03 1.40E-01 
embryonic limb morphogenesis 6 1.8 4.70E-03 1.40E-01 
neuron projection morphogenesis 6 1.8 4.70E-03 1.40E-01 
face development 4 1.2 4.70E-03 1.40E-01 
positive regulation of protein phosphorylation 10 3 4.90E-03 1.40E-01 
patterning of blood vessels 5 1.5 5.00E-03 1.40E-01 
cellular response to retinoic acid 6 1.8 5.40E-03 1.50E-01 
positive regulation of fibroblast proliferation 6 1.8 5.40E-03 1.50E-01 
cell-cell adhesion 10 3 5.90E-03 1.60E-01 
response to corticosteroid 3 0.9 6.00E-03 1.60E-01 
cardiac atrium morphogenesis 3 0.9 6.00E-03 1.60E-01 
Notch signaling pathway 8 2.4 6.20E-03 1.70E-01 
liver development 7 2.1 6.20E-03 1.70E-01 
cellular response to vascular endothelial growth 
factor stimulus 4 1.2 6.30E-03 1.60E-01 
positive regulation of DNA replication 5 1.5 6.50E-03 1.70E-01 
positive regulation of protein binding 6 1.8 6.50E-03 1.70E-01 
signal transduction 35 10.4 6.70E-03 1.70E-01 
epidermal growth factor receptor signaling pathway 5 1.5 7.60E-03 1.90E-01 
neuron apoptotic process 5 1.5 7.60E-03 1.90E-01 
pericardium morphogenesis 3 0.9 7.90E-03 1.90E-01 
positive regulation of extracellular matrix 
disassembly 3 0.9 7.90E-03 1.90E-01 
somatic stem cell population maintenance 5 1.5 8.20E-03 2.00E-01 
Rho protein signal transduction 5 1.5 8.20E-03 2.00E-01 
negative regulation of epithelial cell proliferation 6 1.8 8.30E-03 2.00E-01 
response to estradiol 7 2.1 8.40E-03 2.00E-01 
venous blood vessel morphogenesis 3 0.9 1.00E-02 2.30E-01 
establishment of epithelial cell apical/basal polarity 3 0.9 1.00E-02 2.30E-01 
heart trabecula morphogenesis 3 0.9 1.00E-02 2.30E-01 
negative chemotaxis 4 1.2 1.00E-02 2.30E-01 
cellular response to amino acid stimulus 8 2.4 1.00E-02 2.30E-01 
neural crest cell migration 5 1.5 1.00E-02 2.30E-01 
activation of MAPK activity 6 1.8 1.00E-02 2.30E-01 
positive regulation of epithelial cell proliferation 6 1.8 1.00E-02 2.30E-01 
aging 9 2.7 1.10E-02 2.30E-01 
regulation of cell shape 8 2.4 1.10E-02 2.30E-01 
establishment or maintenance of cell polarity 4 1.2 1.10E-02 2.30E-01 




embryonic eye morphogenesis 3 0.9 1.20E-02 2.50E-01 
response to cytokine 6 1.8 1.30E-02 2.70E-01 
liver regeneration 4 1.2 1.40E-02 2.70E-01 
sprouting angiogenesis 4 1.2 1.40E-02 2.70E-01 
positive regulation of mitotic nuclear division 4 1.2 1.40E-02 2.70E-01 
positive regulation of apoptotic process 13 3.9 1.40E-02 2.80E-01 
post-embryonic development 7 2.1 1.50E-02 2.80E-01 
actin filament organization 6 1.8 1.50E-02 2.80E-01 
cellular response to fibroblast growth factor stimulus 4 1.2 1.50E-02 2.80E-01 
response to radiation 4 1.2 1.50E-02 2.80E-01 
extracellular fibril organization 3 0.9 1.50E-02 2.80E-01 
bleb assembly 3 0.9 1.50E-02 2.80E-01 
astrocyte differentiation 3 0.9 1.50E-02 2.80E-01 
negative regulation of neuron migration 3 0.9 1.50E-02 2.80E-01 
pulmonary valve morphogenesis 3 0.9 1.50E-02 2.80E-01 
salivary gland morphogenesis 3 0.9 1.50E-02 2.80E-01 
branchiomotor neuron axon guidance 3 0.9 1.50E-02 2.80E-01 
limb bud formation 3 0.9 1.50E-02 2.80E-01 
skin morphogenesis 3 0.9 1.50E-02 2.80E-01 
negative regulation of protein phosphorylation 6 1.8 1.50E-02 2.90E-01 
organ regeneration 5 1.5 1.60E-02 3.00E-01 
bone development 5 1.5 1.60E-02 3.00E-01 
positive regulation of filopodium assembly 4 1.2 1.60E-02 3.00E-01 
regulation of ERK1 and ERK2 cascade 4 1.2 1.60E-02 3.00E-01 
prostate gland epithelium morphogenesis 3 0.9 1.80E-02 3.20E-01 
morphogenesis of an epithelial sheet 3 0.9 1.80E-02 3.20E-01 
cell differentiation 23 6.8 1.80E-02 3.20E-01 
response to hydrogen peroxide 5 1.5 1.80E-02 3.20E-01 
positive regulation of angiogenesis 7 2.1 1.90E-02 3.30E-01 
cholesterol metabolic process 6 1.8 1.90E-02 3.30E-01 
receptor-mediated endocytosis 5 1.5 2.00E-02 3.40E-01 
cardiac epithelial to mesenchymal transition 3 0.9 2.10E-02 3.40E-01 
planar cell polarity pathway involved in neural tube 
closure 3 0.9 2.10E-02 3.40E-01 
fibroblast migration 3 0.9 2.10E-02 3.40E-01 
cardiac right ventricle morphogenesis 3 0.9 2.10E-02 3.40E-01 
cellular response to transforming growth factor beta 
stimulus 5 1.5 2.10E-02 3.50E-01 
negative regulation of neuron apoptotic process 8 2.4 2.20E-02 3.50E-01 
actin filament bundle assembly 4 1.2 2.30E-02 3.60E-01 
blood vessel morphogenesis 4 1.2 2.30E-02 3.60E-01 
heart looping 5 1.5 2.30E-02 3.60E-01 
neuron differentiation 7 2.1 2.40E-02 3.70E-01 
vasculogenesis involved in coronary vascular 




kidney morphogenesis 3 0.9 2.40E-02 3.70E-01 
cellular response to epidermal growth factor 
stimulus 4 1.2 2.40E-02 3.70E-01 
ossification 6 1.8 2.60E-02 3.90E-01 
kidney development 7 2.1 2.60E-02 3.90E-01 
positive regulation of protein kinase B signaling 6 1.8 2.70E-02 4.00E-01 
establishment of epithelial cell polarity 3 0.9 2.70E-02 4.00E-01 
Wnt signaling pathway, planar cell polarity pathway 3 0.9 2.70E-02 4.00E-01 
positive regulation of cholesterol efflux 3 0.9 2.70E-02 4.00E-01 
inner ear development 5 1.5 2.80E-02 4.00E-01 
positive regulation of canonical Wnt signaling 
pathway 5 1.5 2.90E-02 4.10E-01 
cell communication 4 1.2 3.00E-02 4.20E-01 
transmembrane receptor protein tyrosine kinase 
signaling pathway 6 1.8 3.00E-02 4.20E-01 
response to calcium ion 5 1.5 3.10E-02 4.20E-01 
vasculogenesis 5 1.5 3.10E-02 4.20E-01 
positive regulation of cell size 3 0.9 3.10E-02 4.20E-01 
positive regulation of histone H3-K4 methylation 3 0.9 3.10E-02 4.20E-01 
positive regulation of cartilage development 3 0.9 3.10E-02 4.20E-01 
histone H3-K4 trimethylation 3 0.9 3.10E-02 4.20E-01 
positive regulation of peptidyl-tyrosine 
phosphorylation 6 1.8 3.10E-02 4.20E-01 
substrate adhesion-dependent cell spreading 4 1.2 3.20E-02 4.30E-01 
regulation of growth 5 1.5 3.20E-02 4.30E-01 
negative regulation of canonical Wnt signaling 
pathway 6 1.8 3.30E-02 4.30E-01 
sensory perception of sound 7 2.1 3.40E-02 4.40E-01 
transcription from RNA polymerase II promoter 7 2.1 3.40E-02 4.40E-01 
regulation of transcription, DNA-templated 52 15.5 3.40E-02 4.40E-01 
ventricular trabecula myocardium morphogenesis 3 0.9 3.40E-02 4.40E-01 
astrocyte development 3 0.9 3.40E-02 4.40E-01 
positive regulation of meiotic cell cycle 2 0.6 3.40E-02 4.40E-01 
canonical Wnt signaling pathway involved in 
positive regulation of wound healing 2 0.6 3.40E-02 4.40E-01 
extrinsic apoptotic signaling pathway in absence of 
ligand 4 1.2 3.60E-02 4.50E-01 
transcription, DNA-templated 44 13.1 3.80E-02 4.70E-01 
positive regulation of protein export from nucleus 3 0.9 3.80E-02 4.70E-01 
smooth muscle tissue development 3 0.9 3.80E-02 4.70E-01 
pharyngeal system development 3 0.9 3.80E-02 4.70E-01 
definitive hemopoiesis 3 0.9 3.80E-02 4.70E-01 
axonal fasciculation 3 0.9 3.80E-02 4.70E-01 
establishment of protein localization to plasma 
membrane 4 1.2 3.80E-02 4.70E-01 




positive regulation of peptidyl-serine 
phosphorylation 5 1.5 4.00E-02 4.70E-01 
embryonic skeletal system development 4 1.2 4.10E-02 4.80E-01 
establishment of skin barrier 3 0.9 4.20E-02 4.90E-01 
negative regulation of neuron differentiation 5 1.5 4.30E-02 4.90E-01 
SMAD protein signal transduction 5 1.5 4.50E-02 5.10E-01 
chondrocyte differentiation 4 1.2 4.60E-02 5.10E-01 
spleen development 4 1.2 4.60E-02 5.10E-01 
positive regulation of cell differentiation 4 1.2 4.60E-02 5.10E-01 
anterior/posterior pattern specification 6 1.8 4.60E-02 5.10E-01 
regulation of microtubule cytoskeleton organization 3 0.9 4.60E-02 5.10E-01 
positive regulation of cell-cell adhesion 3 0.9 4.60E-02 5.10E-01 
camera-type eye development 5 1.5 4.70E-02 5.10E-01 
osteoblast differentiation 6 1.8 4.70E-02 5.10E-01 
positive regulation of smooth muscle cell 
proliferation 5 1.5 5.10E-02 5.30E-01 
negative regulation of cell death 5 1.5 5.10E-02 5.30E-01 
positive regulation of cysteine-type endopeptidase 
activity involved in apoptotic process 4 1.2 5.10E-02 5.30E-01 
branching involved in ureteric bud morphogenesis 4 1.2 5.10E-02 5.30E-01 
glial cell differentiation 3 0.9 5.10E-02 5.30E-01 
embryonic hemopoiesis 3 0.9 5.10E-02 5.30E-01 
positive regulation of focal adhesion assembly 3 0.9 5.10E-02 5.30E-01 
intermediate filament organization 3 0.9 5.10E-02 5.30E-01 
convergent extension 2 0.6 5.10E-02 5.30E-01 
distal tubule development 2 0.6 5.10E-02 5.30E-01 
transforming growth factor beta receptor complex 
assembly 2 0.6 5.10E-02 5.30E-01 
planar cell polarity pathway involved in axis 
elongation 2 0.6 5.10E-02 5.30E-01 
epicardial cell to mesenchymal cell transition 2 0.6 5.10E-02 5.30E-01 
regulation of epidermal cell division 2 0.6 5.10E-02 5.30E-01 
positive regulation of TRAIL-activated apoptotic 
signaling pathway 2 0.6 5.10E-02 5.30E-01 
regulation of gluconeogenesis by regulation of 
transcription from RNA polymerase II promoter 2 0.6 5.10E-02 5.30E-01 
regulation of developmental process 2 0.6 5.10E-02 5.30E-01 
heparan sulfate proteoglycan metabolic process 2 0.6 5.10E-02 5.30E-01 
cell morphogenesis 5 1.5 5.20E-02 5.40E-01 
cell development 4 1.2 5.30E-02 5.40E-01 
cell growth 4 1.2 5.30E-02 5.40E-01 
cartilage development 5 1.5 5.40E-02 5.50E-01 
regulation of actin cytoskeleton organization 4 1.2 5.60E-02 5.60E-01 
regulation of apoptotic process 8 2.4 5.90E-02 5.70E-01 
membrane depolarization 3 0.9 6.00E-02 5.80E-01 




regulation of insulin secretion involved in cellular 
response to glucose stimulus 3 0.9 6.00E-02 5.80E-01 
positive regulation of cardiac muscle cell 
proliferation 3 0.9 6.00E-02 5.80E-01 
palate development 5 1.5 6.10E-02 5.80E-01 
hair follicle development 4 1.2 6.10E-02 5.80E-01 
actin cytoskeleton reorganization 4 1.2 6.10E-02 5.80E-01 
hemopoiesis 5 1.5 6.30E-02 5.90E-01 
cellular response to calcium ion 4 1.2 6.40E-02 6.00E-01 
middle ear morphogenesis 3 0.9 6.50E-02 5.90E-01 
decidualization 3 0.9 6.50E-02 5.90E-01 
homophilic cell adhesion via plasma membrane 
adhesion molecules 7 2.1 6.50E-02 6.00E-01 
cellular response to insulin stimulus 5 1.5 6.70E-02 6.00E-01 
intrinsic apoptotic signaling pathway in response to 
DNA damage 4 1.2 6.70E-02 6.00E-01 
outflow tract morphogenesis 4 1.2 6.70E-02 6.00E-01 
negative regulation of prostatic bud formation 2 0.6 6.80E-02 6.00E-01 
positive regulation of extracellular exosome 
assembly 2 0.6 6.80E-02 6.00E-01 
response to high density lipoprotein particle 2 0.6 6.80E-02 6.00E-01 
response to human chorionic gonadotropin 2 0.6 6.80E-02 6.00E-01 
cell migration involved in endocardial cushion 
formation 2 0.6 6.80E-02 6.00E-01 
transformation of host cell by virus 2 0.6 6.80E-02 6.00E-01 
heterochromatin assembly 2 0.6 6.80E-02 6.00E-01 
central nervous system development 5 1.5 6.90E-02 6.10E-01 
response to light stimulus 3 0.9 6.90E-02 6.10E-01 
positive regulation of peptidyl-threonine 
phosphorylation 3 0.9 6.90E-02 6.10E-01 
morphogenesis of an epithelium 3 0.9 6.90E-02 6.10E-01 
neuronal stem cell population maintenance 3 0.9 6.90E-02 6.10E-01 
positive regulation of cell growth 5 1.5 7.20E-02 6.20E-01 
response to drug 11 3.3 7.20E-02 6.20E-01 
rhythmic process 6 1.8 7.30E-02 6.20E-01 
negative regulation of osteoblast differentiation 4 1.2 7.30E-02 6.20E-01 
somitogenesis 4 1.2 7.30E-02 6.20E-01 
negative regulation of neurogenesis 3 0.9 7.40E-02 6.20E-01 
release of cytochrome c from mitochondria 3 0.9 7.40E-02 6.20E-01 
ovarian follicle development 4 1.2 7.70E-02 6.30E-01 
inflammatory response 11 3.3 7.80E-02 6.40E-01 
Wnt signaling pathway 8 2.4 7.90E-02 6.40E-01 
integrin-mediated signaling pathway 5 1.5 7.90E-02 6.40E-01 
adrenal gland development 3 0.9 7.90E-02 6.40E-01 
positive regulation of Rho protein signal 




negative regulation of transcription, DNA-templated 16 4.8 8.00E-02 6.40E-01 
response to wounding 4 1.2 8.00E-02 6.40E-01 
response to oxidative stress 6 1.8 8.20E-02 6.50E-01 
brain development 8 2.4 8.30E-02 6.50E-01 
convergent extension involved in organogenesis 2 0.6 8.40E-02 6.50E-01 
axis elongation 2 0.6 8.40E-02 6.50E-01 
diterpenoid metabolic process 2 0.6 8.40E-02 6.50E-01 
cell-substrate junction assembly 2 0.6 8.40E-02 6.50E-01 
cellular response to indole-3-methanol 2 0.6 8.40E-02 6.50E-01 
urinary bladder development 2 0.6 8.40E-02 6.50E-01 
eye morphogenesis 2 0.6 8.40E-02 6.50E-01 
dichotomous subdivision of terminal units involved 
in salivary gland branching 2 0.6 8.40E-02 6.50E-01 
ciliary body morphogenesis 2 0.6 8.40E-02 6.50E-01 
morphogenesis of a polarized epithelium 2 0.6 8.40E-02 6.50E-01 
positive regulation of basement membrane 
assembly involved in embryonic body 
morphogenesis 2 0.6 8.40E-02 6.50E-01 
regulation of oligodendrocyte differentiation 2 0.6 8.40E-02 6.50E-01 
myelination 4 1.2 8.60E-02 6.60E-01 
cell surface receptor signaling pathway 8 2.4 8.80E-02 6.60E-01 
regulation of gene expression 10 3 8.90E-02 6.70E-01 
positive regulation of gene expression 12 3.6 8.90E-02 6.70E-01 
cell proliferation 8 2.4 8.90E-02 6.70E-01 
osteoclast differentiation 3 0.9 9.00E-02 6.70E-01 
negative regulation of mitotic cell cycle 3 0.9 9.00E-02 6.70E-01 
protein localization to plasma membrane 4 1.2 9.30E-02 6.80E-01 
regulation of protein phosphorylation 4 1.2 9.30E-02 6.80E-01 
regulation of blood pressure 4 1.2 9.30E-02 6.80E-01 
cell aging 3 0.9 9.50E-02 6.80E-01 
response to progesterone 3 0.9 9.50E-02 6.80E-01 
pituitary gland development 3 0.9 9.50E-02 6.80E-01 
endochondral ossification 3 0.9 9.50E-02 6.80E-01 
neuron projection guidance 2 0.6 1.00E-01 7.00E-01 
response to aluminum ion 2 0.6 1.00E-01 7.00E-01 
notochord morphogenesis 2 0.6 1.00E-01 7.00E-01 
interleukin-4 secretion 2 0.6 1.00E-01 7.00E-01 
bundle of His cell-Purkinje myocyte adhesion 
involved in cell communication 2 0.6 1.00E-01 7.00E-01 
muscular septum morphogenesis 2 0.6 1.00E-01 7.00E-01 
positive regulation of endothelial cell chemotaxis 2 0.6 1.00E-01 7.00E-01 
positive regulation of transcription of Notch receptor 
target 2 0.6 1.00E-01 7.00E-01 
intracellular cholesterol transport 2 0.6 1.00E-01 7.00E-01 




glial cell development 2 0.6 1.00E-01 7.00E-01 
planar cell polarity pathway involved in axon 
guidance 2 0.6 1.00E-01 7.00E-01 
salivary gland cavitation 2 0.6 1.00E-01 7.00E-01 
positive regulation of protein kinase activity 4 1.2 1.00E-01 7.00E-01 
positive regulation of phosphatidylinositol 3-kinase 










































Table 3.3:  List of Genes with Reduced Expression in Bmpr1a Null Differentiating Progeny Cells 
(padj≤0.05, baseMean≥5) with MITF and LEF1 Motifs Within Their Putative Promoter Region 












































Table 3.4:  Motif Analysis of ATAC Peaks Increased in Differentiating Progeny Proximal to 
Genes Whose Expression is Diminished in Bmpr1a Null Cells (see also Table S14 from Infarinato 
et al., 2020) 
*Values shown to three decimal points, where applicable 
 
Motif Expected Observed Obs/Exp P-value 
NR2F1 39.105 62 1.585 2.824E-06 
MAFG::NFE2L1 108.882 116 1.065 7.989E-06 
USF1 40.514 61 1.506 1.526E-05 
TFEC 27.381 45 1.643 6.182E-05 
USF2 30.671 48 1.565 9.500E-05 
MITF 24.811 41 1.652 1.323E-04 
TFEB 27.342 41 1.500 8.354E-04 
TCF7L2 64.483 75 1.163 9.346E-04 
Tcf7 58.028 69 1.189 1.319E-03 
Rarb 32.239 45 1.396 1.598E-03 
TFE3 31.288 44 1.406 1.625E-03 
Arnt 49.484 61 1.233 1.829E-03 
SOX13 28.956 41 1.416 2.257E-03 
NEUROD1 40.694 52 1.278 3.003E-03 
Sox2 42.263 53 1.254 3.725E-03 
TFAP4 27.031 38 1.406 3.887E-03 
HEY2 13.105 22 1.679 4.444E-03 
Creb3l2 15.987 25 1.564 6.098E-03 
MEIS3 24.178 34 1.406 6.625E-03 
CREB1 24.439 34 1.391 7.674E-03 
Sox6 67.102 72 1.073 7.807E-03 
SOX15 55.966 63 1.126 8.382E-03 
RARA 27.526 37 1.344 8.546E-03 
Bhlha15 10.968 18 1.641 1.124E-02 
ZSCAN4 46.305 54 1.166 1.166E-02 
Rhox11 16.133 24 1.488 1.240E-02 
NRL 26.689 35 1.311 1.493E-02 
Ddit3::Cebpa 12.235 19 1.553 1.611E-02 
MAX::MYC 21.232 29 1.366 1.748E-02 
Nr2f6(var.2) 31.292 39 1.246 1.928E-02 
ZBED1 2.110 5 2.370 1.970E-02 
MEIS1 29.436 37 1.257 2.095E-02 
TEAD1 30.485 38 1.247 2.117E-02 




OLIG3 7.770 13 1.673 2.189E-02 
MYC 20.736 28 1.350 2.212E-02 
RXRB 31.711 39 1.230 2.292E-02 
Esrrg 28.641 36 1.257 2.304E-02 
LEF1 59.559 63 1.058 2.418E-02 
SRF 9.472 15 1.584 2.425E-02 
Hnf4a 27.799 35 1.259 2.479E-02 
Sox3 93.604 87 0.929 2.587E-02 
SOX10 72.044 72 0.999 2.791E-02 
NR2F2 36.604 43 1.175 2.911E-02 
RUNX1 72.331 72 0.995 2.979E-02 
SIX2 31.336 38 1.213 2.987E-02 
SREBF2(var.2) 14.895 21 1.410 3.034E-02 
NKX2-3 21.439 28 1.306 3.156E-02 
MYCN 15.058 21 1.395 3.345E-02 
NR4A1 27.553 34 1.234 3.426E-02 
PRDM1 37.126 43 1.158 3.490E-02 
Gmeb1 3.094 6 1.939 3.587E-02 
SPIC 41.730 47 1.126 3.641E-02 
Twist2 16.235 22 1.355 3.905E-02 
ZNF263 242.212 154 0.636 3.913E-02 
TBX19 10.109 15 1.484 3.954E-02 
Hic1 23.930 30 1.254 4.042E-02 
RORA 29.027 35 1.206 4.091E-02 
ESRRB 29.093 35 1.203 4.197E-02 
BHLHE41 11.996 17 1.417 4.453E-02 
Mlxip 15.582 21 1.348 4.501E-02 
Srebf1(var.2) 17.442 23 1.319 4.536E-02 
Hoxc9 20.290 26 1.281 4.551E-02 
PBX1 16.715 22 1.316 5.033E-02 
NFIC 44.166 48 1.087 5.323E-02 
CLOCK 9.690 14 1.445 5.330E-02 
Rarg 27.729 33 1.190 5.479E-02 
ZNF143 33.031 38 1.150 5.503E-02 
Rarb(var.2) 28.787 34 1.181 5.515E-02 
FOXH1 23.754 29 1.221 5.697E-02 
Npas2 16.968 22 1.297 5.713E-02 
Pax6 13.313 18 1.352 5.771E-02 




SIX1 22.927 28 1.221 6.110E-02 
TEAD3 33.454 38 1.136 6.320E-02 
HEY1 13.482 18 1.335 6.340E-02 
MYB 23.068 28 1.214 6.466E-02 
Hmx1 20.118 25 1.243 6.503E-02 
NKX2-8 25.138 30 1.193 6.590E-02 
NFIA 27.225 32 1.175 6.658E-02 
RARA(var.2) 31.464 36 1.144 6.685E-02 
NFKB1 14.518 19 1.309 6.769E-02 
Nr5a2 52.350 54 1.032 6.798E-02 
MAFK 27.381 32 1.169 7.038E-02 
MEIS2 24.301 29 1.193 7.056E-02 
Pou5f1::Sox2 39.439 43 1.090 7.144E-02 
MAFG 16.531 21 1.270 7.285E-02 
MSC 31.747 36 1.134 7.328E-02 
Nr1h3::Rxra 29.728 34 1.144 7.636E-02 
MLX 13.871 18 1.298 7.791E-02 
BHLHE40 12.110 16 1.321 8.043E-02 
TCF7L1 52.127 53 1.017 8.604E-02 
TEAD2 33.599 37 1.101 9.235E-02 
RXRG 31.440 35 1.113 9.327E-02 
ONECUT3 20.021 24 1.199 9.373E-02 
Gfi1 28.284 32 1.131 9.533E-02 
EBF1 29.495 33 1.119 9.969E-02 
Hoxa9 20.196 24 1.188 1.004E-01 
Alx4 17.258 21 1.217 1.007E-01 
EOMES 21.259 25 1.176 1.027E-01 
Hes2 13.518 17 1.258 1.035E-01 
THAP1 37.658 40 1.062 1.113E-01 
BARX1 14.659 18 1.228 1.136E-01 
DMRT3 14.692 18 1.225 1.152E-01 
MAX 17.693 21 1.187 1.202E-01 
Esrra 27.991 31 1.108 1.211E-01 
Id2 16.784 20 1.192 1.236E-01 
Gfi1b 45.179 46 1.018 1.242E-01 
Pitx1 15.873 19 1.197 1.267E-01 
POU2F2 32.520 35 1.076 1.270E-01 
BHLHE23 7.589 10 1.318 1.278E-01 




OLIG1 6.730 9 1.337 1.282E-01 
Lhx4 14.985 18 1.201 1.308E-01 
RORA(var.2) 20.980 24 1.144 1.335E-01 
MLXIPL 13.130 16 1.219 1.337E-01 
STAT1::STAT2 85.134 75 0.881 1.359E-01 
OLIG2 6.827 9 1.318 1.366E-01 
NEUROG2 11.337 14 1.235 1.386E-01 
Atoh1 7.746 10 1.291 1.406E-01 
RORB 21.221 24 1.131 1.449E-01 
mix-a 27.650 30 1.085 1.500E-01 
Nkx3-1 19.323 22 1.139 1.518E-01 
SPI1 41.325 42 1.016 1.527E-01 
Mafb 25.631 28 1.092 1.556E-01 
Dux 9.750 12 1.231 1.572E-01 
MYF6 24.638 27 1.096 1.587E-01 
SOX8 26.825 29 1.081 1.610E-01 
BHLHE22 6.220 8 1.286 1.613E-01 
MNT 16.498 19 1.152 1.617E-01 
MAFF 30.211 32 1.059 1.659E-01 
BCL6B 29.160 31 1.063 1.682E-01 
MEF2D 29.212 31 1.061 1.704E-01 
ZNF354C 89.960 77 0.856 1.708E-01 
Bcl6 50.464 49 0.971 1.710E-01 
JUN 32.657 34 1.041 1.749E-01 
RUNX3 28.276 30 1.061 1.777E-01 
HES5 11.885 14 1.178 1.779E-01 
JUN::JUNB(var.2) 15.811 18 1.138 1.807E-01 
RARA::RXRA 32.890 34 1.034 1.849E-01 
PBX2 29.555 31 1.049 1.860E-01 
Nr2e3 29.567 31 1.048 1.865E-01 
Mecom 27.409 29 1.058 1.885E-01 
HNF4G 54.907 52 0.947 1.899E-01 
TGIF2 23.151 25 1.080 1.906E-01 
Nkx2-5(var.2) 36.477 37 1.014 1.910E-01 
PRRX1 21.089 23 1.091 1.927E-01 
UNCX 21.089 23 1.091 1.927E-01 
CDX1 27.510 29 1.054 1.935E-01 
TGIF1 23.216 25 1.077 1.941E-01 




Myod1 67.261 61 0.907 1.961E-01 
GSC2 11.163 13 1.165 1.962E-01 
HIC2 29.776 31 1.041 1.964E-01 
Znf423 27.619 29 1.050 1.989E-01 
TWIST1 35.544 36 1.013 2.006E-01 
HSF1 25.481 27 1.060 2.009E-01 
Arntl 18.177 20 1.100 2.037E-01 
Crx 22.335 24 1.075 2.040E-01 
TAL1::TCF3 25.604 27 1.055 2.075E-01 
NFATC2 54.229 51 0.940 2.105E-01 
IRF9 32.404 33 1.018 2.144E-01 
HOXC13 16.330 18 1.102 2.163E-01 
POU6F1 14.351 16 1.115 2.180E-01 
Tcf12 66.629 60 0.901 2.187E-01 
Sox1 16.400 18 1.098 2.213E-01 
SOX9 22.661 24 1.059 2.233E-01 
NEUROD2 5.875 7 1.191 2.234E-01 
Nr2f6 36.247 36 0.993 2.323E-01 
SREBF2 23.983 25 1.042 2.384E-01 
NR1A4::RXRA 14.623 16 1.094 2.393E-01 
NFAT5 36.477 36 0.987 2.431E-01 
GCM1 11.704 13 1.111 2.437E-01 
NKX3-2 17.789 19 1.068 2.479E-01 
JUND(var.2) 29.669 30 1.011 2.482E-01 
BATF3 15.753 17 1.079 2.489E-01 
GSC 10.788 12 1.112 2.491E-01 
ZNF282 26.401 27 1.023 2.524E-01 
PKNOX2 29.867 30 1.004 2.590E-01 
MXI1 20.066 21 1.047 2.614E-01 
Lhx8 19.048 20 1.050 2.638E-01 
HOXC12 9.016 10 1.109 2.652E-01 
Sox17 24.443 25 1.023 2.668E-01 
LBX1 22.278 23 1.032 2.670E-01 
TBR1 20.152 21 1.042 2.674E-01 
PKNOX1 25.597 26 1.016 2.704E-01 
NFIL3 15.025 16 1.065 2.725E-01 
GMEB2 3.544 4 1.129 2.750E-01 
Dlx2 15.113 16 1.059 2.798E-01 




Crem 7.246 8 1.104 2.809E-01 
Spz1 24.692 25 1.012 2.827E-01 
Stat6 40.938 39 0.953 2.845E-01 
TFAP2A(var.3) 30.330 30 0.989 2.852E-01 
EWSR1-FLI1 134.215 99 0.738 2.888E-01 
TFAP2B(var.3) 34.015 33 0.970 2.973E-01 
MEF2B 23.872 24 1.005 3.011E-01 
NFKB2 14.351 15 1.045 3.027E-01 
Rxra 31.835 31 0.974 3.056E-01 
Nobox 16.458 17 1.033 3.065E-01 
PAX4 13.453 14 1.041 3.141E-01 
HSF4 25.288 25 0.989 3.221E-01 
Sox11 29.926 29 0.969 3.293E-01 
LHX6 15.706 16 1.019 3.316E-01 
TBX1 32.328 31 0.959 3.343E-01 
SHOX 20.009 20 1.000 3.366E-01 
Prrx2 20.009 20 1.000 3.366E-01 
LHX9 20.009 20 1.000 3.366E-01 
RAX2 20.009 20 1.000 3.366E-01 
IRF2 33.567 32 0.953 3.382E-01 
FOXA1 43.274 40 0.924 3.383E-01 
VDR 24.458 24 0.981 3.415E-01 
SOX4 29.078 28 0.963 3.481E-01 
EVX2 13.832 14 1.012 3.506E-01 
NFATC1 30.286 29 0.958 3.516E-01 
ELF5 33.821 32 0.946 3.530E-01 
LHX2 19.167 19 0.991 3.554E-01 
SMAD2::SMAD3::SMAD4 55.306 49 0.886 3.562E-01 
Foxq1 30.457 29 0.952 3.623E-01 
TFAP2C(var.3) 29.413 28 0.952 3.696E-01 
PROX1 9.933 10 1.007 3.711E-01 
FOXF2 26.022 25 0.961 3.724E-01 
GCM2 7.965 8 1.004 3.756E-01 
HNF1B 16.220 16 0.986 3.781E-01 
RREB1 108.233 83 0.767 3.799E-01 
RFX3 18.387 18 0.979 3.804E-01 
Myog 69.897 59 0.844 3.815E-01 
FOS::JUN(var.2) 18.432 18 0.977 3.842E-01 




Neurog1 8.035 8 0.996 3.849E-01 
Pparg::Rxra 67.251 57 0.848 3.909E-01 
Alx1 18.513 18 0.972 3.911E-01 
STAT3 60.313 52 0.862 3.954E-01 
MIXL1 21.866 21 0.960 3.964E-01 
NR4A2::RXRA 13.284 13 0.979 4.003E-01 
Sox5 18.632 18 0.966 4.013E-01 
BARHL2 7.166 7 0.977 4.030E-01 
RELB 19.759 19 0.962 4.043E-01 
RXRA::VDR 17.593 17 0.966 4.053E-01 
TFAP2A(var.2) 45.920 41 0.893 4.077E-01 
JUNB(var.2) 11.281 11 0.975 4.088E-01 
T 10.250 10 0.976 4.089E-01 
ISX 18.758 18 0.960 4.121E-01 
Shox2 18.758 18 0.960 4.121E-01 
Stat5a::Stat5b 47.312 42 0.888 4.130E-01 
E2F1 4.278 4 0.935 4.148E-01 
ZBTB18 43.559 39 0.895 4.175E-01 
BACH2 55.356 48 0.867 4.181E-01 
Dmbx1 11.384 11 0.966 4.205E-01 
Nfe2l2 41.152 37 0.899 4.235E-01 
IRF4 20.017 19 0.949 4.258E-01 
MEF2A 32.737 30 0.916 4.318E-01 
NFATC3 30.382 28 0.922 4.329E-01 
LMX1A 23.521 22 0.935 4.377E-01 
LMX1B 23.521 22 0.935 4.377E-01 
HOXC11 8.429 8 0.949 4.379E-01 
VSX1 16.880 16 0.948 4.387E-01 
VSX2 16.880 16 0.948 4.387E-01 
RHOXF1 20.174 19 0.942 4.389E-01 
CREB3L1 12.603 12 0.952 4.395E-01 
JDP2(var.2) 17.981 17 0.945 4.397E-01 
Dlx1 17.999 17 0.944 4.414E-01 
TFAP2C(var.2) 37.749 34 0.901 4.415E-01 
STAT1 42.755 38 0.889 4.421E-01 
TBX20 23.666 22 0.930 4.488E-01 
LBX2 19.226 18 0.936 4.524E-01 
POU4F2 28.363 26 0.917 4.551E-01 




SOX21 22.634 21 0.928 4.567E-01 
HSF2 27.256 25 0.917 4.593E-01 
DBP 8.610 8 0.929 4.622E-01 
PAX7 8.614 8 0.929 4.627E-01 
Lhx3 27.307 25 0.916 4.628E-01 
RAX 19.368 18 0.929 4.646E-01 
SMAD3 10.731 10 0.932 4.662E-01 
NR1H4 19.398 18 0.928 4.671E-01 
PITX3 18.325 17 0.928 4.703E-01 
Foxd3 66.774 55 0.824 4.872E-01 
ONECUT1 8.799 8 0.909 4.873E-01 
Hoxa11 9.908 9 0.908 4.944E-01 
ISL2 17.494 16 0.915 4.950E-01 
CDX2 31.364 28 0.893 4.974E-01 
RORC 19.752 18 0.911 4.974E-01 
HOXD12 8.880 8 0.901 4.978E-01 
CREB3 9.937 9 0.906 4.979E-01 
TFAP2B 40.023 35 0.874 5.004E-01 
CEBPD 5.772 5 0.866 5.014E-01 
REST 45.265 39 0.862 5.071E-01 
RUNX2 26.797 24 0.896 5.096E-01 
TFAP2A 42.768 37 0.865 5.115E-01 
FOSL1::JUN(var.2) 12.217 11 0.900 5.142E-01 
GSX2 30.437 27 0.887 5.153E-01 
HES7 11.273 10 0.887 5.296E-01 
NOTO 17.881 16 0.895 5.299E-01 
FOSB::JUN 17.962 16 0.891 5.371E-01 
E2F8 19.137 17 0.888 5.412E-01 
XBP1 8.146 7 0.859 5.415E-01 
HLF 11.384 10 0.878 5.422E-01 
RFX4 19.163 17 0.887 5.434E-01 
EN1 14.692 13 0.885 5.442E-01 
ATF4 15.837 14 0.884 5.475E-01 
LIN54 27.416 24 0.875 5.533E-01 
Rarg(var.2) 29.811 26 0.872 5.535E-01 
TBX21 21.613 19 0.879 5.569E-01 
TFAP2C 39.777 34 0.855 5.576E-01 
Atf1 5.073 4 0.788 5.603E-01 




MGA 22.832 20 0.876 5.617E-01 
TBX15 22.832 20 0.876 5.617E-01 
ALX3 25.203 22 0.873 5.642E-01 
IRF8 22.870 20 0.875 5.647E-01 
HLTF 12.696 11 0.866 5.660E-01 
Foxa2 39.944 34 0.851 5.669E-01 
Pou2f3 28.830 25 0.867 5.682E-01 
Barhl1 18.328 16 0.873 5.693E-01 
SPIB 84.186 65 0.772 5.693E-01 
HOXA5 14.949 13 0.870 5.694E-01 
POU3F2 31.284 27 0.863 5.705E-01 
NR1H2::RXRA 31.316 27 0.862 5.725E-01 
MEOX2 29.023 25 0.861 5.811E-01 
FOSB::JUNB(var.2) 13.972 12 0.859 5.831E-01 
DUX4 19.658 17 0.865 5.851E-01 
HOXB2 24.362 21 0.862 5.887E-01 
EVX1 12.965 11 0.848 5.941E-01 
ELF3 26.828 23 0.857 5.952E-01 
ZBTB7C 15.258 13 0.852 5.988E-01 
GBX2 18.769 16 0.852 6.068E-01 
GSX1 24.634 21 0.852 6.084E-01 
Rfx1 34.396 29 0.843 6.101E-01 
FOSL2::JUN(var.2) 21.131 18 0.852 6.103E-01 
Hmx3 24.696 21 0.850 6.128E-01 
SREBF1 23.513 20 0.851 6.129E-01 
SNAI2 36.974 31 0.838 6.138E-01 
NFIC::TLX1 39.593 33 0.833 6.176E-01 
IRF7 38.345 32 0.835 6.194E-01 
Hoxd3 27.194 23 0.846 6.200E-01 
Tcf21 26.064 22 0.844 6.249E-01 
RFX2 16.685 14 0.839 6.251E-01 
POU3F4 23.723 20 0.843 6.282E-01 
SP1 153.810 101 0.657 6.326E-01 
TBP 16.784 14 0.834 6.337E-01 
CEBPG 7.753 6 0.774 6.345E-01 
NKX6-2 23.823 20 0.840 6.353E-01 
NHLH1 39.982 33 0.825 6.383E-01 
TP53 21.500 18 0.837 6.385E-01 




SP2 137.597 93 0.676 6.474E-01 
Hoxd8 30.128 25 0.830 6.517E-01 
MSX1 14.692 12 0.817 6.519E-01 
MSX2 14.692 12 0.817 6.519E-01 
BSX 14.692 12 0.817 6.519E-01 
Arid5a 13.551 11 0.812 6.522E-01 
Hoxb5 24.071 20 0.831 6.528E-01 
MNX1 33.967 28 0.824 6.578E-01 
Ar 15.914 13 0.817 6.581E-01 
GBX1 15.914 13 0.817 6.581E-01 
Creb5 16.023 13 0.811 6.675E-01 
FOXB1 34.181 28 0.819 6.698E-01 
TCF4 31.679 26 0.821 6.703E-01 
MTF1 17.240 14 0.812 6.720E-01 
RBPJ 67.193 52 0.774 6.760E-01 
FOSL2::JUND(var.2) 19.647 16 0.814 6.766E-01 
FOSL2::JUNB(var.2) 13.821 11 0.796 6.773E-01 
HMBOX1 11.554 9 0.779 6.807E-01 
Smad4 26.972 22 0.816 6.844E-01 
KLF4 54.477 43 0.789 6.865E-01 
HOXC10 12.782 10 0.782 6.881E-01 
Stat4 53.170 42 0.790 6.902E-01 
Bach1::Mafk 46.340 37 0.798 6.909E-01 
OTX2 14.034 11 0.784 6.964E-01 
HOXA2 17.564 14 0.797 6.978E-01 
NR3C1 14.073 11 0.782 6.999E-01 
HOXB13 32.243 26 0.806 7.022E-01 
Six3 9.479 7 0.738 7.041E-01 
POU5F1B 24.869 20 0.804 7.058E-01 
GATA2 21.274 17 0.799 7.080E-01 
POU3F3 32.368 26 0.803 7.090E-01 
HOXB3 24.942 20 0.802 7.104E-01 
IRF3 48.215 38 0.788 7.136E-01 
DUXA 17.774 14 0.788 7.138E-01 
MEF2C 49.757 39 0.784 7.207E-01 
Arx 15.527 12 0.773 7.232E-01 
ESX1 19.167 15 0.783 7.284E-01 
HOXA13 32.737 26 0.794 7.286E-01 




ONECUT2 12.153 9 0.741 7.369E-01 
POU3F1 31.675 25 0.789 7.394E-01 
IRF1 125.912 85 0.675 7.406E-01 
Ahr::Arnt 55.911 43 0.769 7.420E-01 
NR2C2 54.590 42 0.769 7.457E-01 
TCF3 29.294 23 0.785 7.470E-01 
OTX1 2.695 1 0.371 7.482E-01 
RARA::RXRG 31.923 25 0.783 7.520E-01 
PLAG1 49.185 38 0.773 7.528E-01 
MEOX1 22.051 17 0.771 7.585E-01 
TFAP2B(var.2) 41.228 32 0.776 7.604E-01 
VAX1 22.104 17 0.769 7.617E-01 
VAX2 22.104 17 0.769 7.617E-01 
Msx3 22.134 17 0.768 7.635E-01 
CUX2 4.067 2 0.492 7.666E-01 
ESR1 17.328 13 0.750 7.677E-01 
PPARG 23.445 18 0.768 7.682E-01 
Nr2e1 31.013 24 0.774 7.701E-01 
SRY 23.532 18 0.765 7.732E-01 
Pax2 7.794 5 0.641 7.743E-01 
GATA6 23.597 18 0.763 7.768E-01 
Hmx2 23.628 18 0.762 7.785E-01 
KLF13 27.389 21 0.767 7.791E-01 
NR3C2 13.878 10 0.721 7.799E-01 
HOXD11 10.307 7 0.679 7.835E-01 
FOXK1 31.312 24 0.766 7.844E-01 
IRF5 16.407 12 0.731 7.873E-01 
ZBTB7B 12.847 9 0.701 7.931E-01 
CUX1 4.278 2 0.468 7.951E-01 
GRHL2 29.003 22 0.759 7.961E-01 
EMX2 15.327 11 0.718 7.965E-01 
DLX6 16.550 12 0.725 7.966E-01 
Ascl2 49.062 37 0.754 7.990E-01 
GLI2 17.822 13 0.729 7.996E-01 
PAX9 10.508 7 0.666 8.002E-01 
RELA 27.881 21 0.753 8.033E-01 
FOSL1::JUND(var.2) 11.768 8 0.680 8.034E-01 
GATA3 20.481 15 0.732 8.105E-01 




Dlx4 14.341 10 0.697 8.122E-01 
PAX3 8.205 5 0.609 8.129E-01 
ASCL1 73.555 53 0.721 8.228E-01 
FOXP2 45.653 34 0.745 8.245E-01 
ZNF24 34.936 26 0.744 8.277E-01 
HOXA10 32.340 24 0.742 8.289E-01 
RFX5 18.362 13 0.708 8.306E-01 
Dlx3 18.399 13 0.707 8.326E-01 
Tcfl5 9.715 6 0.618 8.342E-01 
PDX1 18.643 13 0.697 8.453E-01 
REL 24.992 18 0.720 8.457E-01 
MZF1(var.2) 43.760 32 0.731 8.520E-01 
PPARA::RXRA 32.962 24 0.728 8.523E-01 
CEBPE 7.457 4 0.536 8.553E-01 
PAX1 10.025 6 0.599 8.559E-01 
TP73 21.398 15 0.701 8.559E-01 
NKX6-1 23.964 17 0.709 8.564E-01 
FOXD1 22.718 16 0.704 8.579E-01 
FOXO3 22.718 16 0.704 8.579E-01 
KLF9 100.397 68 0.677 8.589E-01 
TEF 8.810 5 0.568 8.600E-01 
SCRT2 21.594 15 0.695 8.645E-01 
EMX1 19.107 13 0.680 8.673E-01 
HESX1 16.564 11 0.664 8.674E-01 
Gata1 28.296 20 0.707 8.733E-01 
EHF 24.416 17 0.696 8.743E-01 
GLIS3 16.726 11 0.658 8.750E-01 
TP63 16.810 11 0.654 8.788E-01 
E2F3 3.710 1 0.270 8.827E-01 
E2F7 13.080 8 0.612 8.843E-01 
ZEB1 43.572 31 0.711 8.853E-01 
POU6F2 24.750 17 0.687 8.864E-01 
JUN(var.2) 55.143 39 0.707 8.880E-01 
POU1F1 32.789 23 0.701 8.897E-01 
CEBPB 7.968 4 0.502 8.902E-01 
JUND 51.009 36 0.706 8.931E-01 
SPDEF 11.967 7 0.585 8.932E-01 
FOXI1 30.302 21 0.693 8.952E-01 
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FOXO6 30.302 21 0.693 8.952E-01 
FOXP3 30.302 21 0.693 8.952E-01 
PROP1 21.116 14 0.663 8.960E-01 
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MYBL2 3.904 1 0.256 8.992E-01 
FOXP1 30.520 21 0.688 9.014E-01 
POU2F1 27.940 19 0.680 9.039E-01 
HIF1A 8.216 4 0.487 9.043E-01 
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MYBL1 4.019 1 0.249 9.079E-01 
CEBPA 24.144 16 0.663 9.092E-01 
GLIS1 11.057 6 0.543 9.119E-01 
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HNF1A 21.651 14 0.647 9.136E-01 
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FOXC1 37.935 26 0.685 9.162E-01 
ARNT::HIF1A 7.142 3 0.420 9.202E-01 
FOSL1::JUNB 48.080 33 0.686 9.210E-01 
Atf3 8.572 4 0.467 9.218E-01 
EN2 12.707 7 0.551 9.243E-01 
POU5F1 31.587 21 0.665 9.276E-01 
GATA1::TAL1 20.856 13 0.623 9.288E-01 
PAX5 13.062 7 0.536 9.362E-01 
KLF16 114.026 72 0.631 9.362E-01 
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NFYA 23.300 14 0.601 9.528E-01 
Zfx 57.913 38 0.656 9.542E-01 
FOXG1 26.138 16 0.612 9.543E-01 
Foxj2 26.138 16 0.612 9.543E-01 




SP8 92.714 59 0.636 9.568E-01 
FOSL2 52.167 34 0.652 9.575E-01 
ZNF410 15.378 8 0.520 9.595E-01 
FOSL1 55.456 36 0.649 9.602E-01 
CENPB 5.063 1 0.198 9.603E-01 
INSM1 42.246 27 0.639 9.619E-01 
E2F2 6.848 2 0.292 9.646E-01 
POU4F1 29.776 18 0.605 9.663E-01 
Hes1 14.391 7 0.486 9.673E-01 
Foxo1 48.868 31 0.634 9.688E-01 
FOS 54.957 35 0.637 9.691E-01 
ID4 30.168 18 0.597 9.707E-01 
FOXK2 31.935 19 0.595 9.740E-01 
Gata4 24.823 14 0.564 9.742E-01 
FOS::JUN 48.369 30 0.620 9.763E-01 
TFCP2 10.575 4 0.378 9.768E-01 
ELF4 25.284 14 0.554 9.786E-01 
E2F6 72.768 45 0.618 9.802E-01 
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ELF1 22.684 12 0.529 9.810E-01 
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SP4 74.715 46 0.616 9.814E-01 
ETV6 31.424 18 0.573 9.815E-01 
GLIS2 18.550 9 0.485 9.829E-01 
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JUN::JUNB 35.993 20 0.556 9.900E-01 
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ELK4 29.598 13 0.439 9.985E-01 
ETV3 16.964 5 0.295 9.990E-01 
EGR3 42.517 20 0.470 9.993E-01 
ETV2 23.148 8 0.346 9.995E-01 
HINFP 12.775 2 0.157 9.997E-01 
ETV1 14.873 3 0.202 9.997E-01 
ZBTB7A 37.832 16 0.423 9.997E-01 
ZIC4 31.384 12 0.382 9.998E-01 
ZIC1 33.446 13 0.389 9.998E-01 
ERG 19.412 5 0.258 9.998E-01 
Gabpa 27.035 9 0.333 9.999E-01 
EGR1 23.727 7 0.295 9.999E-01 
EGR4 36.063 14 0.388 9.999E-01 
ELK1 16.264 3 0.184 9.999E-01 
ZIC3 31.412 11 0.350 9.999E-01 
ELK3 16.733 3 0.179 9.999E-01 
FEV 17.807 3 0.168 1.000E+00 
E2F4 31.344 10 0.319 1.000E+00 
ETV4 15.815 2 0.126 1.000E+00 
ETS1 20.646 4 0.194 1.000E+00 
ETV5 14.030 1 0.071 1.000E+00 
FLI1 20.017 3 0.150 1.000E+00 
CTCFL 86.496 36 0.416 1.000E+00 
NRF1 31.519 7 0.222 1.000E+00 
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